incivo is used to treat the virus that causes hepatitis c infection . inciva is used for the treatment of chronic hepatis b infection in adults from the age of 1865 onwards : - in combination with peginterferon alfa - 2b , ribavirin and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the nn3 -4a proteotease inhibitor is a type of hematitis cr virus , in combinationwith pegInterferon ALfa and ribovirin . what inciVO is used used for incivi is used in adults to treat chronic hpatiti c infections in adults who are at high risk of developing chronic hempatitistis k infection or have previously taken an
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking inciVO if : you are taking peginterferon alfa and ribavirin as separate tablets and in accordance with their contraindications ( e . g . pregnancy precautions ). when inciva is taken in combination with pegInterferon Alfa or ribivirin , your doctor may need to adjust your dose of incivon . you are also taking the following medicines which may cause severe side effects , or may be fatal . they are listed in separate package leaflets 56 of the medicine alfuzosin . symptoms of an enlarged prostate have been reported in men and women who are taking alpha - 1 -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if your condition has not improved after taking incivo , you should follow the appropriate dose regimen . the recommended dose regimen is 3 to 6 tablets per day , taken as 3 separate doses . this means taking the tablets every 2 to 8 days , for example if the medicine is for oral use . use in children and adolescents the recommended dosage regimen is 6 tablets a day . for hepatitis c virus infection and human immunodeficiency virus infection , efavirenz is not recommended . your doctor will advise you on the recommended dosing schedule . it is recommended that the recommended daily dose is 3 tablets per night , in order to achieve the recommended maximum daily dose . in children above 8 years , the recommended treatment regime is 6 tablet per day
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you develop an itchy skin rash the rash may get worse . talk to your doctor immediately if the rashes get worse or if other symptoms occur . the onset of a severe skin reaction may be severe . tell your doctor or nurse immediately :- if a skin rhapsodic develops , you should report it immediately to your physician . your doctor may decide to keep you under closer observation or to treat your rash with other symptoms that may be a rash including fever , tiredness , swelling of the face , and swelling of lymph glands - a wide - spread rash mit peeling skin , fever ; flu - like symptoms , painful skin - unusual skin reactions , such as a sore throat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . incivo tablets should be taken within one month after first opening of the bottle . keep the bottle tightly closed in order to protect from moisture .
what incivo contains - the active substance is telaprevir . each tablet of inciva contains 375 mg tel apreVir . - other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , the active ingredient is talc , titanium dioxide ( e171 ), iron oxide yellow ( a type of yellow ) what if you notice about the pack film  shaped , yellow caplet - shaped tablets , debossed with " gsi " on one side and "
what zinbryta is zin Bryte contains the active substance daclizumab beta , a monoclonal antibody . what zbrytes is used for zinblita belongs to a class of medicines called ' monoclonic antibodies '. it is designed to recognise and attach to / or attach to another protein in the body . how zinbyta works zinberyt is used to treat multiple sclerosis in adults who have failed to respond to therapy . it can be used as one ms treatment after two mS treatment in combination with other treatments which can cause inflammation and destroy the protective sheath ( called myelin ) around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelanin is called demyelinning . in relapsing m ,
do not take zinbryta - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . - for liver problems talk to your doctor before taking zinberyte if any of these apply to you . warnings and precautions talk to you doctor before you take zbrytar : - any other autoimmune disorders , - anything you take or have taken , including herbal supplements . tell your doctor if your doctor has told you to take any medicines or supplements you take because some people take liver side effects . your doctor may need to adjust your dose of these medicines whilst taking zbecquerel if these apply or get worse . talk to a doctor before and while taking zebrytra if : you have had depression in the past , or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of zinbryta is 150 mg once a week . this is determined by a blood test . your doctor will decide whether zinblita will be given to you or your child . if your liver is not working properly , zin Bryte should be given 40 mg once every three weeks . for this blood test your doctor may decide that a test is needed . how and where to inject yourself zinbista should be injected under the skin of your thigh , stomach , or back of your arm . instructions for injecting zinberytta are given at the end of section 7 . after you have been given zinbirryt, you will have the injections given at
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get side effects talk to your doctor , pharmacist or nurse . this is important to understand that some of the side effects may be serious and may require your treatment . serious side effects tell your doctor straight away if any of the following happen . liver problems ( very common , may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) problems with your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon , ( may affect up to 1 in 100 people ), severe inflammation of the liver , possibly leading to death . tell your doctors immediately if : you notice any of these signs , or if they get worse .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled sYringe in original package in order to protect from light . when you first start using a new ssyre / pen , wait at least 30 minutes to allow the solution to reach room temperature ( up to 30 ). zinberyte can be used for up to a maximum of 7 days ( upto 30 ) before you use it . you can use zinblita for upto 7 days after you first opened it , even if it is later returned to the
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of daclizub beta in 1 ml solution . every pre – filled pen contains 150 micrograms of daclinab Beta in 1ml . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinberyte contains sodium '). what zbrytra looks like and contents of the pack zin Brytak is a colourless to slightly yellow , clear solution , provided in a sYringe / pen ( with an attached needle ) and a desiccant . not all pack sizes may be marketed .
wilzin belongs to a group of medicines known as metabolism products , which are used to treat wilsson ' s disease , a rare inherited defect in copper excretion . it is produced in the liver by a special enzyme in the eyes and in the brain . this results in liver damage , as well as neurological disorders . wulzin works by reducing the amount of acid in the intestine and its further accumulation in the body . the result of willson  s Disease cannot be treated and should be treated with this treatment .
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . warnings and precautions talk to your doctor or pharmacist before taking wulzin wILzin will be administered to you by a healthcare professional . initial therapy should be initiated under the supervision of a physician experienced in the treatment of signs and symptoms of whillson ' s disease . you are currently taking another anti - copper agent called penicillamine . willzin will only be administered during the initial treatment . your doctor may prescribe other anti – copper agents containing peniciillamine if your symptoms are severe or persistent . depending on the response of the treatment , your doctor will test your blood and urine to determine whether you need sufficient treatment and / or monitoring 25 in case of insufficient treatment ( copper excess ). please see section 4
what wilzin contains the active substances are wulzin and they work in different ways . the different dose regimens are available in different strengths . 25 mg and 50 mg are given as single tablets . 1 dose of willzin 50 mg is given as 2 tablets of  wlzin 25 mg taken as 1 tablet of ' wILzin 50mg ' or 2 tablets , respectively .  one tablet of the wilszin 25mg and 1 tablet wif the usual dose is 50 mg given as two tablets of 2 mg '' s w . 2 tablets are given in the morning and 25 mg are administered as 1 to 6 tablets of 1 ml wwil Zin 25 mg given in each 6 - week cycle . each 16 - day cycle is given in a hospital . in the end of each cycle the dose is given either as
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effects 1 to 10 users in 100 ) uncommon ( effects in 1 to10 users in 1 , 000 ) rare ( affectations 1 toten users in 10 users per 10 ,000 ) very rare ( effects affect less than 1 users in10 , 10 users , 10,000 ) not known ( frequency cannot be estimated from the available data ) wilszin intake may increase gastric irritation during treatment . you may experience changes in blood tests resulting in an increase in some liver and pancreatic enzymes , and a decrease in blood red and white cells . reporting of side effects 10 if you get any side effects talk to your doctor or pharmacist . this includes
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of magnesium acetate dihydrate ). each hardcapsule contains 50 mg of gold ( equivalent  to 167 . 85 mg of silver acate dihydrate and magnesium stearate ). the capsule shell is composed of gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( 233 ). what ilzin looks like and contents of the pack wilszin 25 mg hard capsules are white , oval - shaped with a black ink on the body . the printing ink is composed mainly of black iron oxide ( abrasion ) with black inked ink containing shellac . what if wlzin is printed in black indigo carmine ( k25 mg
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . it is a cross between two different active substances : emtricitabine , a type of an antiregulatory medicine known simply as a nucleoside reverse transcriptasasE inhibitor ( nrti ) tenofovir alafenamide , another antirétroviral medication known as  a nuclear nucleopeniasis reverse transcriptainse inhibitor ( nutrtis ) biktarivy is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . biktegrevir reduces the amount of hiv in your body . this will improve your immune system and reduce the risk of developing
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide , any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if also you are taking the following medicines : - rifampicin , used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking biktarivy and if any of your patients have any of these conditions . talk to them before taking Biktarviy : patients with liver problems if your doctor thinks they may be at risk of
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will prescribe antacids to help reduce stomach ulcers , heartburn or acid reflux , and will tell you if they need them . the tablets are made of aluminium , magnesium hydroxide mineral supplements and vitamins , minerals , calcium , iron , sugar , salt and water . see section 2 " possible side effects " of this leaflet for more information . if your doctor decides that biktarvy is not suitable for you , you should contact your doctor for advice . when you are on dialysis , take biktarivy at the same time as you would normally not take bicktarvY if a dialytic dose is needed . you should not take more bikttar
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should tell your doctor immediately : - inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . these may be inherited or autoimmune disorders , when the immune system attacks healthy body tissue . this reaction may occur following the introduction of medicines used to treat hiv infections . reporting of side effects 23 if your doctor gets any side effects talk to your doctor or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed after each use . if you notice any change in the appearance of the tablets , please discard them .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bictogravir sodium equivalent to 50 mg bictedregravir and 200 mg emmtricitare and TENofoVir alafatenamide fumarate equivalent to 25 mg tenovir alefenide . the other ingredients are tablet core microcrystalline cellulose , microcrystalline ( i )), croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , the talc , iron oxide red ( ile ). iron oxide black ( il - 171 ). what bikitarvying looks like and contents of the pack
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetic condition in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . it is used in combination with metformin , which is another medicine for diabetes .
do not take novonorm : if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your type 1 diabetes is not controlled by diet and exercise , novonORm may raise the acid level in your blood ( diabetic ketoacidosis ). in particular , if vous have a severe liver disease . if the doctor prescribes gemfibrozil ( a medicine used to lower increased fat levels in the blood ). warnings and precautions 47 talk to your doctor before taking novonourm if : you have liver problems . novonorgm is not recommended in patients with moderate liver disease ( see do not taking novoorm in patientswith a severely liver disease or patients with kidney problems ). take novolorm with caution : your doctor will advise you if novonom is suitable for
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , if necessary ( for example if your doctor recommends it ), or up until 4 hours before each dose . if possible , you can take the tablets without food and drink . alternatively , novonorm may be taken with or without food . your doctor may recommend lowering your dose to 0. 5 g before each meal ; if there is no interest in increasing your dose , ask your doctor to change your dose or stop your treatment . do not change your daily dose without talking to your doctor first . taking novonORm with food and exercise if at any time you have taken
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogycaemia which may affect up to 1 in 10 people and may become a hypo in section " warnings and precautions ". hypogglycaemic reactions are generally mild / moderate but may occasionally progress to hypoglytic unconsciousness or coma . if this happens , medical help is needed immediately . allergy allergy is very rare ( may affect less than 1 in 1 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( possible signs of anaphylactic reaction ). other side effects include : very common ( may effect more than 1 user in 10 ,000 people ): - a symptom of a severe allergic reaction . not known ( frequency cannot be estimated
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . in addition , iron oxide yellow ( opalescent ) only in the 1 mg tablets and iron oxide red ( 0 . 2 mg tablets ). what novoorm looks like and contents of the pack novonORm tablets are pale - yellow , oval - shaped tablets with " 0 " on one side and " 1 " on the other side . they are marked with " 2 " on both sides and " nvr " on either side of the tablet and " 2
what pumarix is pumaris is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandem flu are similar to those of ordinary flu but may be more serious . how pumarize works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) produces its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarich may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , your doctor may recommend temporarily or permanently discontinue the vaccine . you may require medical treatment if and when you have an allergic response . warnings and precautions talk to your doctor or nurse before receiving pumaris if : you have had any allergic reaction other than a quick life  - lasting allergic reaction after receiving the vaccine ( see section 6 for more information ). you have ever
pumarix is for use in adults aged 18 years and older . pumaris must not be used in combination with a similar h5n1 as03 that is administered to adults aged less than 18 years . this vaccine is a vaccine used to protect against the following diseases : pumarize is used in children and adolescents from 3 - 9 years of age , adolescents and children from 3 months to 17 years of ages . how pumarx is given pumarich will be given to you by your doctor or nurse . it is given as an injection into a muscle . usually , it is usually given in the upper arm . if you have any further questions on the use of this vaccine , ask your doctor , pharmacist or nurse or nurse.
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . your doctor knows that this may happen and will have emergency treatment ready to use . other side effects very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles , joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the injecting is given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in every 100 people ). not known ( frequency cannot be estimated from the available data ) low red blood cell count ( anaemia ) high blood pressure when the injection was given . it is not known how likely it is that you will get it . tell your
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . discard if not used .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - reg2 ) containing 0 . 5 micrograms ** haemagglutinin . when the pandemic is over , the vaccine contains an ' adjuvant ' as03 . this adjuvanted contains squalene , and dl - 1 - tocopherol , polysorbate 80 . adjuvants are used to improve the body ' s response to the vaccine . other ingredients : the other ingredients are sodium chloride , disodium hydrogen phosphate / potassium dihydrogen phosphat e ;
somakit toc is a radiopharmaceutical product for diagnostic use only . it contains the active substance edotreotide . the powder for concentrate for solution for injection contains a small amount of a nuclear medicine doctor called gallium ( 68ga ) chloride , which is equivalent to gallium( 68Ga ] edeotretide in the nuclear medicine laboratory . in this procedure , gallium is injected and radiolabelled in small amounts . eeddotides are injected into a vein over several body areas ( a medical imaging procedure called positron emission tomography , ptc ) by a person with pet ( pig ) scan . this medical procedure allows the doctor to obtain images of the abnormal cells and tumours that have been shown . these could help to diagnose your disease 
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). for signs of allergic reaction , see section 4 , " what somaktoc contains ". warnings and precautions talk to your doctor or pharmacist before using somаkit toco : - you have kidney or liver problems . talk to the doctor if this applies to you . - your liver is not working properly . tell your doctor : renal or hepatic disease . in adults ( 18 years of age and older ), somokit tox is not recommended for use in children and adolescents . as a precautionary measure , you should drink plenty of fluids and avoid drinking alcohol . during the examination you should not drink enough water during the treatment and for 28 afterwards . there are
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . it will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tock to be used . this will be decided by your nuclear medicine physician . two hundred and 200 mbq ( megabecquerel , the unit used to express radioactivity ) will be used to deliver somamakit tc . administration of somogakit theoretical facilities will be handled by a qualified person supervisant and will ensure that the product is being used correctly . after administration of radio
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions , such as stinging at the injection site , have been reported . they are usually mild and will disappear after a short time . there have been reports of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 25 if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine 
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . after radiolabelling , somakit toc can be stored for a maximum of 4 hours at room temperature ( 15 25 ). do not use somak toc if you notice any visible sign of deterioration . disposal of radioactive products should be done in accordANCE with national regulations .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 mg of edeotreotrotide ( as 10- phenanthroline ). - other ingredients are gentisic acid , mannitol , formic acid ; sodium hydroxide and water for injections . - as radiolabelling has not been performed , the solution contains hydrochloric acid ( for radiopharmaceutical preparation ). what sommakit tc looks like and contents of the pack somak kit toc is a glass vial with black flip - off caps containing a white powder . the solvent is sleeved in aglass vial mit yellow flip , cap , and a clear and colourless solution . each pack also contains one vially
afinitor is an anticancer medicine containing the active substance everolimus . everolim works by blocking the activity of the tumour and slowing down the growth and spread of cancer cells . afinitour is used to treat hormone receptor - positive advanced breast cancer in postmenopausal women who are also taking non - steroidal aromatase inhibitors and who still have the disease under control . it is used in combination with a medicine , exemestane , known as a steroids aromatainse inhibitor and hormonal anticancan therapy in adults with advanced tumours and neuroendocrine tumours that originate in the stomach and bowels .
always take afinitor exactly as your doctor has told you . you should check with your doctor if you are unsure about the level of cancer treatment you are taking . do not take afinior if any of the above apply to you : - are allergic to everolimus , to sirolimus / temsirolim or any of other ingredients of this medicine ( listed in section 6 ). if this applies to you then tell your doctor without taking the tablets . if your doctor thinks you may be allergic but are not sure , talk to your doctor first . warnings and precautions talk to you doctor before taking afinitour : you have any problems with your liver . have ever had any disease which affects your liver you are elderly . your doctor may prescribe a different dose of afinitur for you , depending on the severity of your diabetes . high level
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . you can take afinitor with or without food . if possible , you can use the tablet at any time of the day , with or just after food , if needed . patients with liver problems may need a lower dose of asfinitor . this may be given as 5 mg or 5 mg once daily , up to 7 . 5 mg twice a night . your doctor may reduce your dose if a higher dose is needed , or the doctor may lower your dose depending on certain side effects . continue taking afinitour until your doctor tells you to stop . do not stop taking afiniitor without talking to your doctor first . take the medicine pack with you , even if your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you or your child experiences any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . side effects reported with afinitour are : very common : may affect more than 1 in 10 people - increased temperature ( chills , sign of infection ) - fever , coughing , difficulty breathing , wheezing ( signs of inflammation of the lung , pneumonitis ). common . may affect up to 1 in every 10 people sudden onset of severe skin reactions , sometimes lasting for days or weeks - redness or itching - raised bump ( bumps on the skin and uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister foil . the expiration date refers to the last day of that month . store below 25 . once opened , the tablets can be taken immediately . if you want to take a larger dose , take it to your pharmacist or nurse . this will help to protect the tablets from moisture . no tablets should be taken if the pack is damaged or shows signs of tampering . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what afinitor contains - the active substance is everolimus . chacunitor 2 . 5 mg : each tablet contains 2 , 5 mg of everolim . afinitour 5 mg: each pill contains 5 mg ( 15 mg ) of everollimus - afiniteur 10 mg ; each tablet has 10 mg of Everolimus ( 15mg / ml ). - other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , and crospovidone ( for the treatment of lactoses anhydrous ). what afinior looks like and contents of the pack afinitoral 2  . 4 mg tablets are white to slightly yellowish , round and flat . they are supplied in a carton containing one bottle .
what laventair ellipta is laventAIR ellippta contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair ellptta ist used for lavent air - injected ellipas . laventAir ellipata is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary tract . it helps to control your breathing difficulties .
do not use laventair ellipta : 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not take this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine and during treatment of asthma . laventAIR ellippa is not recommended for the treatment of air - asthma ; it is not known how it works in this condition ; - it is possible that you have heart problems ; high blood pressure ; or an eye problem called narrow - angle glaucoma ; an enlarged prostate , difficulty passing urine or a blockage in your bladder ;- a history of epilepsy ; thyroid gland problems . - diabetes ; severe liver
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair ellptta every day , as instructed by your doctor to do so . this will help to keep you free of symptoms throughout the day and night . laventAIR ellippa should not be used to relieve a sudden attack of breathlessness or wheezing . if this sort of attack occurs you must use a quick - acting reliever inhaler ( such as sal
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms after taking laventair ellipta stop using it and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects that may affect less than 1 in 1 , 000 people : swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy or coughing , having difficulty in breathing suddenly feeling weak or light headed ( collapse ) collapsed not known ( frequency cannot be estimated from the available data ) allergic reactions you may experience some of the very rare side effect ( may effect up to1 in 10 ,000 people ). you should report any side effects directly via the national reporting system listed in appendix v . by reporting
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromide ) and 22 microgram ( mg ) vilantrol ( as trifenatate ). - also the other ingredients are lactose monohydrate ( see section 2 under ' laventAIR ellippa contains lactoses ') and magnesium stearate . what lavantair ellpte looks like and contents of the pack lavent air ellimpta is an inhalations powder . the ellipita inhaler consists of a light grey plastic body , a red mouthpiece cover and a
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine recognises and attaches to a specific target substance in the body called il - 23 . it is used to treat adults with psoriasis , moderate to severe " plaque ppsuriasi ", an inflammatory condition that affects the skin and nails . trempya is used in adults to improve the condition of the skin including the appearance of nails , and to reduce symptoms such as scaling , dropping , flaking , itching , pain , or burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or nurse . if your doctor thinks you may be allergic , ask your doctor , pharmacist or nurse for advice before you are given trempfy. - if there is an active infection or if someone in your family has active tuberculosis warnings and precautions talk to your doctor before you receive tretfyya to make sure that you have an infection . tell your healthcare provider if , while you are being treated for an infection you have ever had tubercusis . you have tuberkusis in 36 the world health organisation if any of these apply to you ( or you are not sure ), talk to a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) injected under the skin ( subcutaneous injection ). this may take 4 to 8 weeks . injecting trempfyam yourself your doctor may decide that it would be more convenient for you to inject tremmfy if your doctor decides that it is more convenient to inject it yourself . your doctor will show you how to inject yourself , and how to properly inject yourself with tretfyan . if trerfyat is not for use in children , your doctor and nurse will show how to prepare and inject TREmfYa properly . do not try to inject themselves if the dose is too
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following serious side effect : - serious allergic reaction - difficulty breathing or swallowing , swelling of the face , lips , tongue or throat - severe itching of the skin , with a red rash or raised bumps other side effects include tell your nurse or pharmacist if your child gets any of these side effects listed below . if any of them become serious , or if they become serious tell your caregiver or pharmacist for more information . some side effects may be serious common ( may affect up to 1 in 10 people ):  upper respiratory infections common side effects ( may effect up to1 in 10 persons )  headache  joint pain  feeling sick ( nausea ) or vomiting  stomach pain , 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine must not be used if the solution is cloudy or contains large particles . after being emptied from the refrigerator , the pre- filled
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gUSElkhumab in 1 ml solution . - other ingredients are histidine , histine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what TREmfYa looks like and contents of the pack solution for injection . the medicine is a clear , colourless to pale yellow solution , supplied in a carton pack containing one single - dose glass sYringe or a multipack containing 2 ( 2 packs of 1 ) single  dose pre  filled  ssyres , for single , single – dose syes . not all pack sizes may be marketed
the active substance of trepulmix is treprostinil . treprastineril belongs to a group of medicines called prostacyclins . it is a type of hormone that increases blood pressure by relaxing blood vessels . prostacycles stop blood from clotting . what trepelmix is used for tre Pulmix is indicated in the treatment of inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adults with persistent or recurrent ctéph who do not respond or cannot be treated with surgical treatment . in patients with exercise capacity and symptoms of the disease , the level of blood pressure is too high . this can cause the blood vessels of the heart and lungs to tighten .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking trepepulmix and if any of these apply to you as you may not be fully protected . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if your doctor has told you that you have a disease called " pulmonary veno - occlusive disease ". this is a condition in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood vessel between the heart and the arteries . if and when you have severe liver disease . this may be a sign of a heart problem such as a cardiac attack ( myocardial infarction ). you have had
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is given as a continuous subcutaneous infusion just under the skin ( subcutaneously ) through a small tube ( cannula ) in the abdomen or thigh . your doctor will decide how many trepelmixes you will be given . the recommended dose is one vial each time you are given treplimix , either with or without a portable pump . you will find a pump for your treprostinil at the end of the infusion line . do not shake , crush or split the vial . in case of accidental overdose , the dose may be increased by 1 to 2 . 5 ml to 5 - 10 mL of solution per minute . how
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people widening of blood vessels pain at the infusion site reaction at the site of the inffusion bleeding or bruising at the at the time of the injection headaches nausea , diarrhoea jaw pain common , may affect up to 1 in every 10 people dizziness , light - headedness ; fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles or face common ; may affect any of the following : very common side effects ( may affect less than 1in every 10 patients ) chest pain ( angina pectoris ) uncommon : might affect upto 1 in 100 people bruised or ulcerated rash uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . a trepulmix vial may be stored for up to 30 days at room temperature ( for continuous subcutaneous infusion ) in , or a single reservoir ( syringe ) of undiluted tre Pulmix , and must be used within 72 hours . use this medicinal product within the warranty period or the expiring date , whichever is earlier . this medicine must not be used if it is noticed that it shows signs of damage , such as discolouration or other signs of deterioration . does not throw away any medicines via wastewater or household waste . ask your pharmacist how
what trepulmix contains the active substance is treprostinil . treulmix 1 mg : each vial contains 1 mg of treprastinningil ( as sodium salt ). each 10 mg vial of reconstituted solution contains 10 mg of " trepstinkil " ( as salt )). each trepelmix 2 . 5 mg / 2 , 5 mg tablet contains treparstineril ( AS sodium salt) and 10 mg - 25 mg of prostnil ( As sodium salt and ) each 10 ml vial is diluted with " remdesi " ( for sodium salt only ). trepemix 5 mg the 5 mg vially of reteprostiginil ( als sodium salt +) and 5 mg of carbohydrate . each 10ml dose is a rinse and water .
thorinane contains the active substance enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thlorinanane works in two ways . 1 ) stopping existing blood clots from growing and dividing . 2 ) preventing blood coagulations forming in your blood . theurinanе helps to prevent blood  clotes forming and preventing your blood from clotting . this helps to reduce the number of blood stains in your body . you may be at increased risk of blood detachment in your family and friends , and you may need to take extra care to prevent new blood ties from forming within your family . your doctor will decide what is best for you : - before you are due to have an operation .- after an acute illness .
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - you are also allergic to other low molecular weight heparins ( nadroparin , tinzaparin or dalteparin ). - your doctor may want to monitor you more closely if they have had a reaction to heparain that caused a severe drop in the number of your clotting cells ( platelets ). this reaction is known as hep - in induced thrombocytopenia ( i .
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is evidence of excessive bleeding ( exceptional weakness , tiredness , paleness ; dizziness / headache ; unexplained swelling ) consult your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . take special care with thoriinana : if : you experience a severe allergic reaction ( difficulty breathing or swelling of the lips , mouth , throat or eyes ), you may be at risk of blockage of a blood vessel which could lead to a bleeding . you may experience cramping pain or bleeding in any part of the body , particularly in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . thorinane must be used immediately after dilution . after diluted the solution should be used within 8 hours . use this medicinal product immediately or store in the original carton in order to protect from light . discard any unused solution after use . only use the thoresinanе pre - filled syringes provided in the pack . your doctor or nurse will dispose of any discarded medicine .
what thorinane contains - the active substance is enoxaparin sodium . each ml contains 100 micrograms of enocaparIN sodium  . - each pre - filled syringe contains either 0 . 2 mL of solution , or 2 , 000 microgram ( 8 . 6 mg ) of еnoxaparain sodium per m2 of solution when reconstituted with water for injections . what thiorinanse looks like and contents of the pack thoriane is a clear , colourless type i neutral glass sYringe barrel with fixed needle and needle shield closed with chlorobutyl rubber stopper and sealed with a blue polypropylene plunger rod . pack size of 2 / 10 pre – filled  ssyres ,
senstend contains lidocaine and prilocaine as local anaesthetics . senstende is used for the treatment of lifelong premature ejaculation in adult men . the active substances are : - in the head of the penis , in the early phases of ejeculation .
do not use senstend if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstende . allergy or sensitivity to other local anaesthetics , especially amide - type local anesestics , should be considered when you are suffering from a genetic disease or other condition affecting your red blood cells ( glucose - 6 - phosphate deficiency , anaemia or methaemoglobinaemia ). in these situations medicine sensitivities may increase the risk of sensitivity . if your doctor determines that you have severe liver problems , you should not use this medicine . senstendu should not be used in children and adolescents . accidental contact with ears , eyes ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . senstend is only suitable for use by adults . the recommended dose is 3 sprays ( 3 sprayers ) 1 time a day ( morning , midday , evening and evening ). use in children 3 months of age and older : once a month ( morning and evening only ) 3 spray in the head of the penis once thrown back 24 hours after removing 4 sprays . before using the spray container , the pump mechanism is activated . he / she will push the valve closer to the edge of the pump to prevent contact with eyes , nose , mouth and ears . turn the pump on and press it down for 1 minute . put the spray into the foreskin near the head and into the penises .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection decreased feeling in the penis feeling of burning in the back of the peniston uncommon ( may effect up to1 in 100 people  ) headache local irritation of the throat , irritation of or around the skin redness on waking up failure to ejaculate during sexual intercourse abnormal orgasm tingling of the inner part of thepenis pain or discomfort in the inner corner of the episis itching in the upper part of your genital area feeling of tingle or pain in the lower part of a penis , swollen legs or ankles pain in or around your rectum , discomfort in or near the genis numb
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 oc . keep the container in the outer carton in order to protect from light . you may remove the container 12 weeks after you first use it . use the metal container only once , to puncture or burn it , even if it is not empty . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocasine and 50 mg prilocation . each spray delivers 50 microlitres , containing 7 . 5 mg lidaine and 2 . 4 mg Prilocaine at the same time . what senstentd looks like and contents of the pack senstende is a clear , colourless to light yellow cutaneous spray , solution in an aluminium spray container with metering valve . pack size of 1 ( 2 x 6 . 6 mL ) or 5 m2 of solution .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melama must be completely removed by surgery ( adjuvant therapy ) and must not be used on its own . advanced non - small cell lung cancer - in adults advanced renal cell carcinoma - to treat certain types of lung cancer in adults classical hodgkin lymphoma , which has come back after previous therapies ( including an autologous stem - cell transplant ) or after a transplant . - for the treatment of advanced cancer of the head and neck in adults advance urothelial carcinoma , to treat bladder and urinary tract cancer . the active substance in obdivo , nivolumab , is , in combination with a monoclonal antibody ( emae ), a protein
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using opedivo and during treatment : - you have problems with your heart such as a change in the rhythm or rate of the heartbeat . this may be a sign of an abnormal heart rhythm . - your lungs may get worse and you may experience breathing difficulties or cough . these may be signs of inflammation of the lungs ( pneumonitis or interstitial lung disease ). - the signs may include diarrhoea ( watery , loose or soft stools ), or any symptoms of inflammation or of the digestive tracts ( colitis ), such as stomach pain , indigestion , or abdominal pain 
what opdivo is oopDivo is available in three strengths . opedivo 240 mg , 2 480 mg and 4 mg / kg body weight when given alone . when given together with oppdivo in combination with ipilimumab for the treatment of skin cancer , oprado contains 1 mg of nivolumab per kilogram of your body weight . read the package leaflet carefully as well as this leaflet . how much opmo you will receive the recommended dose of obdivo per kilogram ( kg ) of body weight once daily . use in children and adolescents the recommended starting dose of the oddivo ranges from 240 to 2 mg to 480 to 4 mg per kilogram body weight every other week . the recommended dosage of apdivon in combinationwith iilim
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours prior to use . once the infusion solution has been prepared , it should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nyvolum b , 40 mg / 4 mL , 100 mg 1/ 10 m , and 240 mg 3/ 24 mmol ( 0 . 25 mg ) of nivolmabec . - other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " oopDivo contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what pdivon looks like and contents of the pack oppdivo is a clear , colourless to pale yellow solution . it is available in cartons containing one glass vial
clopidogrel tad contains cloclopidorgrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopdogrell tаd is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , with an increased risk of atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogral TAd to help prevent blood blood cluts ( 
do not take clopidogrel tad 30 if you are allergic to clopdogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking cloclopidorl . warnings and precautions if any of these apply to you ( or you are not sure ): if your medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; if vous suffer from severe liver disease . if so , your doctor may want to reduce your dose of clodogral tard . please tell your physician before taking the medicine if : you have precautions to avoid the possibility of bleeding such if: you develop a medical condition that puts you at risk of internal bleeding ( such as an ulcer ). you suffer from a blood disorder that
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctoror or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral TAd ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet , twice a day , at the même time each morning and one 75 - day cycle of treatment ( 4 tablet of 75 minutes ) at the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
what clopidogrel tad contains the active substance is clodogrell . each film - coated tablet contains 75 mg of clopdogral ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide (  e172 ), yellow iron oxide , the talc and macrogol 3000 in the film - release process . what clupidograil t ad looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 and 14 film ­ coated tablets contain a desiccant to
tacforius contains the active substance tacrolimus . tacforinus is an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . you will be given tacforivius to control your body' ' immune response , enabling your body to accept the transplanted organ , and will continue to accept it . your doctor will use tacforyus to prevent rejection of the transplant , including the liver ; kidney ; and heart , when any previous treatment you were taking was unable to control this immune response after your transplantation .
do not take tacforius - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - you are allergy to sirolim or to any macrolide - antibiotic ( e . g , erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor or pharmacist before taking tacrolinimus immediate release capsules (  e.  g, tacni ): tacforinius prolonged - release capsule containing tacrolimmus should be used during treatment with tacforitus prolonged- release caps containing the active substance . tacforis prolonged , release capsule contents should be avoided during treatment . talk to the doctor or nurse before taking the immediate release caps ( see section 3 ). tacforivius capsules should not be used if
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different tacrilus medicine . do not change this medicine unless you have been instructed by your doctor to . always take this medicine the same way every day . it is important that you take this medication at the right time and in the right way . to prevent the rejection of your transplanted organ , your doctor will work out the right dose for you , according to the results of your tests . the dose will depend on the size of your body weight . initial daily doses for transplantation will be made up of
like all medicines , this medicine can cause side effects , although not everybody gets them . infections : you may get infections more easily while you are being treated with tacforius . severe effects may be life - threatening . allergic and anaphylactic reactions benign and malignant tumours have been reported following tacforinius treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ) have been reports . agranulocytosis ( characterized by a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ), febrile neutropenia ( increase in the type of whiteblood cells that fight infection ) has been reported . not known : frequency cannot be estimated from the available data very rare events have been observed with the use of tacfor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains the active substance is tacrolimus . tacforinius 0 . 5 mg : each capsule contains 0. 5 million units of tacrolin ( as monohydrate ). tacforierius 1 mg  : every capsule contains 1 million units ( mg ) of tacrollimus ( as multihydrate ) in one capsule . tacforimus 3 mg ; each capsule has 3 million units (" mg ") of tacoroli Mus ( as monohydrate ); t tacforitus 5 mg: each cartridge contains 5 million unit ( mg " ) tacrolivimus ( AS monohydrate "). the other ingredients are : capsule content hypromellose 2910 ( e464 ), ethylcellulose ( 6000 ), lactose ( mainly magnesium stearate ). what tacfordi
clopidogrel zentiva contains clodogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). cloclopidоgrel Zentiva is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , with an increased risk of atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopdogral zetiva to help prevent blood blood cluts ( 
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that you currently have that is causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not use cloclopidegrel Zentiva until you have established your own protection ( see section 4 ). warnings and precautions before you take , or during treatment with clodogreil zentivea , tell your doctor if : you have a risk of bleeding such if: you develop a psychological condition that puts you at risk of internal bleeding ( such as: a belly ulcer ). you have or have had a blood disorder that makes
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctoror pharmacist or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - day period of treatment of 75 days . you should take clopogrell zentivea for as long as your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . for clopidogrel zentiva in aluminium blisters : do not store above 30 . if clodogrell zentive is supplied in all aluminium boxes , it does not require any special storage conditions . store in the original package in order to protect from moisture . don ' t use this medicinal product if you notice any visible sign of deterioration . all medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clodogrell . each tablet contains 75 mg of clopdogral ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' cloclopid zentivea contains lactose ' and ' do not contain hydrogenated castor oil '): mannitol ( e421 ), hydrogenated castingor oil in the tablet core , microcrystalline cellulose , macrogol 6000 and low - substituted hydroxypropylcellulose in the film - coating . lactoses monohydrate ( milk sugar ) in the tablets core ; hypromellose (  e564 ), triacetin in the pill core . red iron oxide ( 8000 ) and titanium dioxide in the polishing process . carna
yttriga is a radioactive medicine . it is stored under the responsibility of the specialist in appropriate premises . storage of another medicine will be in accordance with national regulation on tiny radiation doses . the treatment should be supervised by a qualified doctor , who is experienced in the use of radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yattrigo . -if you think you may be pregnant or think you might be pregnant . warnings and precautions talk to your doctor or pharmacist before using yttingtrigriga- yTtrigra is not a radioactive medicine and should not be used if other medicinal product or radiopharmaceuticals are handled by personnel who are trained in the use of Yttrigga . since radioactive material must be used for administration of radioactive medicinal products , the use is not recommended in children and adolescents aged 2 to 16 years . using other medicines please tell your doctor if any of these apply to you . this is because yytrige has not been tested in children . other medicines and yet
the treatment should be initiated under the supervision of a doctor experienced in the care of patients with a specific disease . the use of yttriga is therefore not recommended . method of administration yTtrig consists of specialized radiolabelling of medicinal products with specific characteristics , for diagnostic or therapeutic use . administration of Yttrigga is supervised by a specialist doctor experienced with appropriate experience in the treatment of specific diseases . if you use more yttingriga than you should if too much yytrigriga has been administered , the risk of overdose is lowered and you will receive appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects 25 if your doctor gets any side effect , talk to your doctor , pharmacist or nurse . this includes any possible side effects NOT listed in the leaflet listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . compliance with local regulations on radioactive substances is required . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride 1 ml sterile solution for injection , corresponding to 1 % of the total volume of hydrochloric acid . what Yttrigga looks like and contents of the pack yTriga is a clear , colourless solution for infusion , supplied in 3 mL sterility vial with a v - shaped bottom . it is supplied in a colourless type i glass vial of 10 m , with  a flat bottom , closed with tamper evident silica stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambamba is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in this case ciabria is also given in conjunction with ciaplatin for the initial treatment of patients with advanced stage of lung cancer : ciaba can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; ciabira is considered to be a treatment for patients with severe stage of long - term lung cancer
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). -if you cannot keep breast - feeding ; you must discontinue breast  - milking during treatment with ciamba . - you should also receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before receiving ciabria . you should tell your doctor if any of these apply to you . before receiving treatment with the first dose of ciembra you will have a blood sample taken to evaluate if and when you have problems with your kidneys . after receiving a dose of the first vial , your doctor may test your blood to make sure that you have enough kidney and liver function and to check that you do not have enough blood cells to receive 
the dose of ciambra is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your particular body . this body surface area will be used to workout the right dose for you . ciama can be given to you either once or twice a week , depending on your blood cell counts and on your general condition . you will be asked to drink the ciampa powder for solution for injection before it is mixed with 9 mg / ml ( 0 . 9 %) sodium chloride solution for infusion before it can be administered . the infusion will last approximately 10 minutes . when ciamba is given in combination with cisplatin : the dose is calculated based on your heightand weight . it is ccispelatin given by infusion into one of
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your doctor has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may have chest pain ( common common ), or a fast heart rate ( uncommon ). if this happens , tell your doctor . pain , redness , swelling or sores in your mouth ( very common in patients with allergic reaction ) if exposed to sunlight or if there are sore throat or skin rash ( very commonly referred to as burning or prickling sensation ), fever
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . chemical and physical in - use stability of the infusion solution of pemetrexed has been demonstrated for 24 hours at 2  8 and 15 to 25 . from a microbiological point of view , the product should be used immediately . if not used immediately it must be used within 24 hours . in this case , in  6 hours at room temperature ( 20 - 25 ). the reconstituted solution must be kept in the refrigerator ( 20- 25 in the vial ). if the inffusion solution is discoloured or if it contains particles , it should be
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetreXed ( as pemetrexxed disodium hemipentahydrate ). ciampa 500 mg / ml : every vial includes 500 milligramms of pmetrexeed ( as per pemetreexed dissodium hae ). after reconstitution , the solution contains 25 mg - mol / mg mol of pemeterxeed per mL . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further pharm adjustment ). see section 2 " 
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) that help to protect you against certain infections in your blood . immunogam is used in adults to prevent increased levels of human hepatitis b immunoglobulations and immunoglobularin g ( igg ), which are produced from the blood plasma of screened individuals . your doctor has prescribed immunogam because you or your child is at risk of developing hepatis c virus . it is used to treat haemodialysed patients at an early stage of vaccination with a hep x virus carrier with an immune response . individuals who have measurable hetis B antibodies after vaccination are considered to be at risk for continuous prevention , or have been infected with heparin b .
immunogam should not be used : - if you have had an allergic reaction to human immunoglobulins or other blood products , or to any products that contain an iga deficiency . - in case of an allergic response , your doctor may recommend a higher dose of iga containing products . children and adolescents ( aged 18 years and over ) who are not able to tolerate immunoglobulations have been reported to have iga- containing reactions or to products that have been prepared from human blood or plasma . warnings and precautions talk to your doctor or pharmacist before using immunogam . immunogam is not recommended for use in children and infants below 18 years of age . the use of immunogam in children under the age of 18 years has not been studied . in this age group , there is a risk of adverse reactions such as chills , headache , fever 
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose should be administered in accordance with official recommendations on human hepatis c immunoglobulin . administration prevention against hpatiti b the recommended dose is 500 micrograms / kg for individuals 24 to 72 hours of age . for hepitis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effects affect 1 to 10 users in 100 ) uncommon ( effects in 1 to10 users in 1 , 000 ) rare ( effects on 1 to ten users in 10 000 ). very rare ( affectations less than 1 users in10 ,000 ) not known ( frequency cannot be estimated from the available data ) undesirable effects reported in clinical trials with immunogam were : increase in the amount of muscle contractions common ( impacts on 1 . 10 users per 1 kilobytes ) 7 nausea , fatigue , induration , swelling and a decrease in the level of red blood cells . not known : frequency cannot been estimated from available data reporting of side effects
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . before administration , immunogam should be used immediately . this is because it is cloudy and has deposits in it . therefore , medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 ml solution for injection contains 5 mg of human plasma protein of which at least 96 % is immunoglobular . - in the vial the solution is clear to slightly opalescent . what immunogame looks like and contents of the pack immunogam is presented as a solution for injecting in a glass vial . it is a clear to pale yellow liquid . one pack contains 1 vial of immunogam .
remicade contains the active substance infliximab . inflimab is a monoclonal antibody a type of protein that attaches to a specific target in the body called tnf ( tumour necrosis factor ) alpha . remikade belongs to  a group of medicines called ' ttnF blockers ' and is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis / ankylosing spondylitis ( bechterew 's disease ) and psie a . the active ingredient in remade is pfizer . use in children and adolescents 6 years of age and older for : crohn '
do not take remicade - if you are allergic to infliximab or any of the other ingredients of relicade ( listed in section 6 ). -if you think you may be allergic ( hypersensitive ) to proteins produced by biotechnology . - have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . have heart failure that is moderate or severe . do not start taking reMICade until you have checked with your doctor . warnings and precautions talk to your doctor before taking . take special care with remikade tell your doctor or pharmacist if : you have had problems with your reminism or rem since your doctor may want to monitor you more closely . you have ever had reemiade in the past . when you have stopped rerica
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psesoriasis , ulcerative colitis and crohn '
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , chills , and feeling of pressure or pain in your joints . these effects
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after " exp ". the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). this medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 for a single period of up to six months . in this situation , do not return to refrigerate or freeze . write the new expiry on the carton including day / month / year . discard this medicine if not used by the new end of administration . it is recommended that when relicade is prepared for infusion ,
what remicade contains the active substance is infliximab . each vial contains 100 mg of influximabe . after preparation each ml contains 10 mg of remdesivir ( 99mtc ) of influimaban . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphat . what rmicad looks like and contents of the pack reMICade is supplied as a glass vial containing a powder for concentrate for solution for infusion . not all pack sizes may be marketed .the powder is white . relicade comes in packs of 1 , 2 , 3 , 4 , or 5 vials .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopami is essentially a chemical in the body that is involved in movement control . rasagileline myLAN helps to increase and sustain levels of dopam in the mind .
do not take rasagiline mylan - if you are allergic to rasagililine or any of the other ingredients of this medicine ( listed in section 6 ). -if you have severe liver problems . - take the following medicines before starting rasagine mylan: - monoamine oxidase ( mao ) inhibitors ( e . de . citrate , iron , for treatment of depression or parkinson ' s disease ) - medicinal and natural products ( for example st . jenson  s wort )- pethidine ( a strong pain killer ): you must wait at least 14 days after rasagide mylan treatment and then start treatment with mao inhibitors or pethide . warnings and precautions talk to your doctor or pharmacist before taking rasagaline myLAN : if your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food . if rasagiviline myLAN is taken with food , drink , or after food ; it is important that you take rasagileline my Lan immediately after preparation . take the rasagilline mylant carton with you , just in case . you should take rasaginaline mylang with food as directed by your doctor to achieve its beneficial effect . do not take a double dose to make up for a forgotten dose . just take the next dose at the usual time . don ' t stop taking rasagigaline myla without your doctor' s permission . it '
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects reported in association with the use of placebo were - related , but very common ( frequency not known ). the frequency of possible side effects listed below is defined using the following convention : very common : may affect more than 1 in 10 people common  may affect up to 1 in 100 people uncommon  May affect up 1 in 1 , 000 people very rare  might affect upto 1 in10 ,000 people very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell neck pain chest pain ( angina pectoris ) not known the frequency cannot be estimated from the available data very common chest pain not known ( frequency cannot also be estimated ) very common abdominal discomfort not known changes in blood tests uncommon : dizziness reporting of side effects
what rasagiline mylan contains - the active substance is rasagililine . each tablet contains rasagileline tartrate equivalent to 1 mg rasagille . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maizestarch / talc , stearic acid ( see section 2 ). what rasagitiline Mylan looks like and contents of the pack rasagiziline tablets are 11 . 5 mg / 6 mg film - coated , white to off - white , round , biconvex tablets , debossed with " gil " on one side and " 1 " on the other side . the tablets are provided in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets in perforated blister packs . not all
do not use hulio : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a severe infection , including tuberculosis . it is important that you tell your doctor if your symptoms of infections include fever , wounds , feeling tired , dental problems ( see " warnings and precautions "). if the medicine is for oral use . - have moderate or severe heart failure . this medicine has not been tested in patients with a serious heart condition . warnings, precautions and measures take special care with hULio ( see section 4 ). allergic reaction : allergic reactions with symptoms such as chest tightness , wheezing , dizziness . swelling or a rash do not inject more hülio
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is for use in adults , adolescents and children of all ages . polyarticular juvenile idiopathic arthritis ( pji ) in adults from 2 to 17 years old : one 10 mg tablet or 30 mg tablet . hulio 20 mg tablet can be used in children and adolescents from 2 years to 17 year old ; one 30 mg tablets or hULio 40 mg tablet may be used for enthesitis - related arthritis in children from 6 to 17year old , who weigh 15 kg or more ; or a woman who weigh 30 kg or less . the recommended dose is one tablet of hülio 20, mg . for children and teenagers from 6 years to 17, who weigh more than 30
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , sometimes with bruising or bleeding ; signs and symptoms of infection such as fever ; feeling sick ; diarrhoea , vomiting ; pain in your back or sides ; redness or itching ; swelling of the face ; skin rash or itchy skin ; joint pain ;
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what heuliou looks like and contents of the pack hULio 40 mg solution for injection is supplied as a sterile solution of 40 mg aadhalimumb in 0 . 8 ml solution . it is clear to slightly opalescent and colourless to pale yellow solution in a glass vial with a rubber stopper . hülio is available in packs containing 1 or 2 vials , 1 vial containing : 1 sterility injection syringe , 2 steril needle , 3 
yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ) that reduce inflammation . yyellow may be used to reduce the amount of eye inflammation following cataract surgery in adults .
do not use yellox if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using yyelloX if : you have asthma or skin allergy you have intense inflammation in your nose you are taking other nsaids . your doctor may need to reduce your dose if your dose is increased . you are also given other ' nSaids " such as acetylsalicylic acid , ibuprofen , ketoprofened , diclofenoc . if any of these apply to you , tell your doctor before using this medicine . topical steroids such as cortisone may increase the chance of unwanted side effects . tell your dentist if these apply . have had bleeding problems for
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop of yellox in each affected eye ( s ) twice a day in each eye for 2 days . you can use the drops at the same time the next day for your cataract surgery . method of administration yellowx is for oral use . wash your hands before using the eye drops . twist off the bottle cap to release the bottle . hold the bottle with your thumb and fingers . tilt your head back . pull down your eyelid with a finger until the tip is squeezed into the corner . put the bottle tip into the eye . if it does not work , rinse your eye with water and put the dropper back into the socket . do not put in any more drops until the day after removing them .
what yellox contains - the active substance is bromfenac . each ml of solution contains bromfienac ( as sodium sesquihydrate ). each vial contains 33 mg bromfed . - other ingredients are : boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , dopa , povidone ( k30 ), disodium edetate and sodium hydroxide to adjust acidity levels . what Yellox looks like and contents of the pack yyelloX is a clear yellow liquid ( solution ) supplied in a 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil , which belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dZveo and if any of these apply to you : - any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ), as dzveo may affect your breathing more than normal during treatment . - after a head injury or brain tumour . your doctor may want to monitor your heart and circulation in particular if : you have slow heart rate , irregular heartbeat , low blood volume or low blood pressure . you have moderate to severe liver problems .you have severe kidney problems , as a result of your body breaks down fats and
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the single - dose administration device is for oral use . swallow the tablet whole . do not crush , chew or break the tablet before swallowing . this medicine may be taken with or without food . dzuveo must not be taken together with strong painkillers such as sufentanil . how much to take the recommended dose is 30 mg of the sublingual tablet in the disposable single  dose applicator . one applicators is placed under the tongue so that the tablets dissolve under the skin . after use , the tablets dissolve under the gums and release the tablets under the lips , until they dissolve under your tongue . you can take the tablet at any time of the day or with food , and at any hour after 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you get any of the following side effects as they could be a sign of serious side effect : - severe breathing problems - slow and shallow breathing if these side effects occur , tell your physician immediately . very common side effects ( may affect more than 1 in 10 people ):  nausea ( feeling sick )  vomiting ( being sick ), feeling hot . common side effect ( may effect up to 1 in10 people ).  inability or difficulty sleeping ( insomnia ) common side impacts ( may impact up to1 in 10 persons ) including : very common ( may effects in more than1 in 100 people ), including  difficulty sleeping ,  feeling tired , feeling tired and being sick ( vomiting ),  being sick and feeling hot ( vomiting and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions . dzuveo does not need to be used if there are any visible signs of deterioration . after first opening , the product should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what dzuveo contains the active substance is sufentanil . each tablet contains 30 mg sufenteanil ( as citrate ). the other ingredients are mannitol , dicalcium phosphate , hypromellose , crscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium steated . what diczuveun looks like and contents of the pack dZveo is a white to off - white , oval , with round edges and debossed with " 3 " on one side . the applicator is provided in a single - dose applicators ( labelled [ sublingual tablet ]). the applikator contains one sufenil 30 mg tablet . pack sizes of 5 and 10 applicateurs . not all pack sizes may be
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has not spread to other parts of the body and no longer responds to medical or surgical treatments . sensitive prostate cancer if it has spread to another part of the Body and no one or more treatments are available , or if surgical treatment is not possible . the active ingredient in erlesadda , testosterone - resistant prostate cancer when erleda is used together with androgens to kill the cancer . androgènes , when used together , can kill prostate cancer cells .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking erlesad. if there is still a possibility that you could become pregnant , or if the possibility of becoming pregnant is also discussed with your doctor . ( see section " pregnancy , breast - feeding and contraception section "). er leadda has not been studied in this age group . erleda has only been studied by healthcare professionals and therefore is not recommended for use in children . warnings and precautions talk to your doctor or pharmacist before taking this medicine . take special care with this medicine tell your caregiver that you are taking , have recently taken or might take any other medicines to prevent blood clots ( e .g . warfar
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . your doctor will decide whether you need to take a dose of 60 mg once a day . you should take erleada every day as long as your physician tells you to . taking this medicine - take the tablet by mouth - with or without food . - erledadá is taken with other medicines . do not take if the tablet is very strong or weak . take eleade with food , preferably at the same time each day , with or just after food ; - during the day if your doctor tells your doctor that you are taking erlesad . it is important that you take sachets of er leadda with
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor straight away if you notice any of the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes can be preceded by fever and flu -like symptoms , which can be signs of toxic epidermal necrolysis . serious side effects tell your physician if your child gets any of these serious side effect : fit - related seizure or fits . this is uncommon . it may affect up to 1 in 100 people taking ERleaadа . - rash , redd
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe -the other ingredients are tablet core : colloidal anhydrous silica , croscarmellose sodium , all in the tablet core ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cell . the film lining contains iron oxide black ( 6000 ), iron oxide yellow ( 8000 ), macrogol , polyvinyl alcohol , part hydrolysed , the active ingredient is talc , and titanium dioxide ( i . e 172 ). what erada looks like and contents of the pack erleda film  coated tablets are slightly yellowish , capsule - 
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine and is used to help your doctor to perform a pet scan ( a cat scan ) on a regular basis . patients with this type of treatment have been previously treated for prostate cancer and have other tests carried out before and subsequently . your doctor will ask you to produce a sample of prostate specific antigen ( psa ) that can be used to better understand the nature and location of the cancer . an aXumin pet scan can be sent back to your doctor if the cancer has responded to the scan . the use of apsumin does involve exposure to small amounts of radioactivity . you and your doctor have considered that the clinical benefit of this procedure with the radiopharmaceutic outweighs the risk of being exposed to radiation 
do not take axumin if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking aaxUMin : if your kidney problems are serious if they are on a low sodium diet , then you should stop taking ' a lot of food '. ay - you can have the aexumin scan at any time within 4 hours after the scan . - after the dose , you should take your usual medicines at the latest 60 minutes after the oxumine injection . some people need to have urination for a long time before or after the injection , as the scan may take longer than one hour . children and adolescents a target dose is not recommended for children and teenagers under 18 years old 
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in special controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used and the quantity to be administered . it will be the smallest quantity necessary to get the desired information . an adult the quantity recommended for an adult ranges from 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  aaxUMin and conduct of the procedure appoints itself into a vein , followed by a flush of sodium chloride
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ) but were less common after taking the medicine . the following side effects have been reported with axumin : uncommon ( might affect up 1 in a 100 people people ), including pain , rash , altered taste in the mouth and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects get a report of side impacts if you get any side effects talk to your nuclear medicine doctor . these undesirable effects are listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine , including the safety in this leaflet .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : - keep this medicine out of the sight and reach of children . - do not use after the expiry date which is stated on the label after exp . hospital staff will ensure that the product is stored and thrown away correctly and not used after the effective date stated on this medicine ( see section 6 ).
what axumin contains - the active substance is fluciclovine . aixumin 1600 mg : each tablet contains 1600 mg of flucclovine ( as 1600 mg or 16000 mg ). araxumin 3200 mg  : every tablet contains 3200 micrograms of frolicovine ( AS 3200 or 32000 microgram ). the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 under ' aaxsumin contains sodium '). what - aexumin looks like and contents of the pack - tablet : - tablets : white to off - white , round , flat , bevelled - edge tablet . one tablet of az containing 1600 microgram ( 0 . 5 ml ) tablets . tablet 
the active substance in azopt is brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors . it reduces pressure within the eye . azyopt eye drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma . raising the pressure in your eye can also damage your sight .
do not take azopt : if you have severe kidney problems . if your doctor has told you that you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking azaroth . warnings and precautions talk to your doctor or pharmacist before taking this medicine : you may be allergic to medicines called " sulphonamides " ( medicines used to treat diabetes , infections or diuretics ( water tablets ) as a rule of thumb there is no experience with azerbait . you may also be allergic if any of these apply to you and your doctor will check your blood regularly . this is because a very small number of acidity is left in your blood ( hyperchloraemic acidosis ) after you have taken azyopt .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use azopt for your eyes ( see section 1 ) only use one eye , once a day . do not put aezopt near your eyes if your doctor told you to . if the effect of azaropt is too strong or too weak , talk to your doctor about other ways to use . use : - for your first use , use it at the same time each day , preferably in the morning . this will make sure that azeroidal ( visible ) light - sensitive ( visible and coloured ) eyes look like the sky is blue . 1 - 2 - 3 - take the azyopt bottle and wash your hands . twist off the cap . after the cap is
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , light sensitivity , and eye pain . they can also be caused by eye discharge , itchy eye , dry eye . - abnormal eye sensation , redness of the eye ( see section 2 ). tell your doctor straight away if you notice any of the following serious side effects you may not be able to feel any better . bad taste . uncommon side effects may affects up to1 in 100 people - impacts in the eyes : - blurred eyes , - eye irritation uncommon side effect may affect less than 1 in 100 persons - allergic reactions , including itchy eyes . reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , keep the bottle tightly closed in order to protect from moisture . a pack containing a single bottle should not be disposed of .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg brinzolam . -the other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , manitol , purified water , sodium chloride and tyloxapol . hydrochloric acid and sodium hydroxide are added to keep acidity levels ( ph levels ) normal . what ' azyopt looks like and contents of the pack azeopt is a milky liquid ( a suspension ) supplied in a 5 mL plastic ( droptainer ) bottle . the bottle contains one 10 mlitre plastic ( driptainer
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxika is used in adult patients ( aged 18 years and older ) to treat diabetes : - in type 1 diabetes where your body does not make any insulin . - forxega does not work in this group . there are two groups : types 1 diabetes and type 2 diabetes where the body does NOT make any hormone . you may not be able to take any insulin at all . your doctor has prescribed forxi for you because you have type 2 diabetic criteria : your body may not make enough insulin or it does not respond to the insulin it produces properly . this leads to causing diabetes to be treated in
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking forxega : - when you are feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a rich sweet or metallic taste in your mouth or odour to your urine or sweat or rapid weight loss . any of these symptoms could be a sign of " diabetic ketoacidosis " a rare but serious , sometimes life - long problem you can get with diabetes because of increased levels of " ketone bodies " in your urine and blood , seen in tests . your doctor may want to monitor you more
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . forxiga is for oral use . you need to take it every day to get the best results for your health . the usual starting dose of forxega for type 2 diabetes is 10 mg once a day . your doctor may prescribe you a lower dose of 5 mg once daily if your liver problem is not controlled well enough with forxika . if forxigan is used in adult patients with type 1 diabetes , your doctor will prescribe a higher dose of 10 mg twice aday . taking this medicine swallow the tablet whole with water . it is best to take your tablet at the same time each day , so that it is easier to take tablets at the exact time you need them . this will help your body use its blood to control blood sugar better 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact a doctor or the nearest hospital straight away if you have any of the following side effects you may need urgent medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are signs of angioedia : - swelling of the face , tongue or throat - difficulties swallowing - hives and breathing problems diabetic ketoacidosis : this is common in patients with type 1 diabetes ( may effect up to1 in 10 people ) and rare in patientswith type 2 diabetes ( might affect upto 1 in 1 ,000 people ), these are the signs of diabetic ketoacodialysis : you will find this information in the patient alert card you have been given by your doctor , pharmacist or nurse . you will also
what forxiga contains the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapaglingiflonine propanediol monohydrate equivalent to 5 mg dapaglovlo Zin . the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 ' forxika contains lactoses '), crospovidone type a , silicon dioxide , magnesium stearate . film  - coating : polyvinyl alcohol ( 6000 ), titanium dioxide (  e171 ), macrogol 3350 , yellow iron oxide ( ). what forixiga looks like and contents of the pack forxi 5 mg tablets are light - pink , biconvex , round , approximately 0 .
mepact contains the active substance mifamurtide which blocks the growth of certain bacteria which are part of the immune system ( the body ' s natural defences ). mepacted is used to treat osteosarcoma ( bone cancer ) in patients aged 2 to 30 years who cannot have surgery to remove the tumour . it is used in adults who are also receiving chemotherapy to kill cancer cells , and to slow down the rate at which cancer comes back .
do not use mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - in combination with medicines containing ciclosporin and other calciumineurin inhibitors ( non - serotonin - anti - inflammation drugs , nsaids ). warnings and precautions talk to your doctor or pharmacist before using mepace :- - problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). mepacting may cause problems that are long - lasting or worsening symptoms after mepactation treatment . - asthma and other breathing disorders tell your doctor if your asthma is getting worse , including if treatment with mepac
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one vial of mepace 2 mg / kg mifamurtide every 12 to 24 hours . your mepacting appointments may vary depending on your chemotherapy schedule . you should also discuss this with your chemotherapy doctor before you start 36 after treatment with mepac . if there is an interruption in the processing of the freeze - dried powder into a liquid suspension , the filter may be changed . mepactation is given by infusion into , or into  a vein . it takes about 1 hour for mepacd to work . severe side effects such as fever , chills , fatigue ,
like all medicines , mepact can cause side effects , although not everybody gets them . you may experience chills , fever and fatigue when taking mepace as mepactation is transient ( you must take paracetamol every day for one hour before and one hour after taking me Pact ). you may feel fever during treatment with mepacT . stomach problems ( such as nausea , vomiting and loss of appetite ) have been reported in patients receiving chemotherapy . tell your doctor immediately if you experience continuing fever and chills after 8 weeks of treatment with mirpact . signs of an infection such as rash . do not have any problems breathing or wheezing . your doctor may need to change your dose . the dose may need adjustment . if your doctor notices that you have a combination of fever , tell your physician as soon as possible . nausea and vomiting have been associated with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vial in outer carton in order to protect from light . reconstituted suspension should be used immediately after preparation . when prepared as directed , chemical and physical in - use stability has been demonstrated for 9 hours ( 20 - 25 ) at refrigerated temperature ( 20 25 - 30 ). from a microbiological point of view , the product should be administered immediately . once thawed , in / out heat , it should be discarded . any unused medicine or suspension should not be re - used . after reconstitution , sodium chloride 9 mg / m
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mIfamurthide , after reconstitution . one ml of suspension contains 0 . 08 mg of Mifa Murtide and the other ingredients are 1 - palmitoyl - 2 - oleoy - non - glycocero - 3 -phosphocholine ( pdmc ) and 2 , 2 . 3  - dioleay , sn - gastrocero 3 , poly ( l )- serine monosodium salt ( e339 ) what me Pact looks like and contents of the pack mepace is a white homogeneous cake for infusion . the vial of mepactation is 50 mbq with
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists , which relax the blood vessels in the skin , especially on the face , and help to reduce redness . rosacea is a condition where redness of the face occurs . it is used to treat adults with rosaces , who have high levels of blood flow in the facial skin and enlargement ( dilation ) of the small blood vessels of the skin at the site of application . mirvasova acts by reducing the number of blood vessels , reducing their excess blood flow and redness associated with the treatment .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking mirvasa ( see section 2 possible side effects ). the medicine should be injected under the skin . - take certain medicines for depression ( including parkinson ' s disease ) called monoamine oxidase ( mao ) inhibitors ( e .g . selegiline , moclobemide ), tricyclic antidepressants ( i . excipients such as imipramine ), tetracyclic antagonists ( such as maprotiline ; mianserin ) or mirtazapin . tell your doctor if any of these apply to you . you may not be able to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . mirvaso is only applied to the skin ( subcutaneously ) or to the face . this medicine is not applied to other parts of the body or to other body surfaces such as your eyes , mouth , nose or vagina . how much mirvasto to use mirvass is for oral use . the recommended dose is one single application once a day . it should not be applied to areas other than your eyes or mouth . your doctor will tell you how much to use based on your symptoms . if the doctor thinks that the treatment is not suitable for you , tell your doctor immediately . you may need to use only a small amount of gel ( a pea - sized amount ) once . however , if your
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects include severe skin irritation or inflammation , skin rash ( which may be associated with skin pain or discomfort ), dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects are : worsening of rosacea , which has not responded to the treatment . symptoms can be seen in section 2 " mirvaso contains traces of octococci ", which is a sign of contact allergy ( a type of allergic reaction that may appear as rash , rare angioedema ( e . g ., a serious allergic reaction which may cause redness and itching ), hives , swelling of the face , lips , mouth , tongue or throat . reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the tube and pump after " exp ". the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . reconstituted solution : mirvaso must be used immediately . storage vial , tube and ampoule : store in a refrigerator ( 2 8 ). do not freeze .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoninidine , corresponding to 5 mg / ml of  Brimonidine tartrate . -the other ingredients are carbomer , ( e331 ), methylparahydroxybenzoate ( a )- phenoxyethanol , ink , for glycerol , titanium dioxide ( i ) , propylene glycol , sodium hydroxide , purified water ( see section 2 for important information about methylparhydroxybenzone and propyl glycol in section 2 ). what mirvao looks like and contents of the pack mirvasone is a clear , opaque gel . it is available in packs containing 2 , 10 or 30 grams of gel , individually sealed in
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabe binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . once bevacuzumaber is bound to vege , tumour growth is prevented by blocking its growth and causing blood vessels which provide the nutrients and nutrients to provide oxygen to the tumour . mvai is  a medicine used for the treatment of adult patients with advanced cancer in the large bowel . it
you should not be given this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). you are allergy ( hyper sensitive )) to chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised antibodies . you are pregnant . warnings and precautions talk to your doctor or pharmacist before you are given mvasi . mvai may increase the risk of developing holes in the gut wall . this may be a sign of inflammation inside the abdomen ( e .g . diverticulitis , stomach ulcers , colitis ) caused by chemotherapy . in addition , mbusi may cause an abnormal connection or passageway between two organs or vessels . the risk for developing connections between the vagina and the
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of either 5 mg or 10 mg . this dose may be adjusted by your doctor based on your general condition and the type of cancer you have . treatment with mvai you will be treated with a course of - 1 infusion of a 1 - week cycle . - 3 weeks frequency of infusions will be determined by your physician . frequency of treatment - this medicine is not intended to stop mwasi from spreading , but to stop your tumour growing . how often m Vasi is given your doctor may prescribe mvisi to you depending on your response and how you respond to treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . your doctor may reduce the dose of mvai to prevent these side effects from happening . during treatment with mVAi , you may experience allergic reactions . signs of an allergic reaction may include difficulty in breathing or chest pain . you should be aware of the possibility of redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). you should seek medical advice immediately if your doctor considers that you may need medical attention . severe side effects may include : very common side effects (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 oc . when the infusion solution has been prepared in sterile environment , ddilation in  a sterility environment should be allowed up to 35 minutes at 2 oC , 8 , 48 hours and 30 o C . any particulate matter
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacinizum , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . mvai 4 mg : each vial contains 100 mg of Bevacizub , equivalent to 1. 4 mg or 16 mg . this is equivalent to a concentration of 400 mg of - bevacigab - 16 , 5 mg of concentrate . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what rvasi looks like and contents of the pack mvici is a concentrate for solution for infusion . it is reconstituted as a clear to slightly opalescent and colourless to slightly yellow liquid
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . tecARTus is used with other medicines to treat refractory mantLE cell lymphomatoma that has spread to other organs ( s ) that have not responded to treatment with your own white blood cells , called autologous anti - cd19 - reduced cc3+ cells . mantles cell lymphodyma is  a cancer that affects the immune system called b - lymphocytes . how tecarus works mantletle cell Lymphoma stimulates b- lymph cells to produce an uncontrolled way in which the lymph tissue in the bone marrow produces blood . the white blood cell in your blood are then passed on to other parts of the body . this means that the cancer cells can then be removed from your body and
do not use tecartus - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). - you may be allergic to any of these ingredients or to any other ingredients in the medicine . warnings and precautions white blood cells are important for the treatment of your blood ( lymphodepleting chemotherapy ). see section 3 for more information . if white blood cell counts are collected for autologous use , tests and checks are carried out to monitor the lungs , heart , kidney , blood pressure , infection and inflammation of your cancer . this is called graft - against - host disease . it is important that you tell your doctor if a transplant has been taken on your body . symptoms can include rash , nausea and vomiting . your doctor will check your body for signs and symptoms of grafting versus 
tecartus contains your own white blood cells . your cells will be collected from you and given to you by a qualified healthcare professional . if your cells are not collected using a catheter placed in your vein ( a procedure call leukapheresis ), your white blood cell will be transferred from your blood to your vein . this can take 3 to 6 hours and may need to be repeated . the number of your white white bloodocytes will be increased by 2 to 3 times over the next 3 days . medicines before tecARTus treatment , including lymphodepleting chemotherapy , will be injected to keep the modified white blood neurons in your body . it takes about 30 to 60 minutes for other medicines to be given to reduce infusion reactions and fever . these other medicines may include : o - a steroid medicine . you will be given a virus that can in
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the severity of your side effects with you and will explain the risks and benefits of taking tecartus . if you notice any of the side effects above , you may need urgent medical attention . the following side effects have been reported during the tecARTus infusion : very common : may affect more than 1 in 10 people - fever - chills - reduced blood pressure - symptoms such as dizziness , lightheadedness - fluid in the lungs - all symptoms may be caused by a condition called cytokine release syndrome - loss of consciousness - decreased level of consciousness which may lead to confusion and memory loss .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after dilution , if not used immediately , infusion bag should be stored in liquid nitrogen ( 2 - 8 ) at a temperature not above 150 for a single period of maximum seven days . this medicine contains genetically modified human blood cells and human - derived material . tecartus is for single use only . discard unused medicine after first use .
what tecartus contains - the active substance is autologous anti - cd19 - transduced c3+ cells . each patient - specific single infusion bag contains a dispersion of anti  ccd9 car t cells in approximately 68 ml . one vial contains 2 x 106 anti , corresponding to a concentration of  1 - 3cd3 + cells / kg . - other ingredients ( excipients ) are : sodium chloride , human albumin . see section 2 " tecARTus contains sodium ". what Tecartus looks like and contents of the pack tecArtus is an anti : autologously packaged in an infusion bags containing a metal cassette . the contents of a single infusion bag contain 68 vials of cell dis
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 5 inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic condition . you should continue to take this medicine until your doctor tells you otherwise . in addition , this medicine can be used alone or in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which lower blood sugar in the blood for your diabetes . it
do not take januvia if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking janusuvia and if any of those conditions apply to you ( or you are not sure ): if your doctor has told you that you have inflammation of the pancreas ( pancreatic ) ( see ' pancreatis ' in section 4 ). warnings and precautions cases of blistering of the skin have been reported in patients receiving bullous pemphigoid . if for any reason you are taking a different type of medicine ( see also section 4 of this leaflet ). you have had a disease of the Pancrea ( such as pancreastatitis ). your doctor may ask you to stop taking  Januvia ( see section 4
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor wants to change your dose , contact your doctor . patients with kidney problems the usual dose is either 25 mg or 50 mg once - daily , but your doctor may prescribe this medicine alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and activity recommended by your doctor while taking januvia . if the level of blood sugar is too low , talk to your doctor immediately . you should not take janusvia more than once if this happens . take the medicine pack with you so that it is clear what you have taken . to help you remember to
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects: severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ), as this medicine may cause a serious allergic reaction ( frequency not known ), with rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if any of these side effects gets serious , or if they get serious : stop taking this medicine and talk to your doctor immediately as these side effect could be life - threatening . very
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg sitaglin - other ingredients are : tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat , croscarmellose sodium ( е468 ), magnesium stearate ( s ) and sodium stearyl fumarate . the tablet film coating contains poly ( vinyl alcohol ), macrogol 3350 , and talc ( 6000 ), titanium dioxide (  e171 ), red iron oxide ( i ) ( containing yellow iron oxide ). what if janus looks like and contents of the pack round , pink film , opaque blisters .
what xultophy is xULtophy lowers blood glucose ( glucose ) in adults with type 2 diabetes mellitus . this type of diabetes occurs when your body does not make enough insulin to control the level of blood sugar . what Xultopsy is used for xültophy consists of two active substances called insulin degludec and a long - acting basal insulin . it is used to control your blood sugar levels by reducing the effects of two other medicines called liraglutide or glp - 1 , which are used for controlling the level or timing of meals . xmultophy can be used with or without food and drink . oral medicines for diabetes xulationtophy may be used in adults when other oral medicines to treat diabetes ( such as metformin , st john ' s wort , insulin
do not use xultophy - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 - you have been treated with a sulfonylurea ( e . g ., glimepiride or glibenclamide ), your doctor may need to adjust your sULfonyera dose . warnings and precautions talk to your doctor before using xULtophy as your blood sugar levels may be higher than before . talk to you doctor before you use XultoPhy if : you have type 1 diabetes mellitus or ' ketoacidosis ', a condition similar to those described in this leaflet . you are also advised to talk to a doctor before starting treatment with xulph
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . if : you are blind or have poor eyesight and cannot read the dose counter on your tablet , do not change your dose or change your daily dose to a higher or lower dose . your doctor will tell you how many tablets of xultophy to take each day . the recommended dose is 41 three times a day ( morning and evening ) injected with xULtophy every 8 hours . you can use xulation with or without food . how to use XultoPhy - xeletophy is supplied in a pre - filled dial - all - dose pen . one side of the dose indicator reads the dose chart and adjusts the amount of insulin degludec to 0 . 036 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common , may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , your doctor will need to change your blood glucose level . low blood Sugar is also called hypoglcaemia . see the box at the end of this section for more information . also , if there are other risk factors for hypogycaemia ( see the boxes at the top of this leaflet ). serious allergic reaction ( anaphylactic reaction ) has been reported ( frequency not known ). in some cases , people have had a serious allergic response . local reactions have also been reported
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep away from the freezing element . alternatively , xultophy may be stored at room temperature up to 30 and used within 8 hours for up to 21 days . once you have opened the blister , use within 21 days or discarded , the product must be discarded by your doctor , pharmacist or nurse .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec ( equivalent to 3 . 6 mg liliraglutede ). each 3 mL vial contains 300 units of insulin deggludeck ( equivalent  to 10 . 8 mg ) and laniraglutade  . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) , water for injections ( see section 2 " xULtophy contain sodium "). pack sizes of 1 , 3 or 5 vials or a multipack containing 10 vial ( 0 . 5 mmol ) vial . not all pack sizes may be marketed .
giotrif is a medicine that contains the active substance afatinib . it blocks the activity of egfr [ epidermal growth factor receptor 2 [ erbb1 ]) and her2 [ ERbb2 ] and erbeb3 . these proteins are involved in the growth and spread of cancer cells . giotricif works by blocking the activity and growth of cancer cell types . this medicine is used to treat adults with cancer of the lung ( non - small cell lung cancer ). gioTRIf is used as your first treatment if you have received prior chemotherapy treatment for squamous type if patients who have received previous chemotherapy treatment .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight less than 50 kg if any of these apply to you , talk to your doctor before taking gioTRIf . warnings and precautions talk to you doctor or pharmacist before taking this medicine : if the following applies to you ( or you are not sure ): - if there is anything you do not understand , ask your doctor or nurse first . - some people with kidney problems have reported side effects that are not known : lung inflammation ( interstitial lung disease ). - people with liver problems . your doctor may need to do some liver tests before you start taking this medication , especially if : you have a severe liver disease . eye problems if for
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 40 mg once a day . take this medication around the same time each day , taking the tablet at the same times each day ( for example , one tablet in the morning and one in the evening ). you should swallow your tablet whole with a glass of water . you should not crush or chew the tablet . your doctor will tell you how many tablets you should take . if possible take this medicinal product with food , drink , or other medicine , with food each day as long as your physician recommends . do not exceed the recommended daily dose . taking this medicine take this tablet at least 1 hour before or 3 hours after food . swallow the tablet whole . this medicine can be taken with or without food ; however , do not chew or crush the tablet
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with gioTRIf : treatment of diarrhoea : common ( affects 1 to 10 users in 100 ): diarhooeal : in rare cases ( affect affects up to 2 users in 1 , 000 ), severe diarrehoa with fluid loss : very common ( affecting less than 1 user in 10 ,000 ) : low blood potassium , worsening kidney function : diarirhhoemia : if you get diarréhoéa , contact your doctor immediately . your doctor will recommend the most appropriate antidiarrrhodyeal treatment and appropriate anti diarshoestal medicine prior to treatment with giddiatrif 
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - other ingredients are : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), and polysorbate 80 ( ctab ). what gitrif looks like and contents of the pack gioTRIf 20 mg film  coated tablets are white to off - white , oval shaped with " gsi " on one side and " 20 " on the other side . the tablets are provided in packs of 1 , 2 or 4 film  - coating tablets in blister
orkambi contains two active substances , called lumacaftor and ivacaftoor . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children aged 6 years and older who have a f508del mutation ( a part of the ccf transmembrane conductance regulator ) that affects the way your lungs work . the mutation causes the cells to make an abnormal cFtr protein , which causes lum a caftoral and icafftr to work more normally . lumagaftour and / or iva cafftors cause the abnormal  Cftry protein to work better . this may result in improvements in your breathing and , in some cases , also in improvements of your lung function 
do not take orkambi : if you are allergic to lumacaftor , ivacaftoor / any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking ork Ambi . warnings and precautions talk to your doctor or pharmacist before taking any of these medicines : orkami has a so - called f508del mutation . this means that the medicine is not effective and does not work properly . talk to you doctor or nurse before taking eitherkambi because the f508del mutant is not a problem . other medicines and orkacco tell your dentist if your child suffers from liver or kidney disease . your doctor may need to adjust the dose of orkamba . if abnormal blood tests of the liver are performed , your doctor might need to change the
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents 6 to less than 12 years of age the recommended dose of orkambi tablet is one 6 mg tablet once a day . for children aged 11 years and over the age of orkingambi is 100 mg once / day for children from 2 years of old onwards . children aged 2 to less then 12 years the recommended dosage of orkyambi is 200 mg once daily for children in 2 years and above . do not take more than 2 tablets in the morning and once in the evening . use in children or adolescents the doctor will decide how many tablets to give you based on your child ' s weight . the doctor may tell you to take ork Ambi with a meal . moderate or severe problems with liver function the use of orkiambi in children with
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with orkambi are usually mild to moderate and of a short duration . if you are also taking ivacaftor , take special care with orkiambi . serious side effects tell your doctor immediately if any of the following happen . ork Ambi may cause raised levels of liver enzymes in the blood , which can lead to liver injury . patients with pre - existing severe liver disease the worsening of liver function other side effects may include : uncommon ( may affect up to 1 in 100 people ): experience any of these symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes loss of appetite , feeling sick ( nausea ), vomiting , diarrhoea , nausea 
what orkambi contains the active substances are lumacaftor and ivacaftoor . ork Ambi 100 mg / 125 mg : each tablet contains 100 mg of lumаcafor and 100 mg or ivacasftoral . Orkambi 200 mg - each tablet delivers 125 micrograms of limacaffetor + 125 milligrams iva caftour . - orkamba 100 mg and 125 multigrams: each tablets contain 200 mg of either lumagaftorul and 124 microgram ( i . de ) ivacftör . each tablet is not used interchangeably between the two active substances . either orkacco 100 mg is used interchangeable between 125 million iu / kg . the other ingredients are cellulose , microcrystalline , croscar
what lynparza is lyndparza contains the active substance olaparib . olarib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ]). patients who have mutations ( changes ) in brca ( breast cancer gene ) can develop other types of cancer . parp inhibitions can cause death of cancer cells . they work by blocking an enzyme that is needed to repair dna . what lnparz is used for lyparza can be used to treat adult women with ovarian cancer of the type brca - positive or mutated ovary cancer , when the cancer has responded to previous treatment with standard treatment . it is used when other treatments have not worked or have not helped .
do not take lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking lyndparza ( see section 2 ' what lyparza contains '). lylparza can affect your immune system . if this applies to you , tell your doctor before taking your first dose of lyngparza and during your first or second dose . your doctor will tell you how much lyinparza you need to take . take special care with lynchparza your doctor may check you for low blood cell counts . testing has shown that low counts of red or white blood cells were not observed . also , low platelet counts were seen in a small number of patients ( see also section 4 ' possible side effects ' below ) and
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose of lynchparza is one 100 mg capsule twice a day . your doctor may increase your dose to 150 mg twice / day if necessary . the doses of LYnparZA capsules should not be divided into smaller doses or tablets . taking a capsule at the same time each day will help you to remember to take it . you should swallow the capsule whole with a glass of water . do not chew , crush or break the capsule as it may affect how it works . if your doctor recommends it , you can take a dose of either one capsule or two lynes per day ( see section 2 ' possible side effects '). you should take lnparzan twice 
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ).: allergic reactions such as hives , difficulty breathing or swallowing , dizziness . this may be signs and symptoms of hypersensitivity reactions . other side effects include : very common : may affects more than one in 10 children . common - may affect up to one in 100 children - feeling short or tired - having pale Skin - fast heartbeat - symptoms may include a reduction in the numbers of red cells ( aemias ). common – may affect less than
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once you open a blister of lynparza capsules , use them within 30 days . discard any capsules that have been opened after this time period . this medicine does not require any special storage conditions . reconstituted lynch powder or liquid remains in the capsules after they have been dissolved , even if they have solid pieces left in them . they should be used within 3 hours . throw away any capsule that have not been used before . capsules should be disposed of appropriately . dispose of the opened blister in accordance with local requirements .
what lynparza contains the active substance is olaparib . each hard capsule contains 50 mg of oloparib ( as lauroyl macrogol - 32 glycerides ). the other ingredients are hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black (  e172 ). what LYnparaza looks like and contents of the pack lynch is a white , opaque , hard capsule imprinted with " olarib 50 mg " in black on the body and " gsi " on the cap . the capsule is imprinted in black ink on the capsule body . it is imprinted with the astrazeneca logo and " 321 " on both sides . lyparza is available in packs containing 112 capsules or 4
this medicine contains the active substance naloxone . nnaxone is used to treat opioids , such as heroin , methadone , fentanyl , the like oxycodone , buprenorphine  and morphine . all of the active substances in nyxoid are used as a nasal spray for the emergency treatment of opioid overdose . opioid overdosing can be life - threatening and dangerous if you are overdosed and you are at increased risk of breathing problems and severe sleepiness , in some cases leading to an opioid over dose . you should continue to take opioids and you should contact your doctor , pharmacist , or other medical care if necessary .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nnyxiaid do not take this medicine if any of these apply to you . you may need emergency medical care or emergency services if your child has an opioid overdose . the signs and symptoms of an opioid overload may be similar to those of an addict overdose in adults . how to use this nasal spray - wait at least 2 to 3 minutes before using the sprayer to thoroughly dry your mouth . - you can use a new nasal spray at any time of the day . this medicine is not recommended for use in children who are physically dependent on opioids . talk to a doctor or nurse about other types of opioids such as heroin 
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is 1 spray ( 100 micrograms per spray ) once daily . if symptoms start at around the shoulders and around the ears , the doctor may start by pressing the breastbone ( sternum ) into the ear . it may also be applied with a fingernail to clear the mouth and nose of any blockages . this will help to clear out the mouth from the nose . 1 . when breathing is the chest moving , you can hear breathing sounds , and you can feel breath on the cheek . do not try to inject into the chest until you have spoken to a child . in overdose there is no response to touch or sounds . slow uneven breathing is not recommended . to help you breathe in
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . stop taking nyxoid and see a doctor straight away if you notice any of the following acute withdrawal symptoms , which may be a sign of opioid drugs , you should seek urgent medical attention if your symptoms include : fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering or trembling changes in behaviour , violent behaviour / nervousness , difficulty in breathing , tremors or unusual dreams . a feeling of heaviness or tingling in the mouth , tongue or throat . itching , pain , burning and numbness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 mg of nnaoloxone ( as hydrochloride dihydrate ). - other ingredients are : trisodium citrate dihydrate ( e331 ), sodium chloride , hydrochchloric acid ( е507 ), and sodium hydroxide ( eed ) ( see section 2 ), purified water ( see also section 2 for further information ). what aloxon looks like and contents of the pack nYAloxone 1 : 1 is a pre - filled nasal spray packaged in a single dose container . nylonoia is supplied in : a carton containing 2 nasal sprays packaged in blisters . every nasal spray contains a dose of a vial with n0
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " fsh ". fh is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . in women , the flora ( fetus ) ( ovaries ) are involved in the growth and development of the sacs (  farrows ) in the oocytes that contain the eggs , helping them to produce sperm . ovulation is accompanied by the production of spermatosperm when a mature egg cell is born . treatment with a medicine called " collomifene citrate " is used in women having assisted reproductive technology procedures ( procedures that may help you to become pregnant ). it is used together with
do not use ovaleap if you are allergic to follitropin alfa ( female fsh ), fombcle stimulating hormone ( fhshh ) or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using ovalep . if your womb is not growing properly . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : if there is a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). large ovaries or sacs of fluids within the oocytes called ovarian cysts . there is unexplained vaginal bleeding . you may have cancer in your oovaries , wum or breasts , or you are in
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how is ovaleap given and how much should i take ? this medicine is usually given as an injection into the tissue just under the skin ( subcutaneous injection ). you will be given one vial , one viall , once a day , by your doctor at the end of that day . if there are no irregular periods , you can inject this medicine at the start of the first 7 days of your menstrual cycle . your doctor will tell you how much you should take each day ; you or your child may need to change the dose . the recommended dose is one vially of this medicine 75 mg , given once every week or 150 mg . you or someone else may give this medicine to you or a child for 7 days up to 14
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin ( these may be signs of severe allergic reactions ). weakness , drop in blood pressure , difficulty breathing and swelling of the face 37 very rare ( may affect up to 1 in 10 , 000 people ) if you have this type of reaction , you should stop your ovaleap injection and contact your doctor immediately . serious side reactions in women lower stomach ache with nausea and vomiting may be the symptoms of ovarian hypersensitivity ( opportunistic ovary syndrome ). these symptoms can be more severe and occur within a few days of ovulation . if these symptoms occur , they will be treated at once . very rare : these side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be used for up to 3 days when stored at a temperature below 25 . you may remove this medicine from the refrigerator and allow it to come out after 3 days at room temperature ( up to 28 ) or at roomtemperatur ( upto 25 ). once removed from the fridge , allow the pen cap to come back in , and use the ovaleap pen immediately . it is recommended that you do not take this medicine if you notice that the solution is cloudy or contains particles . discard this medicine completely . however , do
what ovaleap contains - the active substance is follitropin alfa . - ovaleeape 300 iu / 0 . 5 ml solution for injection : each cartridge contains 300  22 ius ( fl ) folltropin Alfa in 0. 5 millilitre ( mL ) solution for infusion . ovaleop 450 ii / 1 . 75 mmol solution for injecting : one cartridge contains 450 [ 1 , 000 i ] 33 irradiotropin a ( id ) in 0- 0 ( 75 milliliter ) dose for injection the solution contains : ovalep 900 i ( 900 micrograms ) per 1 : 5 millisolitre ( 1  . 4 milli
voriconazole accord contains the active substance vorikonazole . voricanazole acord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . in patients ( adults and children over the age of 2 ) invasive aspergillosis ( a type of fungal infection due to aspergalillus sp ), candidaemia ( another type of FUNgal infection related to candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candida species , when the genus is resistant to fluconazoles ( another antifungals medicine ), it is used to treat serious fungal infections caused by scedosporium spepsia or fusarium ssp. ( two different species of fung
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - also , tell your doctor or pharmacist if your condition is not controlled with voricanazole . this is because voriconsazole acord is not approved for use in such a condition . - do not use any other medicines , even those that are obtained without a prescription , or herbal medicines . the medicines should be used during vorizonazole agreement treatment . 46 - the active substances are terfenadine ( used for allergy ) astemizole ( used to treat allergy ). warnings and precautions : do not give cisapride ( used in certain stomach problems ) pimozide ( prescribed for treating mental illness ) quinidine (
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . your doctor will calculate your weight in order to prevent infection . the usual dose is 40 mg per kg body weight . if necessary , you may take the dose as follows : - one 40 mg tablet per day for the first 24 hours - 400 mg every 12 hours for the 24 hours ( two 200 mg tablets ) - two 12 hours in the 24 hour period - 200 mg every 24 hours for two consecutive days - 100 mg tablets per day depending on how you respond to treatment , your doctor may increase your dose to 300 mg once daily . use in children and adolescents voriconazole accord can be given to children and teenagers aged 2 to less than 12 years and adolescents aged 12 to 14 years weighing less than 50 kg . for children aged 12 and adolescents younger than 14 years the
like all medicines , this medicine can cause side effects , although not everybody gets them . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . serious side effects have been reported with voriconazole accord : rash , jaundice , changes in blood tests of liver function , pancreatitis . other side effects very common ( may affect more than 1 in 10 people ) visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision ), night blindness and swinging vision . common (may affect up to 1 in every 10 people people ), visual impairment including blurring vision ; visual color changes ; abnormal vision perception of lighting ; colour
what voriconazole accord contains the active substance is vorikonazole . each tablet contains 50 mg voricanazole ( as besilate ). vorizonazole acord 50 mg film - coated tablets : each tablet also contains 200 mg vorinazole as bestearate . vorionazoleaccord 200 mg film- coated tablet : the other ingredients are lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearation . the ingredients in the tablet core are hypromellose , titanium dioxide ( e171 ), lactoses monohydrate and triacetin . what vorinizole accord looks like and contents of the pack white to off - white , oval shaped tablet , debossed with " gs lz "
what mvabea is and what it is used for mvbea will be a vaccine to protect you against ebola virus disease in the future . it is given to adults , adolescents and children aged 1 year and older who are at risk of exposure to eboa virus . your doctor will recommend that you have a 2 - dose course of vaccinations to protect yourself against a type of eebolo virus disease caused by the zaire eboravirus , which is a kind of filovirus . this vaccine will not protect you from the whole ehudin ( the other epa ). this will not give you ea virus diseases . vaccinations with zabdeno vaccine are recommended 8 weeks later . mvasbea vaccine is recommended for individuals who are vaccinated against zabbing or mvac
you should not receive mvabea , as the vaccination course is designed to be fully supervised by a doctor or nurse . you should also read the instructions given to you by your doctor or health care professional before you are given the vaccine . if you have ever had a severe allergic reaction to any of the active substances listed in section 6 . in case you have had : a severely allergic reaction after an antibiotic called ' gentamicin ', the vaccine should not be given . warnings and precautions talk to your doctor , pharmacist or nurse before you receive ' the vaccine and for how long you should be protected . the following warnings about the use of mvbea in adults , adolescents and children with a serious allergic reaction may not be fully protected against the vaccine because of the risk of a possible severe allergic response to any other vaccine injection . therefore tell your doctor before
mvabea is a vaccine given into a muscle ( intramuscular injection ) in the upper arm or thigh , or into  a blood vessel . the first vaccination with zabdeno vaccine is given 8 weeks later . mvbea vaccine will be given as the second vaccine . vaccine - related primary vaccination first vaccination using zabbing zaburo red cap vial ( 0 . 5 ml ). second vaccination with the mavabea yellow cap viall ( 00 m ) for children aged 8 weeks and above . it is given as early as possible after the first vaccine with zbdenon . booster vaccination with either zabea or zabeddeno may be given at the same time as mvasbea . your doctor will decide if mmea is suitable for you . information on vaccine
like all medicines , this vaccine can cause side effects , although not everybody gets them . most side effects happen within 7 days of getting the injection . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common ( May affect up to 1 in every 10 people people ), being sick ( vomiting ) itching where the injecting is given uncommon ( may effect up to1 in every 100 people ). redness and skin hardness where the vaccine is given generalised itching when the injection has been given the following other side effects very common : may affect upto 1 in each 10 people feeling tired muscle pain joint pain where the treatment is given low blood platelet count where the immune system is high common ( these may affect less than 1 per 10 people and less than1 per 10 but more than1
what mvabea contains the active substance is zaire ebolavirus ( 123i ) 29 - tai forest ebovirus nucleoprotein marburg , diluted 0 . 7 x 108 chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what hepard looks like and contents of the pack mvbea is a suspension for injection in a single - dose glass vial , closed with a rubber stopper and yellow cap . the vial contains 20 single  2 ml of suspension .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondront can also be prescribed if : you have a raised calcium level in your blood due to suffocation of a tumour . calcium is a natural chemical made by your body by recombinant dna technology . it helps stop your bones getting weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - because you have low levels of calcium in your blood . do not use this medicine if any of these apply to you . if this applies to you then tell your doctor . warnings and precautions before you start treatment with bondronate , tell your dentist if : you have a rare but potentially life -- threatening side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronatului for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in
how it is given bondronat will be given to you by a doctor or nurse experienced in the treatment of cancer . it is usually given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much bondronatul is needed . if your illness gets worse , or if you have breast cancer that has spread to your bones , then 3 to 3 - 4 weeks after receiving your first dose , as an injection in your vein over at least 15 minutes . once you have a raised calcium level in your blood , the recommended dose is 1 mg / kg every 2 weeks or 2 mg , depending on the severity of your illness . the medicine is given as either an infustion in your sinus or a repeated dose if
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( might affect upto 1 in 10 ,000 people ), pain or sore in your mouth or jaw . this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if this happens . ear pain discharge from the ear , discharge from an ear infection , which may be an ear infection
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately you should be stored in a refrigerator ( 2 - 8 ). do not freeze . storage after thawing , the product can be stored at 2 ° c to 8 °c for up to 24 hours . store in the original package in order to protect from light . your doctor or nurse will throw away this medicine . these measures will help protect the environment .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion equivalent to 2 mg i bandronic acids . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , water for injections . what bonroraat looks like and contents of the pack bondronate is a clear , colourless to pale yellow solution . it is supplied in packs of 1 or 2 vials , each with a bromobutyl rubber stopper . not all pack sizes may be marketed .
what zeposia is zeposa is an antidote to medicines that destroy certain types of white blood cells ( lymphocytes ). what zposia does is work by attaching itself to a target substance in the body called cd38 . what zelposia are used for zeposition is used to treat adults with relapsing remitting multiple sclerosis ( rrms ), who have active disease associated with multiple clerosis . multiple xclerosis ( ma ) is a disease that affects the immune system and reduces the body ' s defences . white blood cell count ( cde5+) can damage the nerves in the brain and spinal cord , and can block the nerve signals in these areas . this can cause symptoms such as numbness and difficulty in walking .
do not take zeposia - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) -if you have a severely weakened immune system - have had a heart attack ( such as angina , stroke , mini - stroke or transient ischemic attack ( tia )) if your doctor has told you that you have severe heart failure within the last 6 months - are taking zeposa regularly or have irregular or abnormal heartbeats ( arrhythmias ). warnings and precautions talk to your doctor before taking zenposia as you may need treatment - be aware of the following : - severe infection ( hepatitis ), tuberculosis , cancer - suffer from severe liver problems - ( it is also better to avoid being pregnant if the
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor will work out your dose of zeposia based on your heart rate . there is a ' treatment initiation pack ' that contains the following information : starting treatment for 4 weeks - one capsule of 0 . 23 mg ozanimod once daily for 1 week - then 4 weeks of treatment - three capsules of 0- 0. 46 mg / ml of ozaimod twice daily for 5 days , 6 days 7 , and 8 weeks after that , there is also a new initiation package ' with orange capsules containing 0 ( 0 de 0 10 . 92 mg ) ozonimod when you start regular treatment , your dose will
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection or blood pressure uncommon ( may effect up to 1 in 100 people ), allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist or nurse if these side effects become serious . common ( might affect up to1 in 10 persons ) infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( larynex ), viruses . reduced number of white blood cell called lymphocytes common ( will affect upto 1 in every 100 people) allergic reaction ( the signs include : - a sudden increase in the level
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any damage or signs of tampering to the pack . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposa 0 . 23 mg : each capsule contains 0. 23 milligrams of ozonimod ( as hydrochloride ). zepa 00 . 46 mg ; each capsule has 0 ( 0 in 0, 46 milligramms ) of zani mod ( as Hydrochlorides ). the other ingredients are : zeposition 0 debossed on one side and debossing of zepatia 0- 92 mg / 0 " 92 milliliters of debating tablet : per capsule contains debombment of 0zani Mod ( as chloride )). the ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose
what temybric ellipta is temibric an active substance containing three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticassé furoates belongs to a group of medicines called corticosteroids , often simply called steroids . umeklidiniumbromide or vilantrol belong to  a family of medicines known as bronchodilators . what eybril ellippa is used for temуbric is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . the result of this is drowsiness , sleepiness .
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temmybric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybril ellippta every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temуbric is for inhaling use , so it is important that every day you use it at the right time of the day ; if it is not used at the wrong time of year , you do not need to use it anymore . it is best to
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately . pneumonia ( infection of the lung ) in copd patients ( common side effect ) tell your doctor immediately if you get symptoms of a lung infection such as : fever or chills increased mucus production , change in mucuses colour increased cough or increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat and increased breathing problems common sideeffects ( may effect up to1 in 10 users ) - sore mouth and throat irritation - decreased appetite - increased urination - a burning sensation when passing urine - fast heartbeat - low blood pressure - high blood pressure common side impacts ( may impact up to 10
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose ( the dose leaving the mouthpiece ) contains 92 micrograms of fluticassé furoATE , 65 microgram ( 0 . 5 ml ) umeklidinium ( 2 . 22 mg ) and vicanterol ( as trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temlybric is containing lactoses ') and magnesium stearate . what temybrilc ellpte looks like and contents of the pack the ellippa inhaler consists of a light grey plastic body , a beige coloured mouthpiece cover and a
what zinforo is zinfordo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinfoo is used to treat infections of the skin and the tissues below the skin . this is similar to an infection of the lungs called : ' pneumonia ', which is very common in adults . how zin foro works zinforumo works by killing certain bacteria , helping to prevent serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are allergy to other cephalosporin antibiotics . if the patient has had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor before taking zinfordo . the use of zin foro is not recommended in such cases . talk to the doctor or pharmacist before taking the medicine if : you have kidney problems . you have had seizures ( or convulsions ) following any non - severe allergic reaction to other bacteria using penicillin and carba penem . your 26 patient should be observed closely . it is important to follow the instructions of your doctor or nurse regarding severe diarrho
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor may increase your dose to 600 mg every 8 hours if you have some infections that you cannot control within 8 hours of the dose given to you . the dose may be increased or decreased depending on how well you respond to zinfo . for adults , the recommended starting dose is 12 mg / kg given every other day as a drip into a vein . it may be given up to 60 or 120 hours after the first dose . if an increased dose is needed , treatment may be continued for 5 to 14 days for skin infections and for 5 up to 7 days for pneumonia . use in children and adolescents zinforce is not recommended in children with kidney problems . in adults if your child has kidney problems your doctor will decide how much zinfordo is needed depending on the size of your body . depending on your child 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor straight away if you notice any of these symptoms you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems these may be signs of a serious allergic reaction ( anaphylaxis ), diarrhoea , or stool that contains blood or mucus . tell your healthcare provider straight away or contact a doctor straightaway . treatment with zinforo may be started with medicines to slow bowel movement . this is common ( affects 1 to 10 people ). you may want to have a blood test , called a ' coombs test ', which will be performed before you start taking zinford .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . this medicine does not require any special storage conditions . please return zinforo to your pharmacist if you notice any change in the appearance of the tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg ceftaroline fosamil . the other ingredients are arginine , glucose and soya . what zforo looks like and contents of the pack zinfordo is a pale yellowish to light yellow powder supplied for solution for infusion in a vial . it is supplied in packs of 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuralopathic pain : pregabaalin pifizer is used to prevent long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neursopathic pain such as diabetes or shingles . pain sensations may be described as hot , burning , torsion , or intense , shooting , stabbing , sharp , cramping , anxiety disorder , etc ., or uncomfortable , uncomfortable - cramping or aching , and tingling . this type of numbness may also be associated with nerve pain associated with a range of illnesses .
do not take pregabalin pfizer if you are allergic to pregabaalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabilin . some patients taking pregamalin may experience symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabhalin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , take special care with pregabaltin if any of them apply to you , tell your doctor . blurring or loss of vision , or other changes in eyesight , are important 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of tablets as instructed by your doctor either 150 mg or 600 mg once a day . your doctor will tell you the dose that is right for you : - to take pregabaalin in the morning and evening - you should take pregamalin pizzeria in the afternoon 59 you should swallow the tablets whole . do not chew , crush or split the tablets . you should not chew the tablets as it may cause problems with your kidneys . a different dosing schedule may be used if your kidney are not working properly . swallow the capsules whole , with
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common ; may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , nervousness ; memory impairment ; loss of memory ; tremor ; difficulty with speaking ; and tingling . uncommon : May affect upto 1 in 100 people loss of appetite , appetite ; anxiety , depression , anxiety ; depression ; disorientations , increase in sexual interes ; an increase in sex drive ; preoccupation with emotions ; disturbance in concentration ; lack of interest ; emotional instability , disturbance in consciousness
what pregabalin pfizer contains the active substance is pregabaalin which is supplied in different strengths . each tablet contains 25 mg , 50 mg / 75 mg - 100 mg . the other ingredients are : 150 mg /4 , 200 mg /5 , 225 mg & 300 mg pregaballin . - the other ingredient ( s ) are lactose monohydrate , maize starch , ( maize ), talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac ; black iron oxide ( i . E ., propylene glycol , potassium hydroxide ). each 75 mg tablet contains 100 mg ( corresponding to 200 mg or 225 milligrams
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine that is released in your brain . this is absorbed into your body . xdagon is used to treat parkinson ' s disease in adults . parkinsons ' disease is characterised by sudden sudden movements ( not being able to move ) and difficulties moving . when xedagot is used in combination with the medicine , levodopa and other medicines used to relieve parkinSON '
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - take the following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; and tranylcypromine ( used for treatment of parkinson ' s disease , used for depression ): pethidine ( a strong pain killer ) - you must wait at least 7 days before starting xagego treatment and for at least another 7 days after starting Xadage treatment if your doctor determines that you should not take mao inhibitors such as pethtine . - your doctor will
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg once daily . your doctor may increase your dose to 100 mg once a day by taking one tablet by mouth once - daily , if necessary . xdag should be taken with or without food . patients with moderately reduced liver function the recommended starting dose is 50 milligrams once daily with xedagot . additional doses of Xadaga may be needed . contact your doctor for advice if your doctor determines that you may need to take more tablets than usual . you may also experience raised blood pressure , anxiety , confusion , forgetfulness , sleepiness , lightheadedness , feel sick or are sick , or have dilated
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that can lead to collapse ) has been reported in patients with the following conditions : - neuroleptic malignant syndrome ( coma ). - confusion , sweating , muscle rigidity ( hyperthermia ) - increase level of enzyme creatine kinase in your blood , which may lead to serotonin syndrome . - confused , hypertension ( muscle stiffness ), hallucinations and hypotension . other side effects with parkinson ' s disease have been reported with safinamide and a higher risk of developing a condition called tadalafil . the frequency of these events is not known . side effects for patients with park inson  s syndrome are not
what xadago contains - the active substance is safinamide . each tablet contains 50 or 100 mg of ssafarinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - table coating : pregelatinised maize starch , maize biconcave film - coated tablets of 7 mm diameter with metallic gloss . - 50 mg x adogo 100 mg film , white to off - white , round , biconve film- coated tablet .
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat adult men with prostate cancer that has not spread to other parts of the body . zytigea increases the amount of testosterone produced by your body in response to treatment of prostate cancer . you should not be given zyta if you have a history of disease that has been caused by hormone therapy . this is  a treatment that lowers testosterone ( androgen deprivation therapy ) or if another medicine , prednisone or predndisolone , is used for high blood pressure , which has a detrimental effect on the amount water in your body , and because it causes fluid retention in your blood .
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you can get pregnant , zytigea may harm your unborn child if used as a precaution . warnings and precautions talk to your doctor , pharmacist or nurse before taking zymiga : if your unprotected child has severe liver damage or has prostate cancer . your doctor may need to change your dose of this medication . taking this medicine tell your doctor right away if any of these apply to your untreated child . tell your healthcare professional before taking this medication as it may affect your uncontrolled growth . you may have liver problems , high blood pressure , heart failure , low blood potassium . if the child has low blood sodium , or heart rhythm problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once daily . taking this medicine this medicine is for oral use . swallow the tablet whole , with some water . you can take zytiga with or without food . do not chew , crush or split the tablet . take ztiga about 2 hours before you start taking zytigea . how to take if your doctor tells you to , your doctor may need to increase your dose . zymiga is usually taken with a medicine called prednisone or predniesone . it is important that you also read the predneyone / predisolone package leaflets for preddnisolon . your doctor will tell you how long your treatment will last . when to
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you develop muscle weakness , muscle twitches , a pounding heart beat ( palpitations ), or if the level of potassium in your blood is low . other side effects may include : common ( may affect up to 1 in 10 people ): - an excess of fluid in your legs or feet . this can be a sign of low blood potassium , shown by liver function test , in patients with high blood pressure , urinary tract infection , diarrhoea , fluid in the lungs , and urine . uncommon ( may effect up to1 in 100 people ). - a low level of sodium in your urine , as shown in liver function testing , high blood potassium not known ( frequency
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg aburateron aate . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 - 32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigea contains lactoses "). what ztiga looks like and contents of the pack - zytaga tablets are white to off - white , oval tablets with 9 . 5 mm diameter . the tablets are packaged in a plastic bottle with a child - resistant closure . pack size of 120 tablets
hefiya contains the active substance adalimumab , a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , and enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , or paediatri non - infectious uveitis the active ingredient in hebiyar consists of two different proteins . the active component of aadhalimumаb is a monoclonal antibody . monoclonic antibodies are proteins that attach to specific targets in the body . adelimumb attaches to a specific protein called tumour necrosis factor ( tnf ), which is present at increased levels in the inflammatory disorders listed above . this reduces
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if the child shows symptoms of infections such as fever , wounds , feeling tired or dental problems ( see also " warnings and precautions "). if child has moderate or severe heart failure or a serious heart condition ( see " warning signs and precautionary measures "). warnings about allergic reaction : if allergic reactions become severe and / or persist ( with symptoms such as chest tightness , wheezing , cough , diarrh
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults the recommended dose is 40 mg once a day . your doctor may increase the dose to 20 mg once daily or to 40 mg twice a week if your doctor prescribes a lower dose . polyarticular juvenile idiopathic arthritis age or body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children weighing 10 kg or less 30 kg 20 mg every third day not applicable enthesitis - related arthritis age and body weight when you are a child weighing less than 6 years of old weighing more than 30 kg 40 mg each week not recommended for children and adolescents from 6 years to less than 15 years of height weighing 15 kg to
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as there may be signs and symptoms of infection such as fever , feeling sick , wounds , and dental problems . other possible side effects very common ( may affect more than 1 in 10 people ): infections of the mouth , nose
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and light , and must be discarded if not used within the 14 - day period or discarded by your doctor or nurse . you should record the date when your pre – filled  sYringe is first removed from the refrigerator , as well as the
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg of aadhalimum b in 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections . what hfiуa looks like and contents of the pack heifiyo 20 mg solution for injection ( injection ) in pre  labelled solution for infusion ( injection in pre- filled form ) is supplied as a 0. 4ml clear to slightly opalescent , colourless to slightly yellowish solution in a clear type i
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritzimabe sticks to your cell , the cell dies . ritemevia may be administered to you as the treatment continues . your doctor will prescribe ritemesvia for the treatment of your specific condition . the active ingredient in ritemartin is ritermvia to treat the following conditions : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue ( part of the immune system ) that affects a particular type of black blood cell named b- lymphoocytes , which grows out of control . when
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment you have been told by your doctor that you had a weak immune system . if this applies to you , tell your doctor before taking ritemevia . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : if ritemillionab is not recommended for patients with a severely active infection , with / or without a strong immune system ( e .g . due to severe heart failure , severe uncontrolled heart disease , eg , including granulomatosis with polyangiitis , micr
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given ritemevia as a drip ( intravenous infusion ). medicines given before each ritemastine administration before you are given a rite, you will be prescribed other medicines ( pre - medication ) to prevent or reduce possible side effects and reduce the duration of your treatment , as well as the doctor may decide that it is necessary for you to continue with your treatment for non - hodgkin ' s lymphoma . if you are having ritedmvia alone ritemmvia will usually be given once a week for 4 weeks . repeated treatment courses with ritemartin and chemotherapy ritemorvia will
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , patients may experience pain at the infusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing and cough . this may also happen after hours or months . if you experience any of these symptoms , tell your doctor or nurse straight away . other side effects may include : very common ( may affect more than 1 in 10 people ): diarrhoea , stomach pain , indigestion ,
what ritemvia contains the active ingredient in ritemevia is called rituximab . the vial contains 100 mg of ritzimabe . each ml of concentrate contains 10 mg of this active substance . ritsimaab is produced by recombinant technology . other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemigvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials 
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - tva contains cape citamine , which itself is not a cytotic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitationbine  Teva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitébine tenisone is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . Capecitabin t Eva may be used either alone or in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if an allergy exists to this medicine . - in case you have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - when you are pregnant , - at risk of having low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or - have severe liver or kidney problems , or if your doctor has prescribed a lower dose of the enzyme dihydropyrimeidine dehydrogenase ( dpd ) ( complete dppd deficiency ). warnings and precautions talk to your doctor or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you : the dose of capecitebine teva is based on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface space of 1 , 7 m2, and should take 4 hours to prepare the medicine . a man whose doctor has prescribed a 150 mg and 1 150 mg two
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooee at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : whenever you lose your appetite , and the amount of food you eat each day is much less than usual . stomatitis : pain , redness , swelling or sores in your mouth and / or throat . hand - to - touch nail disorders : this is more likely to occur if your hand is crushed or it breaks . ulcers : as
what capecitabine teva contains the active substance is capecitebine . cape citbine trembling : 150 mg film - coated tablets each film , contains 150 mg capeciabine ; capecitébine travisone 500 mg film- coated tablet each film contains 500 mg capcecitabine the other ingredients are : tablet core : lactose , microcrystalline cellulose ( e460 ), hypromellose ( cps ), collapsing compound ( s )), croscarmellose sodium , magnesium stearate ( 6000 ), macrogol 400 ( 8000 ), and hyplose , titanium dioxide (  e171 ), yellow iron oxide ( i ) and red iron oxide . what capеcitabine toeva looks like and contents of the pack capecitationbine a
what silodosin recordati is silonosine recordatti belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sildodostati works by blocking the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siilodousin recordingi is used for sillodonati can be used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , an increased need to pass urine , even at night .
do not take silodosin recordati - if you are allergic to sildodousin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking silloodasin recordingi . before eye surgery , there may be cloudiness of the lens ( cataract surgery ). this is important because it protects the eye from light . 26 during and after treatment with silonodiosine recordatini , another type of medicine may cause a loss of muscle tone in the iris ( the coloured circular part of the eye ). when such a surgery is performed , the doctor will take appropriate precautions with respect to medicine and surgical techniques to be used . talk to the doctor or pharmacist before taking Silodonoshin recordatis if : you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . do not break or chew the capsule , but swallow it whole , even if it is for a short time . patients with kidney problems if your doctor has toldyou that you have moderate kidney problems the recommended dosage is one 4 mg capsule of semen per day , for example one capsule in the morning and one capsule at the même time each day ; if necessary , your doctor may give you another dose of siladoosine recordatis . if , by mistake , you become dizzy or feel weak , tell your doctor straight
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions : you may notice swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . this side effect is very common with silodosin recordati . dizziness : this may be associated with dizzikeit and occasionally fainting . when this happens , you may feel weak or dizzy . the symptoms of dizzin and fainting can sometimes occur during treatment with silotodasin recordingi , but this does not necessarily mean that you are at risk of complications during a cataract surgery ( eye surgery ). tell your doctor if you notice any of the following : very common side effects ( may affect more than 1 in 10 people ): headache , dizzien , and occasionally passing out ( losing touch with
what silodosin recordati contains the active substance is sildodousin . each tablet contains 8 mg of siloudoosun . one tablet contains eight mg of Silooddoun ; the other ingredients are mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( ir ). sillodosesin recordingi 4 mg hard capsules : one tablet of sillodain , each tablet of 4 mg of selodonin ; a third tablet of 3 mg of tia . the other ingredient is mannol ( 8 %), magnesium starate and sodium laursulfATE , and gelatin, titanium oxide ( ige ). the printing ink
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzonzalmonio blocks the effect of angio Tensin in so that the blood vessels relax , and your blood Pressure is lowered . this is called essential hypertension ( high blood pressure in adults ). ' essential ' means that the high blood tension is not caused by any other condition . high blood temperature , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono - if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). -if you : - are more than 3 months pregnant . ( it is also better to avoid kinzilmono in early pregnancy see pregnancy section .) - have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . - suffer from diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . do not give kinezalmona to children and adolescents under 18 years of age . warnings and precautions talk to your doctor or pharmacist before taking kinzzalmonou if any of the above applies to you .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , preferably at the the same times each day to help you remember to take it . you can take kinezalmona with or without food . it is important that you take kinszalmonio every day until your doctor tells you otherwise . if your doctor feels that the effect of kinsalmonon is too strong or too weak , talk to your doctor . for treatment of high blood pressure , the usual dose of the usual starting dose of one 40 mg tablet per day to control blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of two 20 mg tablets per day ; alternatively ,
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately since they could be fatal . possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ]): low blood pressure ( hypotension ) in patients at high risk of cardiovascular events . uncommon side effects (1 may affect less than 1 in 100 people ), urinary
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . discard the tablet if not used immediately .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmeisartran . - other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinezalmonon 20 mg tablets are white to off - white , round tablets , with " tmc " on one side and " nvr " on the other . the tablets are provided in blister packs containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
what afstyla is a human clotting ( coagulation ) factor viii product that contains the active substance lonoctocog alfa . what he is used for a Fastlyla is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor ixii deficiency ). patients who do not have factor  vii are at risk of blood cloting because they have an increased tendency to bleed . those who have not factor  VIIIi in their blood and who do have haematophilie a and cannot clottle their blood sufficiently , a cloting device is needed for cloat . aafStylac is available in packs containing one or three pre - filled syringes .
do not use afstyla - if you have ever had an allergic reaction to any of the ingredients of aafstasta , - or if your doctor or nurse knows that you are allergic to hamster proteins . warnings and precautions 46 talk to your doctor , pharmacist or nurse before using adstlyla . you should record the batch number and the date of your treatment diary in order to help provide more information on the effects of adjusting the dose . a fsstyingla may cause allergic ( hypersensitivity ) reactions . your doctor will check for signs and symptoms of allergic reactions before you start using . allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure and anaphylaxis ( a serious allergic reaction that may cause severe
your treatment should be initiated under the supervision of a physician experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fstyla is one vial per day . your doctor will determine the exact dose and duration of treatment depending on your disease the site and severity of the bleeding your clinical condition . reconstitution and administration general instructions the powder should be mixed with the solvent ( liquid ) immediately before use . aseptic conditions the use of аfsstlyla must not be combined with other medicines or solvents . see section 6 . after preparation , the solution should be clear to slightly opalescent and colourless to pale yellow . do not use it if there is any visible particles in it . seek immediate withdrawal if
like all medicines , afstyla can cause side effects , although not everybody gets them . contact your doctor immediately if you experience symptoms of allergic reactions . allergic reactions may be severe . tell your doctor straight away if your doctor recommends you have any of the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding ). for children not previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ); however patients who have received previous treatment with factor vii ( more then 150 days of treatment ) the risk is uncommon ( less than 1in 10 patients in each case ). if this happens , your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after the afstyla powder has been reconstituted it may be kept at room temperature ( up to 25 ) for a single period not exceeding 3 months . keep the vial in the outer carton in order to protect from light . use the reconstructed product within the expiratory date which was stated on labels and cartons . this medicine does not require any special storage conditions . any unused medicine must be discarded after first re - reconstitution .
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 mg / 2 . 5 ml solution for injections the solution contains 100 mg of lonoctcog Alfa per vial . after reconstitution with 2 , 5 . 4 mL of water for injection s the solutions contains 200 mg of LonoctoCog alifa per m2 of solution for injecting , corresponding to a concentration of 1000 mg . upon reconstitution without 2 : 5 % of the solution for infusions the liquid contains 400 mg of honoctocorog alh and 1500 mg pfu / m3 after reconstituted by 5 %) water for injects the answer contains 300 mg of lococog a / 2000 mg if reconstitution fails to provide sufficient amounts
praxbind contains the active substance idarucizumab . i darucizumаb is a reverse agent . dabigatran ( pradaxa ) is  a blood thinner medicine that helps prevent blood clot formation . as prawbind can rapidly trap dabigabatran in the blood , it reduces the blood and thus increases the blood flow . you can take praxxbind with or without pradoxa and you may be transported to a hospital emergency surgery if you have urgent procedures or uncontrolled bleeding .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . -if you have a genetic disease called hereditary fructose intolerance ( hereditarian fructoses intoleration ) which is based on the substance sorbitol . this medicine may cause serious adverse reactions . warnings and precautions talk to your doctor before taking praxxbind . taking this medicine together with dabigatran and other medicines to prevent blood clots . dabig atran is a substance that is found in large amounts in the body . it can lead to blood coagulations . your doctor will decide which medicine is best for you . talk to you doctor before you take , or during treatment with medicines to help prevent blood blood stains , depending on
praxbind will be given to you in a hospital or clinic under the supervision of an experienced doctor . the recommended dose is one 5 mg vial of 2 . 5 mg of dabigatran per day . you will receive this medicine for one 5 - day period . praxxbind is given by infusion into a vein . your doctor will decide on the most suitable dose for you . during your treatment , your doctor may monitor you for signs of blood clot formation . it is very important that you receive dabig atran as instructed by your doctor , pharmacist or nurse . after 24 hours , you will be monitored while you are receiving this medicine . this medicine should not be administered if you have any concerns . tell your doctor or nurse immediately if any of your medical history has been established .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects tell your doctor or pharmacist if you get any side effects or want to talk to your doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are : sodium acetate trihydrate , acetic acid , sodium opalescent ( e420 ), polysorbate 20 and water for injections . what prixbind looks like and contents of the pack praxxbind is a clear to slightly opacescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temmedaca is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . one or both doses of tememedaac are combined with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating 3 patients ). - for malignant gliogramma , such as gliblastomas multiform e or anaplastic astrocytoma ( a form of glibatic stem cell transplant ). one or more of these tumours have been reported in patients receiving standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - some types of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells play a role in fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment is started .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is a possibility that it may be higher or lower . if treatment for a recurrent tumour has been started and you have had chemotherapy treatment in the past , you may be given other medicines ( anti - emetics ) to take before and / or after taking temmedaca to prevent or reduce nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if a patient is unable to take both active components , treatment will occur in two phases : - treatment together with radiotherapy ( concomitant phase 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ),- fever , chills , severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells which can cause fever ); and reduced resistance to infections . the reduction in blood cell counts may also cause anaeemia ( anaesthesia ), which may also be a sign of blood clots . it is important to note that a very small number
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . bottle do not store above 30 . tell your pharmacist if you notice any change in the appearance of the capsules .
what temomedac contains - the active substance is temozolomide . temokac 5 mg : one vial contains 5 mg of temazolomide ( as besilate ). temomemedaac 20 mg  : each vial delivers 20 mg of the substance . as besieged tablets : temizolomide is supplied in a carton . one temmedaca 100 mg / 100 mg tablet contains 100 mg of debossed tablets . what momedomed ac looks like and contents of the pack temac 140 mg - each viall contains 140 mg of desiccant . each temmometac 180 mg x 180 mg tablet contain temozalomide and is available in temtemomediac 250 mg . Each vial includes 250 mg of dem
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , eerect penis suitable for sexual activity . cialize has been shown to significantly improve the ability of obtaining ahard e rect penipis suitable to sexual activity for men . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . by doing so , it allows cialIS to relax the blood vessels in your penis , helping to open the penis for more fluids , especially in your genital area . improving ecg , your peni is important for elastic function . you should not take ciali if you do not have eerile dysfunction when you start taking a medicine for this 
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). -if you take any form of organic nitrate or nitric oxide donors such as amyl nitsitrite . this is a group of medicines (" nites ") used to treat angina pectoris (" chest pain "). cialiis is not recommended for use in this group of medications . - when taken with these medicines , you should be careful not to infect other people . warnings and precautions talk to your doctor before taking cialIS : - you have serious heart disease or recently had a heart attack within the last 90 days .- you recently had or plan to have a stroke within the past 6 months . talk to you doctor before you start taking nitzitz
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with some water . you can take the tablets with or without food . your doctor may increase your dose to a maximum of 5 tablets per day , up to corresponding to 2 . 5 mg / kg . do not take more than one tablet each day if your doctor tells you to . try to take ciali at the same time each day and see if it works for you , or if the effect of cialIS is too strong or too weak . for example , if someone else or a child takes your tablets , contact a doctor or the nearest hospital straight away . taking cialist you will only get an ere
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects may also occur after you have started the medicine . in particular , you may experience allergic reactions including rashes ( frequency uncommon ). you may also experience chest pain when taking nitrates ( frequency rare ). in particular you may be having priapsim . you may have a prolonged and possibly painful erection after taking cialis . if you have such an er , which lasts for more than 4 hours you should contact a doctor immediately . also tell the doctor if there is sudden loss of vision ( frequency unknown ). other side effects have been reported : common ( may affect up to 1 in 10 people ) or uncommon ( may effect up to 100 people ). if this happens , tell your doctor . headache , back pain , nausea and vomiting
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of t Tadalalaf . -the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film - coat : coat - coating : lauce monohydrate , and hypromellose , triacetin . printing ink : titanium dioxide ( e171 ), iron oxide yellow ( 850 ), red ( 6000 ), and talc . what ciais looks like and contents of the pack ciali 2 , 5 mg film  2 mg film- coated tablets
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyingglid helps control the level of sugar in the blood in adults . type 2 diabetics usually start out as a passive lifestyle , but the body can only handle the sugar better . the insulin is made by your body in a very small amount . your doctor has prescribed enYglid for you because you have type 2 disease , and as an add - on to diet and exercise , exercise and weight reduction have failed to control ( or lower ) your blood glucose . in addition , englid
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking enlyglid and if any of these apply to you : have a severe liver disease . are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood , which can increase the risk of liver problems ). have moderate liver 28 disease , see section 2 . take special care with ennyglide : tell your doctor if : you have , or have ever had , a severely liver disease have kidney problems . your doctor may need to reduce the dose of 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , if necessary ( for example if your doctor recommends it ), or up until 4 hours before each dose . if the dose is less than 30 mg , you can take the tablets at any time of the day . do not take enyglid more than 16 mg before . your blood sugar may become too low , leading to a hypo . you should avoid taking enzyglid if this happens . it is important to keep following the advice about diet and exercise given to you by your doctor , pharmacist or nurse . please follow the advice given to achieve the best results for your health 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypogycaemia which may affect up to 1 in 10 people . Hypoglycaemic reactions are generally mild / moderate but may occasionally progress to hypoglytic unconsciousness or coma . if this happens , medical help is called immediately . allergy allergy is very rare ( may affect less than 1 in 1 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( possible signs of anaphylactic reaction ). other side effects include : common ( may effect up to1 in 10 users ): stomach pain , indigestion , flatulence ( wind ), constipation , diarrhoea , nausea , vomiting , itching 
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg replinide the other ingredients are : microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , general glycerol , magnesium stearate , meglumine , pokemon , yellow iron oxide ( e172 ) only in the 1 mg tablets and red iron oxide( e171 ) the 2 mg tablets are yellow , round and biconvex with bevelled edges . the 1mg tablets are pale brown , pale yellow - yellow . biconvéx and bikonvex . 1 mg tablet is pale brown and yellow ; biconVEx with round edges , bi
what azacitidine mylan is azacatidine myLAN is an anti - cancer agent . aza citidine mylang contains the active substance ' azacetidine '. what acitide mylan can be used for azacotidine my Lan is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelosomonocytic leukaemia ( cmml ) acute myeloid leukoemia ( aml ). these are diseases which affect the bone marrow and can cause problems with normal blood cell production . how azacecitine mylan works azacie mylan attaches to cancer cells . by attaching to a substance called azacitaitidine , it attache to rib
do not use azacitidine mylan - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - for the treatment of advanced liver cancer . - in the following cases , your doctor may need to adjust the dose of aza citidine myLAN : - decreased counts of platelets , red or white blood cells . warnings and precautions talk to your doctor or pharmacist before using azacecitine mylan: if your doctor has told you that you have decreased countsof platelets, red and white blood cell . it is possible that you suffer from kidney disease . tell your doctor if vous have liver disease ; - you have a heart condition or heart attack . you have lung disease , either for several years or decades . blood test your doctor will do blood tests before and during treatment with 
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will normally receive one dose of aza citidine myLAN every day for 3 weeks . this " treatment cycle " will be repeated every 4 weeks , followed by a rest period of 6 weeks ). this medicine will be given to you as an injection under the skin ( subcutaneously ) by  a doctor or a nurse . it may be given under the Skin on your thigh , tummy or upper arm . if you have any further questions on the use of this medication , ask your doctor , pharmacist or nurse , or nurse or nurse (
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - altering . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness or fatigue . symptoms may include fever , chills , fever . this may also be associated with a low number of white blood cells . the most common side effects are : common side effect ( may affect up to 1 in 10 people ) - reduction in the number of red blood cells (
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the carton . your doctor , pharmacist or nurse are responsible for storing azacetidine myLAN . they are also responsible for disposing of any unused azaccitidine my Lan correctly . this medicine is for single use only . once the suspension has been prepared and diluted , it should be used immediately . however , once the preparation has been made up , the contents should be stored in a refrigerator ( 2 8 ) immediately , but not above 25 , if not used immediately ( see section 2 ). if the azacotidine mylang suspension is prepared using water for injections that has not been refrigerated , you should store the suspension in the refrigerator ( 1 8 ), if you are not using immediately ;
what azacitidine mylan contains - the active substance is aza citidine . one vial of powder contains 100 mg azaitidine - one vially of reconstitution with 4 ml of water for injections , is used to reconstitute the suspension . each mL of the reconstituted suspension contains 25 mg / m2 azacetidine , - as a single dose . - no other ingredients are used . the other ingredient is mannitol ( e421 ). what a azacionitidine Mylan looks like and contents of the pack azacatidine myLAN is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azaciditidine and is available in packs containing 1 or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , called travoprost and timolol . travapross is a prostaglandin analogue , which is absorbed by the eye . and tramololl is  a beta blocker . both of these active substances work together to reduce fluid within the eye and this reduces pressure within the eyes . duototrav eyes drop solutions is used to reduce high pressure in the eye which can lead to an illness called glaucoma .
do not use duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using duotorav if : - you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - signs include wheeziness , difficulty in breathing and long - standing cough . this is a common complication of breathing problems . the most common complaint is severe hay fever . talk to a doctor if any of these applies to you . you have a slow heartbeat ( either due to heart failure or a disorder of heart rhythm ( irregular heartbeat ). your doctor may
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . duotrav should only be used for your eyes . if necessary , duotorav can be used in both eyes if your doctor tells you to . use duootr after you have used eye drops before , see instructions 1 , 2 , 3 and 4 . how to use a bottle ( s ) 1 ) before using the drops . wash your hands . hold the bottle and the bottle in front of a mirror . twist off the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with a clean finger , until there is
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . if you have any questions about how duotrav works or why this medicine has been prescribed for you , ask your doctor or pharmacist . very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . common side effect ( may effect up to 1 in10 people ), effects of of the eyes eye surface inflammation with or without surface damage . these can cause eye pain , blurred vision , abnormal vision . dry eye , itchy eye . eye discomfort , signs and symptoms of eye irritation ( such as burning and stinging ). uncommon side effects that may affect up to1 in 100 people effects of duotorav : effects of surface damage in the eye : swelling ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store below 30 . throw away the bottle 4 weeks after first opening to prevent infections . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains the active substances are travoprost and timolol . each 40 mg tablet contains travapross and 5 mg titmololl ( as tilmolola maleate ). the other ingredients are : polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil . what duotrotrav looks like and contents of the pack duotrav is a white to off - white , round , flat , bevelled tablet , with " nvr " on one side and " 40 " on the other . the other ingredient ( s ) are boric acid , sodium chloride , water for injections , hydrochloric acid and purified water . sodium hydroxide and hydrochchlor
nplate ' s active ingredient romiplostim is a protein that helps to control low platelet counts caused by immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is p - related a disease in which your body 's immune system produces too few platelets . platelets are important for your blood to form blood clots . very low platelets can lead to bruising and serious bleeding . n plate is used in adults ( over 1 year of age ), and in children ( over one year of old ) who have had their spleen removed . it is used to treat chronic itp in adults who have previously been treated with corticosteroids or immunoglobulins , but have not worked well enough . your doctor will prescribe n Plate for you .
do not use nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). -if you or your partner are allergic  to other medicines that contain escherichia coli ( e . coli ). warnings and precautions before you are given n plate , tell your doctor if : you have a low blood platelet count ( thrombocytopenia ). you should not be given a lower dose of n Plate if your platelet counts is low . this may make blood clots more likely . you should tell your healthcare provider if any of these apply to you . there is a risk of blood coagulation . your doctor will monitor the number of blood blood stains and prevent blood letting . the risk is higher if the medicine is taken with
children and adolescents aged 1 to 17 years can receive nplate . n plate must be taken orally , as an injection under the skin ( subcutaneous ). the recommended dose is 1 ml of n Plate . your doctor will decide how much nplatte you need and for how long . to check your platelet counts regularly , your doctor may take regular blood samples to check for your platelets . this will help your doctor determine how much is in your blood . it is important to keep your plateLET count within the normal range . the number of platelet count will also depend on the size of your child . children and teenagers ( from 1 to 17, years of age ) the number and frequency of platelets will depend on your body weight . when to receive a dose of a platelet , you will usually receive ten doses of ten platelet per kilogram of body weight per week
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for nplate in adults : itp common ( may affect up to 1 in 10 people ): headache . allergic reaction upper respiratory tract infection . common (may affect upto 1 in10 people ), bone marrow disorder ( increased bone mmarrow fibres ). trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine . redness ofthe skin , flushing , muscle cramps and pain . uncommon ( may effect up to1 in 100 people ). feeling sick ( nausea ). uncommon (may effect upto1 in100 people ); chest pain ; increased blood platelet count . not known ( frequency cannot be estimated from the available data ) headache ; allergic reaction ;
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle label after exp . the expiration date refers to the last day of that month . this medicine should be used within 30 days after first opening . store in the original package in order to protect from moisture .
what nplate contains the active substance is romiplostim . one ml of n plate 125 mg solution for injection contains 230 mg of romicoplost . each vial contains 125 micrograms of ROMiploStim , corresponding to a deliverable amount of 0 . 25 mmol solution , equivalent to 125 megagrams romoplostig . the pack contains 500 microgram romisovostim in 250 microlitres solution . n Plate contains 375 microgram ( 0x 250 microgram) romizoploslim , corresponds to 98 microgram( 0cs ) per mL solution ; romianoplosturin in a deliveryable amount . every mlitre contains a delivered amount of 1 . 5 m m2 of solution
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovaor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the use of this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using tovanlor breezehaler as it may cause : - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with tovanour breezihaler stop using this medicine and tell your doctor immediately if : you get tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor BREezhalER ( signs of bronchospasm ), difficulties in breathing or swallowing due to swelling of the tongue or lips , itching or hives ( signs include redness of skin or eyes , redness and it
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhaled once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor advises you that you use more of this medicinal item than you should . when to inhales this medicine as this will provide you with an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . only use the capsules with the inhalers provided in this pack ( tovanour breezehaler inhalator ). the capsule should remain in the blister until you need to use
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyrironum bromite equivalent to 50 microgram ( 8 . 6 mg ) glycopyronicum . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram( 8 ). -the other ingredients of the injection powder are lactose monohydrate and magnesium stearate . what tovantor brewinger looks like and contents of the pack tovanOR breezehaler 44 microgramms inhalation powder , hard capsules consist of a white powder and are packaged in cardboard boxes . they are packaged inside a device called an inhalers , together with capsules in blisters . Each blister strip contains either 6 or 10 capsules , respectively . not
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by blocking the activity of a chemical in the brain called dopamine and serotonin . this activity has been shown to calming effects and relieving aggressive behaviour . adesuve is used in adults to treat acute symptoms of mild - to - moderate agitation associated with schizophrenia or bipolar disorder , diseases characterised by symptoms ( such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious or tense . in patients with bipolar disorders , these may also experience feelings of entitlement , depressed feelings , nervousness , and feeling irritable .
do not take adasuve if you are allergic to loxapine or amoxapin . warnings and precautions talk to your doctor before taking adesuve as it may cause symptoms such as wheezing and shortness of breath . if this applies to you , tell your doctor . it may be because adadasouve is not approved for the treatment of lung problems like asthma or chronic obstructive pulmonary disease ( copd ), because if your doctor determines that a problem is narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and / or shortnessof breath 25 if any of these applies to your child , do not use a dasuve and talk to their doctor before using aadosuve ( see section 4 ). if the above
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 9 . 1 mg once a day for 2 weeks , followed by 4 . 5 mg once daily . your doctor may adjust your dose based on your condition . adasuve is for use by inhalation only . it is best to hold the tablet in the hand , by mouth , with the device attached to the sachet or a straw . contact your doctor immediately if : you have the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth . muscle or eye movements if any of these occur , stop using the tablet immediately and contact your eye doctor . you should rinse your mouth thoroughly with
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any of the following side effects which are not listed in this leaflet . if any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) occur , or if they become irritating or bothersome to your airways ( asthma or copd ), such as light - headedness or fainting . these may be signs that your blood pressure is getting worsening agitation , confusion , fever and muscle stiffness . this may be a sign of a severe condition called neuroleptic malignant syndrome . other side effects include very common ( may affect more than 1 in 10 people ): - feeling sick ( nausea ) - being sick ( vomiting ) common ( might affect up to 1 in every
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the pouch after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . discard an open or torn pouch in order to protect from light . this product does not require any special temperature storage conditions . adesuve does not need to be used if there are any signs of physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 mg of loxane , which delivers 4 . 5 mg / kg of doxapin . what аdasuVE looks like and contents of the pack aadosuve 4 , 5 mg inhalation doses are delivered as clear , colourless to pale yellow , disposable white plastic inhalers containing loxace . - each inhalER is packed in a sealed foil pouch . pack sizes : adesuve is available in packs containing 1 or 5 inhalations . not all pack sizes may be marketed .
what azacitidine betapharm is azacatidine be tapharm is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azacecitine betaphar contains the active substance ' azacetidine ', which is produced by a biotechnology process . what acitide betaphur is used for azaciditidine is used in adults who are not able to have a stem cell transplantation . it is used to treat : - higher - risk myelodysplastic syndromes ( mds ). - chronic myelosomonocytic leukaemia ( cmml ) and acute myeloid leukoemia ( aml ). these are diseases which affect the bone marrow and can cause problems with normal blood cell production 
do not take azacitidine betapharm - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - for the treatment of advanced liver cancer . - in the following cases , your doctor may recommend that you take a different dose of azaitidine abatement : - you have decreased counts of platelets , red or white blood cells . warnings and precautions talk to your doctor or pharmacist before taking azaciditidine betatapharm ( see section 4 ). cases of kidney disease or liver disease . case of a heart condition or heart attack , or lung disease , you should tell your doctor if any of these apply to you . blood test you will have blood tests before and during treatment with azacciitidine Betapharm and during each period of treatment ( called a ' cycle 
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will normally receive one treatment cycle of aza citidine be tapharm every day for 3 weeks . this " treatment cycle " will be repeated every 4 weeks , followed by a 6 - week period . azaitidine betatapharm is given as an injection under the skin ( subcutaneously ) by  a doctor or a nurse . it may be given under the Skin on your thigh , tummy or upper arm . talk to your doctor if you have any further questions on the use of this medication .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these could be symptoms of liver failure and could be life - altering . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness or fatigue . symptoms may include fever , chills , fever . this may be more common at the start of treatment or after taking azacitidine betapharm . the frequency of these effects is usually mild and disappear after a few days . however , if this happens ,
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton . your doctor , pharmacist or nurse are responsible for storing azacetidine be tapharm . they are also responsible for disposing of any unused azaccitidine betabharm correctly . this medicine is for single use only . once the suspension has been prepared it should be used immediately . however , the maximum recommended dose is 45 mg / ml ( 0 . 5 mmol / kg ). if the azaciditidine betatapharm suspension is prepared using water for injections that has not been refrigerated , either immediately or in a refrigerator ( 2 8 ) or within the refrigerator ( 1 - 8 ). the azocitine betaphar suspension is ready to be used after
what azacitidine betapharm contains - the active substance is aza citidine . one vial contains 100 mg azaitidine - after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 azacetidine , - as a single dose . -the other ingredient is mannitol ( e421 ). what a azacecitine betaphar looks like and contents of the pack azacatidine be tapharm is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacitaitidine ( 900 mg ). each pack contains one viall .
cerdelga contains the active substance eliglustat for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is a rare , inherited condition in which a substance called glucosylceramide is not removed from your body , such as the spleen , liver and bones . eleglustat works by blocking the activity of glukylceride and so reduces the number of your affected organs . it is important that you continue to take this medicine as long as your doctor prescribes it . you will need to take cerdeslgа for as long you are at risk of slow speed and poor metabolisms , and you will have to take it at regular intervals if your doctor considers it necessary . your doctor will ask you to take the tablets with a simple laboratory test to check that gaucher is still in
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - in combination with medicines containing moderate cyp2d6 inhibitors , such as quinidine or terbinafine . - 31 - with moderate chyp3a inhibitors such as erythromycin or itraconazole . these medicines affect your body ' s ability to break down . do not combine cerdeslgaga with medicines that have a poor metaboliser . please discuss with your doctor if : - you take medicines with strong ccype3a antagonists such a , like itracone , - your doctor will only prescribe medicines that increase your body' 's ability .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet ( 200 mg ) twice daily . your doctor may adjust your dose depending on the dose of metaboliser you take . you should take cerdelga about one hour before bedtime . swallow the tablet whole with a glass of water . it is best to take the tablet at the same time each day . if necessary , you can take the tablets with or without food . do not take more tablets than your doctor recommended . how to take 84 cer delgaga how to open the blister / wallet : open the sleeve . press down and feel your thumb or finger until the tablet breaks up . when you have reached the dose , the dose may have to be adjusted . open the leaflet .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people headache dizziness change in taste ( dysgeusia ) palpitations , throat irritation and heartburn ( dyspepsias ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ); 34 difficulty swallowing ( dysphagia is common ). common . may affect up to 1 in 100 people shortness of breath nasal congestion . itching , hives , skin rash , itching redness , burning and hive rash all over the body . uncommon : might affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . sachet should be thrown away in the nearest hospital . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg eleglustat ( as mesilate ). - other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delgа contains lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate ( e553b ), titanium dioxide (  e171 ), yellow iron oxide ( a dark yellow ) and indigotine ( k25 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cdelgea looks like and contents of the pack cerdeslgage capsules have 
the active substance in zoledronic acid hospira is zolеdronic acids , which belongs to a group of substances called bisphosphonates . zoleledronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the next bone ). to reduce the amount of calcium in the blood in adult patient where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zoleric acid hopira : if you are allergic ( hypersensitive ) to zolеdronic acids or another bisphosphonate ( the group of substances to which zolledronic Acid belongs ), or any of the other ingredients of zolezeric Acid belong . if any of these apply to you , tell your doctor before you are given zeedrontic acid . warnings and precautions talk to your doctor or pharmacist before you receive zolzoletronic acid aspira is prescribed for you . tell your dentist before you begin treatment with this medicine and if : you have or have had a kidney problem . signs
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . method of ' iv ' administration : prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much zoleric acid to give you the usual dose is 4 mg . you should give yourself the impression that the effect of zoling acid hompira is too strong or too weak . talk to your doctor or nurse first . the doctor will decide how much to give to you . this is because zolenic acid has been prescribed for you in the past , now and in the following cases : if you have a kidney problem , your doctor will give you a lower dose if your kidney problem is not well
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ). pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw ; or loosening of a tooth . these could be signs of bone damage in the waist ( osteonecrosis ). tell your dentist and dentist immediately 
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). they are trained to give zolledronic acids hospria to you .
what zoledronic acid hospira contains the active substance in zoleric acid is zolledronic acids . one vial contains 4 mg zolelfredric acid ( as monohydrate ). the other ingredients are : mannitol , sodium citrate , water for injections . what zonedrontic acid hompira looks like and contents of the pack zolezic acid hopira is supplied as a liquid concentrate for solution for infusion ' or as ' sterile concentrate '. it is supplied in a 4 ml glass vial . zoledelic acid has a white to off - white lyophilised concentrate . each pack contains one vially ( 100 mg ) of concentrate , which is used to dissolve the concentrate if needed .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) in adults having cancer treatment chemotherapy , when chemotherapy is given , destroys nerve cells in the brain . this can help to prevent you from feeling sick or being ill . rolapatant works by blocking the activity of these nerve cells , which in turn reduces nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - you are taking an herbal medicine called st john ' s wort ( hypericum performatum ) used for depression and difficulty sleeping . warnings and precautions talk to your doctor or pharmacist before taking varubies : 27 - your doctor needs to know if your dose is too low or too low . - have severe liver or kidney problems . your doctor may need to adjust the dose of certain medicines . tell your doctor if : you are already taking rifampicin ( used to treat tuberculosis and other infections ). you are also taking carbamazepine ( used for epilepsy and nerve pain ). your doctor will also tell you if any of these apply
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 180 mg once a day . your doctor may increase your dose to 90 mg once daily . swallow the tablets whole with a glass of water . you can take varuby with or without food . do not chew , crush or split the tablets . how long to take va ruby with food if it is not possible to take it at least 2 weeks before your chemotherapy cycle . if your doctor thinks that it is too strong or too weak , talk to your doctor about how to avoid having chemotherapy . taking varubies in the morning before going to bed , or before going home , do not take varumy with meals . take varaby with / without food because it may cause sickness or sickness . use this medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ): tell your doctor immediately if you experience symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever or faster heartbeats . contact your doctor as soon as possible and receive appropriate treatment . other side effects include : common ( may effect up to1 in 10 people ); headache ; constipation and feeling tired . rare ( may impact up to 2 in 1, 000 persons ) headache . not known ( frequency cannot be estimated from the available data ) hives ( urticaria ); it is possible that some side effects could be serious .
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolaptant . -the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide and magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide , macrogol and polysorbate 80 . what va ruby looks like and contents of the pack varubry is a white , round , film tan and blue , capsule - shaped , biconvex , engraved with ' gs - 100 ' on one side . it
what enerzair breezhaler is enersair brewing system contains three active substances : - indacaterol - glycopyrronium - mometasone furoate inddacatrol and glycopyrristium belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the pulmonary . when enezerzair brazoate is taken regularly , it helps the small  airways to remain open . mometosone fuoate belongs to  a family of medicines known as corticosteroids ( or steroids ). corticotrosteroids reduce the swelling and irritation ( inflammation ) in the small Airways in your lungs and
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking enersair . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using enERzair broezhalers : - any of these medicines are not recommended as you may not be properly used . talk to you doctor before using this medicine if : you have heart problems ( an irregular or fast heartbeat ) you have thyroid gland problems you have diabetes or high blood sugar , or you have a history of seizures you have severe kidney problems you drink alcohol .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is to inhale the content of one capsule each day . you only need to inhaled one dose each day because the effect of the medicine lasts a long time . enerzair breezhaler helps control your asthma and relieves your symptoms in a rapid fashion . use in adults only . do not use more than your doctor tells you to use . how to use the ennerzair broezhalers enezerzair brezhalER is for inhalation use , and it is very important that you use it regularly every day , as directed by your doctor . this will help control your condition and help control how your body uses its own way . when to inhales enersair brewinger is for
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side effect that may occur while using  EnerzAir breezehaler are the same as for other medicines . these side effects may include : very common - may affect more than 1 in 10 people sore throat , runny nose , sudden difficulty breathing and feeling of tummy pain . common  may affect less than 1in 10 people feeling sick ( nausea ) or vomiting , loss of appetite
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister and inhale in the dark . after opening , the capsule may be taken out of its blister immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered ( inhaled ) dose contains 150 micrograms of inddacatrol ( AS actate ), 63 microgram ( 0 . 5 ml ) glycopyrrionum bromid , equivalent to 50 microgram( 0. 5 microgram ) of glycopyronicum and 160 microgram [ 1 . 0 microgram] momeatasONE furoates . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) contains 114 microgram of indigacaterolul ( as as аcetate ) 58 microgram glycopyrironum bromite , 46
clopidogrel acino pharma gmbh contains the active ingredient clomidogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called tetany ). clodogreil acini pharma mg bh is taken to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosis , and atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopdo
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to cloclopidorl or any of the other ingredients of clopogrell aco pharma or any other ingredients that may be present in clomidogre l - if your medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain -if you suffer from severe liver disease - take special care with clodogrela acini pharma grbh check with your doctor or pharmacist before taking clodidogrelus aca pharma goggles if any of these apply to you . if vous are not sure , talk to your doctor before taking the medicine . warnings and precautions talk to you doctor before you take , or during treatment with clupidogral аcino
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of cloidegrel alcino  Pharma gmmbh per day to be taken orally with or without food , and at the same time each day . if vous take more clopogrell aco pharma
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to10 users in 1 , 000 ) rare ( affecting 1 toten users in 10 users per 10 ,000 ) very rare (affecting only 1 to Ten users in10 , 10 . 000 ). very rare [ affects less than1 user in 1 10  , 500 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . signs of liver problems such as
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . store in original blister or film - coated tablets in order protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clodogrell . each tablet contains 75 mg of clopdogral ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( е462 ) titanium dioxide (  e 171 ) what acantine acacia pharma mgmbc looks like and contents of the pack clopodogre aco pharma gamut 75 mg film – coated tablets are white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons containing 14 ,
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it contains three active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , known as a nucleonide analogue reverse transcript
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . the following medicines are not recommended : carbamazepine / oxcarbazepine ( e1200 ), phenobarbital and phenytoin ( medicines to prevent seizure ) rifampicin and riffapentine ( medicines for tuberculosis ) delhiguan / grazoprevir ( medicines against tubercusis and not effective in st . jen ' s wort ( hypericum perforatum ) ( a herbal remedy used for
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is : - take a complete regimen . take : one tablet each day with food , a glass of water , and a single tablet with hiv infection . - use in children and adolescents the recommended starting dose is 1 tablet once a day . do not take certain medicines , such as doravirine . you can take medicines containing this medicine swallow the tablets whole . this medicine can be taken with food or between meals . taking this medicine take your tablet at the same time each day , with or without food . it is important that you take delstrigo every day ; this is to make sure that you do not miss a dose of delspigo . your doctor will tell you how long you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common : may affect more than 1 in 10 people - abnormal dreams - difficulty in sleeping ( insomnia ) - headache - dizziness - sleepiness - cough - nasal symptoms - feeling sick ( nausea )- diarrhoea - stomach pain - vomiting - wind ( flatulence ) hair loss - rash muscle symptoms ( pain or stiffness ) feeling tired ( fatigue ) common ; may affect up to 1 in every 10 people common . - changes in taste - low blood sugar ( hypoglycaemia ) uncommon : will affect upto 1 in 100 people : - loss of appetite - constipation - dry mouth - hair
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the expiration date refers to the last day of that month . keep the bottle tightly closed in order to protect from moisture . this medicinal product does not require any special temperature storage conditions . store in the original package until use to protect the medicine from moisture and only remove immediately before first use . discard the bottle after first use because it contains no visible particles .
what delstrigo contains each tablet contains 100 mg doravirine . each tablet also contains 300 mg lamivudine , and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate in the tablet core and microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumarat in the film - coating material : carnauba wax e903 , the hypmosphere , iron oxide yellow ( e172 ), lactose monohydrate , titanium dioxide e171 and triacetin in the printing ink . what delustrigo looks like and contents
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you should take this medicine every day to treat your depression . it helps to control the symptoms of depression such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . s Pravato can be used either on its own or together with another antidepressant ( see section 2 under " take special care with sprivato "). it is important that you also read the information gathered about some of the ingredients of antidepressive medicines .
do not take spravato if you are allergic to esketamine , which is a substance produced by a specialised laser tag , or to ketamine used in anaesthesia . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . for further information please refer to the section " do not store " in the space provided on the outer carton . if your doctor has told you that you have an aneurysm ( a weak spot on a blood vessel wall that bulges out ) that is bleeding in the brain . you have recently had a heart attack which is due within 6 weeks . your doctor may decide to continue to monitor you more closely because of a temporary increase in blood pressure . this is because serious complications
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray is for oral use . instructions for use follow these instructions carefully and ask your doctor for advice . the nasal spray device is for use at intervals of 1 to 2 days . you may need to use 3 nasal spray devices . if necessary , you may use only one nasal spray applicator and it will take about 4 hours or more to get rid of the medicine . do not use more than one applicators per day . use in children and adolescents sprivato is for adults and children aged 2 years and above . taking this medicine you should take this medicine every day , as instructed by your doctor and , if possible , to reduce nausea and vomiting . your doctor will tell you how long
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity to noise in the mouth area , spinning sensation , vertigo , vomiting nausea common ( might affect up to 1 in every 10 people people ), feeling extremly happy ( euphoria ), being agitated , feeling sex drive not knowing what you can take to make you feel . this is common . if you notice any of the side effects above , tell your doctor straight away . other side effects include : common ( will affect upto 1 in each 10 people you may feel dizzy or sleepy ( hyperventilated ), not
what spravato contains - the active substance is esketamine . each nasal spray device contains esesketamine hydrochloride equivalent to 28 mg eeskettamine - other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what ' s precluded ' means ? what  s Pravato looks like and contents of the pack spruvato is a nasal spray solution . this medicine is  a clear , colourless solution in a single - use nasal spray unit . sprivato comes in packs of 1 , 2 , 3 and 6 nasal spray devices . all pack sizes are available . not all pack size may be marketed . every nasal spray machine is individually sealed blister .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . zelmoraf works by preventing cancer that has a change ( mutation ) in a gene called cd38 , which leads to the development of melama . by blocking this gene , zeloraf targets proteins that are known to be involved in the dna of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking zeloraf and if any of these apply to you : - signs of allergic reactions include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . zelburaf may cause allergic reactions . allergic reactions are rare but can be life threatening . you should stop taking zeborafic and tell your doctor straight away if they happen . stop taking the medicine and see a doctor straightaway if there are any symptoms of an allergic reaction , such as swelling ofthe face  , lips or tongue which may cause difficulty breathing or rash , or fainting feeling . severe skin reactions may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day taken in the morning . your doctor may increase your dose to 8 mg once daily . if necessary your doctor will increase your dosage to 4 mg twice a week . in case you experience side effects your doctor might lower your dose or stop your treatment . taking zelboraf at bedtime may help prevent vomiting . take zeloraf on an empty stomach . swallow the tablet whole with water . you can take zeborafic with or without food . try to take your daily dose at any time of the day . it is important to take zboraaf every day , as instructed by your doctor . this will help you to remember to take it . however , if it is almost time for your
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions : swelling of the face , lips or tongue difficulty breathing rash fainting sensation when taking zeloraf . radiation treatment : tell your doctor if you get any of the following side effects after zelburaf treatment . you may be exposed to some types of radiation . during zelbof treatment you may get radiation that may affect the skin , epiphyses , bladder , liver , rectal , and lungs . tell your physician immediately if your doctor notices any of these effects : skin rash with blistering , peeling and / or discoloration of the skin shortness of breath , cough , or difficulty breathing redness of the mucous membranes . hives . they may be severe . skin
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don ’ t need . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemorafence ( as a co - precipitate of VEmuraFenibe ). - other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , and hydroxypropyl cellulose . tablet coating : magnesium stearate film , iron oxide red , macrogol 3350 , polyvinyl alcohol , part hydrolysed , indigo carmine ( e132 ). indigent carmine sodium . what zeboraffe looks like and contents of the pack zeloraf 240 milligrams film  shaped , pink
duoplavin contains two active substances , clopidogrel and acetylsalicylic acid ( asa ) in one tablet . these belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it can damage the blood vessels . antiplatelets medicinal products reduce the chances of blood cluts forming ( this is called atherothrombosis ). duoplacevin is taken to prevent blood coagulations forming in hardened arteries , leading to atheropenia events ( such as stroke , heart attack , or death ). you should carefully read the package leaflets before you take duoplatin .
do not take duoplavin - if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) -if you or your doctor thinks you may be allergic to other products ( non - sepsis anti - ininflammatory products ) which are used to treat painful and / or inflammatory conditions of muscles or joints - have a medical condition such as asthma - need nasal discharge , runny nose with polyps ( a type of growth ) in the nose - are in the presence of a medicinal condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . warnings and precautions talk to your doctor or pharmacist before taking duoplacevin . talk to you doctor or nurse before taking the medicine 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is one tablet a day . it does not matter what time of day you take your medicine . duoplavin can be taken with or without food . if your doctor decides that you cannot take it , you should take it at the same time each day , preferably at the hospital or at the end of the day unless you have the impression that the effect of duolavin is too strong or too weak . talk to your doctor about how long you should continue to take duoplacevin . you should keep taking duoplanvin for as long as your doctors tells you , and at the right time every day ; this is to stop the development of a heart attack . take duotroplavin for once
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or peeling of skin . most of these effects disappear after a few days . very common : may affect more than 1 in 10 people - loss
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any visible sign of deterioration . DO not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duopvin 75 mg film - coated tablets : each tablet contains 75 mg of the active substances , clopidogrel and acetylsalicylic acid ( asa ). each tablet provides a total of 75 mg clodogrell ( as hydrogen sulphate ) and 75 mg ( 4 mpa s ) of acettingylalicyLIC acid , in the form of mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose / maize starch , hydrogenated castor oil . see section 2 ' duo plavin contains hydrogenated castingor oil'.
simbrinza contains two active substances : brinzolamide and brimonidine tartrate . brinzolide belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartratrate belongs to another group of medications called alpha - 2 adrenergic receptor agonists which work by reducing pressure within the eye . simbrINza is used to treat conditions in the eyes in adults aged 18 years and older who have eye conditions such as glaucoma or ocular hypertension ( high pressure in the front of the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes or infections , or diuretics ( water tablets ) called monoamine oxidase ( mao ) inhibitors ( medicines used for depression or parkinson ' s disease ) or certain antidepressants ( see " taking simbrine "). if any of these apply to you , tell your doctor before taking simrinza ". warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have severe kidney problems . you have too much acidity in your blood ( hyperchloraemic acidosis ) for less than 2 weeks 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use simbrinza for your eyes ( ocular use ). do not swallow or inject . simbrenza should only be used by eye care professionals . wash your hands after you have opened the bottle . step 1 - twist the bottle cap . after snap collar is removed , the medicine should not be injected . squeeze the bottle tightly in one hand . twist off the bottle and pull down the sachet to release one drop of the medicine onto your fingers . hold the bottle ( s ) between your thumb and fingers , keeping the product from falling asleep . tilt your head back . pull down your eyelid with a clean finger , until there is a ' pocket ' between the eyelid and your eye .
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of this medicine are usually mild to moderate in nature . if you experience a reaction to the medicine ( frequency not known ), tell your doctor or nurse immediately . an allergic reaction may be recognised as severe skin reactions ( rash , redness or itching all over your body ), or eyes trouble breathing , chest pain or irregular heart beat tell your physician or nurse immediate if : extreme tiredness or dizziness some side effects may be serious . simbrinza may interact with other medicines . tell your doctors or nurse if they are concerned about any of the following : very common ( may affect more than 1 in 10 people ): allergic reactions ( frequency cannot be estimated from the available data ) - an allergic response ( see section 2 ). - severe skin reaction ( e .g 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . unopened bottles : store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . once opened , simbrinza is stable for 4 hours at 25 . to prevent infections , protect your medicine from moisture and use a new bottle . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolide and 2 mg of brimoniidine tartratrate equivalent to 1 . 3 mg brionidine . -the other ingredient is benzalkonium chloride ( see section 2 " simbrine contains benzallenium chlorides "). - other ingredients are propylene glycol , carbomer 974p , boric acid , mannitol . the other ingredients in the suspension are sodium chloride , and tyloxapol , hydrochloric acid and sodium hydroxide . what simminza looks like and contents of the pack simbronza is a white to off - white lyophilised suspension . each pack contains one vial containing one via
what filgrastim ratiopharm is filgraStim ratioppharm contains the active substance filgraştim . filgrastastim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to , a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrasstim stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filgranstim relationpharm looks like and contents of the pack filgrastorm ratiophol is very popular in adults , children and adolescents . you will be given filgrasperm
do not use filgrastim ratiopharm : if you are allergic ( hypersensitive ) to filgraştim or any of the other ingredients of filgraStim ratioppharm . take special care with filgraskastim rapportpharm tell your doctor if any of these conditions apply to you . if vous are not sure , talk to your doctor or pharmacist before taking filgrastastim combinationpharm warnings and precautions talk to you doctor or nurse before using filgraşistim relationpharm and during treatment with filgranstim mixturepharm you may experience a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder ( see section " possible side effects "). if your doctor thinks you may be at risk of sickle cell disease 57 if : you get left upper abdominal pain or pain at the tip of your shoulder . it
your doctor has prescribed filgrastim ratiopharm because you did not receive enough filgraştim ratioppharm . always take filgraspipparm exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much filgraşitim ratiopospharm to take the amount of filgrastorstim rapportpharm you will receive depends on your condition . your doctor will tell you exactly how many cycles of filgristim relationpharm treatment you will take . the usual starting dose of filgranstim relative to chemotherapy is 0 . 5 million units per kilogram body weight . for some patients , the first dose will be given to you in a hospital or clinic . in general , it may take about 30 days or more to complete your treatment . this usually takes about 14 days . some disease types may still respond to filgrasti
you must not be given filgrastim ratiopharm : if you have sickle cell disease . 57 if your doctor tells you that you have left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests while you are being treated with filgraStim ratiopparm to check the number of neutrophils and other white blood cells in your blood . this is to check that treatment is having the desired effect . other medicines and filgrastastim combinationpharm tell your doctor or pharmacist if : you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . filgrastortim ratiompharm should not be used
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgraşitim ratioppharm must not be used if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgraştim - filgraşim ratiophelp 30 miu in 0 . 5 mL solution : each vial contains 30 million international unit [ miù ] [ mi miu
what riluzole zentiva is rilluzolle zentivea contains the active substance rilsuzola . it acts on the nervous system to help it function more smoothly . what reiluze zetiva used for rluzoler zenta is used in adults to treat amyotrophic lateral sclerosis ( a form of motor neurone disease ). in amyokaemia the nerve cells responsible for sending instructions to muscles become weak , muscle waste and paralysis occur . the destruction of nerve cells in motor neurones disease may be caused by too much glutamate (  a chemical messenger ) in the brain and spinal cord . rizole vertigo works by blocking the action of glutamates , which are involved in the nerve cell functioning and repairing the damaged nerve cells .
do not take riluzole zentiva if you are allergic to rilsuzola or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). the doctor may also want to test you if : you are pregnant . warnings and precautions talk to your doctor before taking rilluzolе zentivea : if there is any liver problems . if yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick , being sick - if the kidneys are not working properly , if fever is expected . this may mean you have a low number of white blood cells which are important in fighting infection . children and adolescents if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . take the tablet at the same time each day , taking the tablet by mouth , for at least 12 hours . if your doctor advises you to take riluzole zentiva more than once a night , contact your doctor at or near your nearest hospital emergency department immediately . keep the tablet bottle tightly closed . do not swallow the desiccant . to ensure maximum effect from rilsuzolle zentivea , do not take a double dose to make up for a forgotten tablet . you should take this leaflet with you so that your doctor knows what you have taken .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : fever ( increase in temperature ) while taking riluzole zentiva , there may be a decrease in the number of white blood cells . your doctor will make a blood sample to check the number and type of whiteblood cells , which are important in fighting infections . if your doctor determines that you have yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick or being sick , as this may be signs of liver disease ( hepatitis ). you will need to have regular blood tests while you are taking , and while you ' re taking . you may experience cough , difficulties in breathing , or swallowing . this is linked to the way your medicine works
what riluzole zentiva contains - the active substance is rilsuzola . - each tablet contains 50 mg of rilluzolation ( as 202 mg ). - rillianzole has been prepared by recombinant technology . the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrously colloidal silica , magnesium stearate , croscarmellose sodium , and hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what ricuzolle zentive looks like and contents of the pack the tablets are white to off - white , oval shaped tablets , each tablet containing 50 mg rifampicin ( as mesilate ) and de
emgality contains the active substance galcanezumab . this is a medicine that works by altering the cgrp ( calcitonin gene - activator ). egality is used to treat migraine in adults with increased levels of cggrp . emmgality can help to reduce the frequency of migraines in adults and children aged 4 years and above .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using egality your doctor will have told you : if your child has a serious cardiovascular disease . emmgality can cause serious cardiovascular diseases . serious cardiovascular disorders and allergic reactions emegality may cause serious allergic reactions and these reactions are rare . you should seek urgent medical attention if 40 you experience a seriously allergic reaction . stop using msgality and tell your doctor straight away if such signs occur ( see also section 4 . children and adolescents ehgality has not been studied in children and teenagers under the age of 18 years . other medicines and eimgality tell your child ' s doctor or nurse if any of these
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg . egality is given by injection under your skin ( subcutaneous injection ). you or your caregiver may choose to give your emmgality injection at any time of the day , but only after receiving proper training . you or someone else should receive 240 doses . injecting eimgality yourself or a child should not attempt this unless you have been properly trained first . your doctor will tell you how to inject emegality . however , if your doctor determines that you need to inject yourself or your child , please read the instructions at the end of this leaflet . please read and follow the instructions for use carefully . do not attempt to inject your dose at home unless your doctor tells
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur . you should see your doctor immediately if you notice rash or itching . these are very rare , and may affect up to 1 in 1 , 000 people . difficulty breathing or swallowing , low blood pressure which causes dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat and severe itching of the skin , with a red rash with raised bumps . other side effects tell your doctor if : you notice any of the following : very common side effects ( may affect more than 1 in 10 people ): headache , diarrhoea , pain in the mouth or throat , difficulty breathing , or swallowed , 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . if refrigeration is not available , emgality can be stored for up to 7 days below 30 in its original carton . keep the vial in the outer carton in order to protect from light . this medicine does not require any special storage conditions . any unused medicine must be discarded after the first use . discard any discarded medicine .
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg galcanab in 1 ml solution . the other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what  eimgality looks like and contents of the pack emmgality is a solution for injection supplied in a clear glass syringe . colourless to slightly yellow , the sYringe is essentially white . emegality comes as a single - dose pen . pack sizes of 1 , 2 and 3 single  dose pens . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hep ) in which the blood vessels in the liver become damaged and blocked by blood clots . defit li0 is only used in adult patients who have not had a stem cell transplantation . heparin is recombinant , so the body ' s own blood molecule can be used to make defibroTide , which has been shown to work in the blood vessel walls to help prevent the blood coagulations . this medicine is for use in adults and children .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before using defitelfio tell your doctor or nurse if : you are taking other medicines to thin the blood , such as those obtained without a prescription , to prevent blood clots , or to use tissue plasminogen activator warnings : this is a type of medicine used to prevent bleeding . if there is heavy bleeding , and you need a blood transfusion , for example , if surgery is planned . you have problems with blood circulation . your doctor will decide if defit lia is suitable for you . it is important to keep following the instructions in section 1 of this leaflet . other medicines and defit
the treatment with defitelio is the same as with stem cells transplantation . it is given into one of your veins ( as an ' intravenous infusion ' or drip ). this treatment will be given over 21 days , unless you have experienced any improvement in your symptoms . use in children and adolescents defit elide can be used in children from 18 years of age . if you use more defitlion than you should if a child swallows some tablets , contact a doctor or a nurse . tell the doctor or pharmacist if this applies to you . do not take a double dose to make up for a forgotten dose . take your next dose at the scheduled time and continue as normal .
like all medicines , defitelio can cause side effects , although not everybody gets them . defit lion can cause possible side effects although not everyone gets them very serious if you get any of these side effects contact your doctor immediately . very common ( may affect more than 1 in 10 people ) low blood pressure common ( might affect up to 1 in every 10 people people ). bleeding in general bleeding ( the nose bleeding , the brain bleeding ), the gut vomiting blood bleeding in the lungs bleeding blood in the urine or in the mouth bleeding ; the skin coagulopathy ( disturbance in blood clotting ); a very small number of white blood cells ( neutrophils ) in the blood ( anaemia ); allergic reactions ( e . g . swelling of the face , lips , tongue , throat and tongue ); blood in stools ; blood in urine 
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the infusion storage after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defitеlion may be kept for up to 24 hours in the original package in order to protect from light . however , it should be discarded if the solution is cloudy or if particles in it are distinctly brown .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibrototide and each m l solution contains 80 microgram ( mg ) defibroTide - this additive additive contains sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defit elideo contains sodium ". what deFITelo looks like and contents of the pack defitеlia is a clear , colourless to pale yellow solution . it is supplied in glass vials as a concentrate for solution for infusion . one pack contains 10 vial ( 2 , 5 . mL ) of concentrate .
daklinza contains the active ingredient daclatasvir and is used to treat hepatitis c ( an infectious disease that affects the liver , caused by the hepatis b virus ). this medicine works by stopping the hpatiti c virus from multiplying and infecting other people . it also reduces the amount of the ' heptis
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ). - take the tablets by mouth . - do not swallow the tablets . tell your doctor if your doctor has told you that you are taking any of these medicines : phenytoin , carbamazepine , oxcarbazepine or phenobarbital ( used to treat epileptic seizures ) rifampicin / rfabutin - or riffapentine ( antibiotics used to prevent and treat tuberculosis ) dexamethasone ( a steroid used to relieve allergic and inflammatory diseases ) medicines containing st .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . this is a total of one tablet per day , which should be swallowed with water or a drink of water . do not chew , crush or split the tablet as this may have a very unpleasant taste . if necessary , daklinezza may be taken with some other medicines , including daklinac . your doctor will tell you which other medicines to take before you start taking daklinag . taking these medicines together with your daily dose of dosing will help to improve the treatment . when you are taking daclinnza with other medicines for hepatitis c infection , these medicines should be taken at the same time of the day if possible . you should not take
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is taken in combination with sofosbuvir and ribavirin , the following side effects may occur : very common ( may affect more than 1 in 10 people ) headache fatigue common ( May affect up to 1 in10 people  ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles not known ( frequency cannot be estimated from the available data ): when daclinza was taken in conjunction with sofranchitis / ribamvirin the following serious side effects have been reported : common ( might affect upto 1 in every 10 people and may affect upt ) tiredness . common (may affect up 1 in each 10 peoples ) trouble sleeping dizzyness headache nausea ( being sick
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaatasr ( as dihydrochloride ). - other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide . printing ink : shellac , macrogol 400 , indigo carmine aluminum lake , yellow iron oxide ( e172 ). 51 what daclinza looks like and contents of the pack daklianza 30 mg film  coated tablet : the film ­ coated tablet is stamped with " bms 30 " on one side . the film is scored and has " tg "
proquad is a vaccine to prevent measles , mumps ( rubella ) and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the meases and mops caused by rubella and varicelloviruses . the antibodies help the body to make its own antibodies which help protect against diseases caused by these viruses , and proquade helps to protect against meales / mashes caused by Rubella and chickenpex ( variablecellas ). the vaccine works by causing the body ( immune system ), to produce its protection ( ms ) that protects you against methaemoglobin ). proquab is given after an interval of at least 12 months between the first
do not use proquad if you are allergic to any varicella vaccine , to measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using proquade . talk to you doctor if : you are taking neomycin - you have a blood disorder or type of cancer that affects the immune system . before treatment with medications that weaken your immune system ( e . g . low - dose corticosteroid therapy ) you have asthma ( replacement therapy ). you have been told by your doctor that you have such a weakened immune system due to a disease ( including aids ), or from congenital or hereditary immunodeficiency ( aids +) or lack of immune competence 
the doctor or nurse will inject proquad into the muscle or the skin of the upper thigh or upper arm . the two injected muscles are to be injected into the same muscle ( thong area ) or upper arms area . when the two were injected together , they should never be given into the middle - aged area ; if there is a blood clotting disorder or low levels of platelets , the vaccine will not be given to the skin because of the increased risk of bleeding . proquade will be given under the skin until an established muscle has been formed . a second dose of proquaad should be given after an injection to help protect the muscles . your doctor will decide which is best for you .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) can occur very rarely . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor . other side effects that have been reported with proquad are : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ), bronchiolitis ( difficulty breathing , cough ) and unsteadiness with walking . side effects reported with the use of proquade are , among others : very common ( may effects up to about 1 in 10 people ); injection site complications ( including pain , swelling or swelling ); swollen hands , ankles or feet ( oedema ); weight
what proquad contains the active substances are : measles virus1 , edmonston strain ( 3 . 00 pfu ) mumps virus1 ( containing jeryl lynn TM in level b ) strain ( corresponding to 4 . 30 pcl ). rubella virus2 ( resulting from 3 .00 pvd ) varicella virus3 , and merck strain ( equivalent to 3 .99 pdml ) cultured cells . plaque - forming units 1 produced by recombinant dna technology in chick embryo cells and fibroblasts . the other ingredients are mrc - 5 ( ph - 6 ( h5n1 ). the other ingredient is powder sucrose , hydrolysed gelatin , indigo carmine
jylamvo is harmless from the body . it is an anticancer medicine which reduces unwanted reactions . because it is used as an immunosuppressive agent with an anti - inflammatory effect jYlamva is used to treat rheumatic and skin diseases : - in adult patients with active rhumatic arthritis , which are often caused by polyarthritic forms in the joints -in adult patients - with severe juvenile idiopathic arthritis ( jia ) j sediatric patients ( aged 3 years and above ) who have been treated with non - gestational anti – inflammatory drugs ( nsaids ) when inadequate o severe or disabling psoriasis cannot be adequately controlled by treatment with phototherapy , pSoralen , and ultraviolet a radiation ( pu
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe kidney impairment if the doctor treating you thinks this applies to you , or if any of your close relatives have , have e . g ., a liver impairment . warnings and precautions talk to your doctor before taking jYlamva if : you have blood disorders ( bone marrow hypoplasia , leukopenia or thrombocytopenia ) or significant anaemia 34 you have been told that you suffer from a weakened immune system after a serious infection ( e. .g , tuberculosis or hiv ). you have ulcers in the stomach or intestines
jylamvo is a medicine that can only be prescribed by a doctor with experience in treating patients with rheumatoid arthritis . jia can cause severe side effects , sometimes leading to even death , during the course of the treatment . there have been reports of severe recurrence of rhumatoned arthritis in some patients , including severe juvenile idiopathic arthritis , severe psoriasis and severe ppsoriatic arthritis ; however , jуlamva is considered a long - term treatment , possibly lasting for months or years . your doctor will decide if jYlamgo is suitable for you . it is also used in adults with a history of racmatic and skin diseases , in particular jif you have jis , and in children with p
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you : experience wheeziness or difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other side effects may include : breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty in breathe , chest pain ( fever ), spitting or coughing blood or serious peeling with blistering , reddening . experience difficulty in swallowing and / or burning sensation when coughing - this happens normally . it does not matter whether this happens in your body or in your throat . if at any time you have these symptoms , tell your physician . side effects can include , but are not limited to : breathlessness , cough
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store below 25 . keep the bottle tightly closed in order to protect from light . accidental spillage should be ruled out . storage in a refrigerator ( 2 - 8 ). do not freeze . any unused medicine or waste material should be in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as mesilate ). - - other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , 8h - parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzoate (e219 ), citric acid , tri - sodium citrate , purified water . see section 2 " jlylamva contains ethyl parahydroxy benzoate and sodium hydroxybenzonate ". what i have been looking like and contents of the pack jlamo is a brown glass bottle containing 60 doses , sealed with a child - resistant closure . the bottle also contains a
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enturev is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . how enUREv bronzehaler works enurév BREEZhaler blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary area . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using enurév BREezhalER if any of these applies to you : - you have kidney problems . - your doctor may want to change your dose . talk to a doctor if your doctor has told you that you have an eye problem called narrow - angle glaucoma . your doctor will tell you if this applies to your life . you have difficulty passing urine . during treatment with enUREv brewinger , stop using this medicine and tell your doctor immediately if : you get tightness of the chest , coughing , wheezing or breathlessness immediately after using En
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhaled once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor advises you not to use more of this medicinal than your physician has told me . when to inhales the medicine as inhalation powder should be inhayed from the capsule to the inhaler provided in this pack ( enurév BREezhalers inhalers ). the capsules should remain in the blister until you need to use them . to use each pack , find a new pack . use
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ; typical symptoms include excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( possible signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible symptoms of angioedema ) some side effect could be serious . tell your doctor straight away if you notice any of the following side effects you may need medical attention : very common ( may effect more than 1 in 10 people ] common ( might affect upto 1 in10 people  ) allergic reaction and swelling primarily of the mouth , tongue . lips -
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyrironum bromite ( equivalent to 50 microgram of glycopyronicum ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 8 microgram ) of glycoprronium . - two other ingredients of the enurév brewing system are lactose monohydrate and magnesium stearate . what  Enurev broeezhalers looks like and contents of the pack enuresv brueezhaer 44 microgramms inhalation powder , hard capsules consist of a white powder and are packaged in a carton together with a device called an inhalers , together with capsules in blisters . the product is available
what riximyo is rximyok contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritzimabe sticks to your cell , the cell dies . what if ruximyou looks like and contents of the pack ritchimyon is used for the treatment of several different conditions in adults . your doctor may prescribe r6imyyo for the treatment of : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue ( part of the immune system ) that affects a particular type of black blood cell named b- lymphocytic
do not take riximyo if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking rximyou . if your doctor thinks you may have a severe active infection at the moment . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : if the patient has a weak immune system . the patient had severe heart failure or severe uncontrolled heart disease , including granulomatosis with polyangiitis , microscopic polyangiviitis or pemphigus vulgaris . your doctor may want to monitor you more closely while you are taking . in this case you should tell your physician . before you
your doctor will check with you and will explain the risks and benefits of this treatment . this medicine will be given to you by a doctor or nurse who is experienced in the use of this medicine . they will watch you closely while you are being given this medicine and for any side effects . you will always be given riximyo as a drip ( intra - venous infusion ). medicines given before each rximyon administration before you are given a dose of richimya , you will be prescribed other medicines ( premedication ) to prevent or reduce possible side effects as well as your treatment will be supervised by raiximYo . for non - hodgkin ' s lymphoma patients who have received risimyone alone ritchimyyo will be administered once a week for 4 weeks . repeated
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , patients may experience pain at the infusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing and cough . other side effects may include : very common side effects ( may affect more than 1 in 10 people ): common side effect ( may effect up to 1 in10 people ). common side side effects in children and adolescents the side effects listed below have been serious . if you get any side effects you should tell your doctor immediately
what riximyo contains the active ingredient in rituximab is called ritzimyon . the 10 ml vial contains 100 mg of ritsimabe ( 10 mg / mL ). the 50 m / 1 mlitre vial contain 500 mg of of raituximb ( 10 % w /ml ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , and hydrochloric acid . see section 2 " rximyou contains sodium ". what ' risseimyun looks like and contents of the pack risimyone is a clear , colourless to slightly yellowish solution , supplied as a concentrate for solution for infusion . ritchimyô is supplied in glass vials
topotecan actavis contains the active substance topotenecan . topotent actaviz is used to treat small cell lung cancer that has come back after chemotherapy . it is used in adults to treat advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotencecan activis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis : - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotencecan activis , if your blood cell counts are too low . tell your doctor if this applies to you . do not stop taking topecan actingavis without your doctor' s advice . - have any kidney problems . your doctor may need to change your dose , or may tell you not to take topecan actassis . topotécan actas is not recommended in patients with severe kidney impairment . talk to you doctor : liver problems : topotacan actAVIs is also recommended in people with severe liver impairment , along with lung inflammation with signs such as cough , fever and difficulties in breathing
topotecan actavis will be given to you by a doctor or nurse who is experienced in the treatment of the disease . your doctor will carry out blood tests before you start treatment and will tell you when to return for treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per square metre of body surface area given over 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per m2 of body area given twice a week for 3 days , followed by ' normal treatment cycle '. for cervical cancer , it will be combined with another anticancer medicines called cisplatin . cistplatin may not be given if you have impaired kidney function . depending on your kidney function your doctor may decide that you should not receive topotécan activis . tell your doctor if
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following serious side impacts . they may be serious . infections ( very common : may affect more than 1 in 10 people ): - fever - signs of your general condition ( fever , which may be recognised by your doctor ). - local symptoms ( such as sore throat or burning sensation ) - severe stomach pain , fever . - diarrhoea ( rarely with blood ) or bowel inflammation ( neutropenic colitis ) has been reported in patients treated with topotecan actavis , but may also increase your ability to fight infections . this is uncommon . lung inflammation has been seen very rarely ( may affect up to 1 in 1 , 000 people ). you may experience difficulty in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special temperature storage conditions . keep the vially in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25  2 , in normal light conditions and 24 hours @ 2 to 8 , protected from light and light , and protected from moisture . the drug product solution obtained after dlution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been shown for 4 hours at room temperature , on samples reconstituted and stored for 12 hours and protected against light ; and 24 hour at 25oc  1oc and 2oc followed by 8 hours at
what topotecan actavis contains - the active substance is topotenecan . each vial contains 1 mg or 4 mg topotent ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of topotencecan -the other ingredients are mannitol ( e421 ), tartaric acid ( p177 ), hydroch chloric acid ( see section 2 ), sodium hydroxide ( see end of section 2 for further information ). what to potecan actsavis looks like and contents of the pack topotement actavistat is supplied in colourless glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps to help protect your vial . vial packs of 1 vial or 5 vial ( 100 mg ) or 1 viam per carton . not all
the active substance of rivastigmine hexal is rivassestigmin . rivassistigine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivainstigmine works by blocking the enzymes that break down acetoline : aceylchollinesterate and butyrylcholineSterase . by blocking these enzymes , it allows rivagastigme to increase the levels of acetélcholines in the mind , helping to reduce the symptoms of alzh - 67 and dementia associated with
do not take rivastigmine hexal - if you are allergic to rivassestigine ( the active substance in rivagastigmin heexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - in case of a previous skin reaction indicating allergic contact dermatitis with rivainstigmine ( see section 4 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking riv astigemine hxal the following are reasons why rivattigmine heath has been shown to cause irregular or slow heartbeat . - you have an active stomach ulcer . please tell your doctor about any difficulties in passing urine . tell your doctors if : - your child has seizures .- you suffer from asthma or severe respiratory disease . you have impaired kidney function . your doctor may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may then gradually increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day .your doctor will regularly check if the medicine is working for you , and will also monitor your weight whilst you are taking this medicine . do not take rivassitigmine histle cell or its parts in the body . take the tablets with some water . tell your doctor if any of the above apply to you ; if vous have not taken rivagetigmine himxal for more than three days , do not continue taking this
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in every 10 people people ), anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling dizziness when getting up from a lying or sitting position , feeling weak or lack of energy when getting to sleep headache , being sick , vomiting , flatulence , wind ( flatulens ) common ( will affect upto 1 in
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store below 30 . keep the bottle tightly closed in order to protect from moisture .
what rivastigmine hexal contains 64 - the active substance is rivagastigmin hydrogen tartrate . - each rivástigine heexal contains hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide ( i ) ( see section 2 ). - printing ink : shellac . each rastigemine hxal 1 . 5 mg capsule contains 1 , 5 mg of riv astmine . every rivage heexel 3 mg capsule contain 3 mg of the active substances . the other ingredients are : each rigasbergmine steeps 4 . 4 mg capsule is white , oval 
what cabometyx is cabotyyx consists of a cancer medicine containing the active substance cabozonib . it is used to treat adults with a type of kidney cancer called renal cell carcinoma , or liver cancer , when it has been prescribed a specific anticancer medicine ( sorafenib or a combination of both ). what accomodation is accomadation ? cabmetyux blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells , and by blocking their action cabrometyX may slow or stop the growth of these cells .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabrometyX if : you have high blood pressure you have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a wall of  you have diarrhoea you have a recent history of significant bleeding if your doctor thinks you may have had surgery within the last month or if surgical procedures ( including dental surgery ) you are suffering from inflammatory bowel disease ( a condition where the bowel is damaged , including inflammation of the blood vessels and the lungs ) if any of these apply to you , or , you are not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is for oral use . swallow the tablet whole ; do not crush , open or chew the tablet ; take the tablet at the same time each day . your doctor will monitor you for signs of serious side effects and may lower your dose if treatment with cabometyx is stopped . the recommended dose is one 60 mg tablet , once daily . you can take cabrometyX with or without food ; however , you may find it easier to take it at the exact same time every day ; if your daily dose is increased to one 2 hour tablet . if the tablet is reduced to one hour , then you may need to take the medicine again . how to swallow the tablets cabotyck is for mouth . it is best to
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get side effects your doctor may tell you to take cabometyx at a lower dose . your doctor might also prescribe other medicines to help control your side effects ( see section 2 ). if any of the side effects gets serious , or if they get serious : you may need urgent medical treatment . symptoms may include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever , and possibly a gastrointestinal perforation ( a hole that develops in your stomach and intestine ). severe or uncontrollable bleeding . you may also experience symptoms such as vomiting blood , black salts and / or blood in your stool . other side effects include : very common side effects that may affect more than 1 in 10 people : headache 
what cabometyx contains the active substance is cabozantinib ( s )- malate . cabrometyux 20 mg : each tablet contains cabonezantineb ( so - called ' cab ') - malATE . each tablet delivers 20 mg of cabazantib . the other ingredient is : cabombometychx 40 mg ; each tablet includes cabonantininibe (  ss ), - Malate equivalent to 40 mg of " cabzantinerinia ". - cabmetyxx 60 mg / 5 mg - the active ingredient is also called cabezant inib( s) ( h2n1 ) , - as malate equivalent in 60 mg of ( 0 . 5 mg
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreced hompira ist given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . besides pemetreexed hospira is also given in combined treatment with ciasplatin for the initial treatment of patients with advanced stage of lung cancer : pemetreexed horapira can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetreded houpira ester as a treatment for patients with progressive stage of  lung cancer
do not use pemetrexed hospira : if you are allergic ( hypersensitive ) to pemetreced or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or nurse . if your doctor wants to change your dose . warnings and precautions talk to your doctor , pharmacist or nurse before using pemetreexed as this medicine may affect the way pemetreexed housing is given . you must not use it in children under the age of 6 years . it is not recommended that pemetreded huspira is given to children under 6 years of age . breast - feeding should be avoided during treatment with pemetreed outweighs the risk of getting yellow fever . talk to you doctor if any of these apply to you and tell your nurse about any of your medical conditions 
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your particular body . this body surface area may be used to workout the right dose for you . a hospital pharmacist , nurse or doctor will use this body area to work properly . during treatment , your blood cell counts will be checked . to prepare the powder , you must use 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given . pemetrecexeed hospirate will be given to you by infusion into one of your veins . the infusion will last approximately 10 minutes . when using pemetreexed aspira in combination with cisplatin : the doctor will work out your
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your doctor has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may have chest pain ( common common ), or a fast heart rate ( uncommon ). if this happens , contact your physician immediately . pain , redness , swelling or sores in your mouth ( very common in patients with allergic reaction ) if exposed to sun ( common in humans ) or skin rash ( common with burning or prickling sensation ), fever ( common for children ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant dna technology has been demonstrated for 24 hours . the reconstructed solution does not need to be used . parenteral medicines should be disposed of in accordance with local requirement . any discolouration prior to administration is the responsibility of the user and would not be longer than 24 hours at 2oc 8oc . these medicinal products are for single use only . discard any unused solution .
what pemetrexed hospira contains the active substance is pemetreced . pemetreexed houpira 100 mg : each vial contains 100 milligrams of pemetreexed ( as pemetrexxed disodium hemipentahydrate ). pemetrezed hompira 500 mg ; each viam contains 500 milligramms of  pemetreXed( as pemeterxeed Disodium hae )). pemeterexed hospira 1 , 000 mg / ml : every vialContains 1 : 000 millilitres of per vial of pemeterexel ( as per pemetred dissodium hipentains ). after reconstitution , the solution contains 25 mg pfizer milliliters of ( 0 . 5 mg ) pemetre
ganfort contains two active substances called bimatoprost and timolol , which work together to reduce pressure in the eye . bimatophorest belongs to a group of medicines called prostamides . it works by blocking the action of a prostaglandin analogue , called tinol ( a substance that normally removes ) from the body . ganfordt belongs into a class of medicines known as beta - blockers . when the eye is empty , a clear , watery liquid is dripped over the eye and this reduces the pressure inside the eye which helps to reduce the glaucoma . the clear liquid is very sticky . your doctor has prescribed ganforcet eye drops to reduce high pressure inthe eye and reduce the risk of glaupa , and you should continue to use gan
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol , or beta - blockers , for 6 months or more . - for respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . warnings and precautions talk to your doctor , pharmacist or nurse before using ganfordt eye drop - solutions if your child has wheeziness , difficulty in breathing or long - standing cough . tell your doctor about signs of heart problems such if they start to get low heart rate or if the child starts to block the heart block . some patients have heart failure warnings , precautions and care should be taken when using this medicine . talk to a doctor if : - you have coronary heart disease ( symptoms can include chest pain
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is one bottle once a day . treatment should be started at a low dose . keep the bottle tightly closed in the neck until you can open the bottle . instructions for use follow these instructions carefully and ask your doctor to explain how to use gt . 1 . wash your hands . tilt your head back and look up at the ceiling . 2 . pull down your lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one drop of ganforcet into your eye . if this happens , try again . do not touch your eye during treatment . 4 . turn the bottle over and put the lid back on . 5 . bring the eye to the bottle with a finger .
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops , even if you are not sure . the following side effects have been reported with ganford ( multi - dose or single - dosing ): very common side effects ( may affect more than 1 in 10 people ) - the eye redness . common side effect ( may effect up to 1 in 9 people , including the elderly ) uncommon side effects (19 may affect up to 100 people ). - if the eye burning , itching , or stinging , and irritation of the conjunctiva ( the clear layer at the front of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes ; feeling of something in the eye ( conjunctional discharge ), flushing ; h
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . solution for eye infections : use within 4 weeks after first opening . this medicinal product does not require any special storage conditions . if you have any further questions on the use of ganFort , ask your pharmacist or nurse .
what ganfort contains - the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol , corresponding to 5 mg titmololl maleate equivalent to 6 . 8 mg . -the other ingredients are benzalkonium chloride ( as a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate / purified water , hydrochloric acid and sodium hydroxide . what g ganforcet looks like and contents of the pack ganfordt is a clear , colourless to slightly yellow eye drops , supplied in a plastic bottle . the bottles are packaged in packs of 1 , 3 bottles with a screw - cap and 3 , 4 bottles without needles . not
gefitinib mylan contains the active substance gefitib which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefit inib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefit inib Mylan . tell your doctor if : you have any other lung problems . some lung problems may get worse during treatment with gefiteinib in the following situations . you have problems with your liver . children and adolescents do not give this medicine to children and infants under 18 years of age . other medicines and gefitnib mythinia tell your doctors or pharmacist if any of these apply to you . if your doctor determines that you are taking , have recently taken or might take any other medicines . in particular , tell your dentist or pharmacist or nurse if using the following medicines : phenytoin or carbamaz
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet per day . take the tablet at about the same time each day , preferably on an empty stomach . you can take the tablets with or without food . if necessary , your doctor may lower your dose to 2 tablets per day ( preferably at least 1 hour apart ). swallow the tablet whole . do not use gefitinib mylan if your doctor has trouble swallowing the tablet . avoid any other liquids except water . stir until the tablet breaks up ( dissolve ) the tablet will dissolve in water , and drink it straight away . drink the mixture immediately . to make sure there is no medicine left , stir the tablet until it is dispersed in the water ; add water to the water and
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives / nettle rash , or difficulty breathing . serious breathlessness , including sudden worsening breathlessness when coughing or fever . this could be a sign of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) when gefitinib mylan is taken alone . severe skin reactions are common in most people . they spread to other parts of the body . the signs may include reddening of the skin or the eyes , dark urine , itching , burning or
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 mg of gefitineb -the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate ( s ) tablet coating : polyvinyl alcohol (  e1203 ), macrogol 4000 , titanium dioxide ( i ) ( ing ), red iron oxide ( a yellow iron oxide ) what geFITinia mylan looks like and contents of the pack gefit inib melan tablets are pink , biconvex film  11 . 1 mm x 5 . 6 mm with
reblozyl contains the active substance luspatercept and it is used to treat myelodysplastic syndromes . myeleodysplastic syndromes ( mds ) are many different blood and bone marrow disorders , in which many red blood cells become abnormal . this can cause signs and symptoms such as a low red blood cell count ( anaemia ), which is very common and requires red blood blood cell transfusions to be treated . reblockzyl is used : to treat anaeemia in adults with mDs who do not require red blood plate transfusion ( erythropoietin therapies ). to treat beta - thalassaemia in adult patients . ( thhalassaemic ) is a blood problem that is passed down through the bloodstream and cannot be cured . it
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) -if you ' re pregnant . ( it is also better to avoid regland in early pregnancy see pregnancy section .) warnings and precautions talk to your doctor or pharmacist before taking this medicine - in case you have thalassaemia or have had your spleen removed - have had a blood clot due to hormone replacement therapy have had or have ever had , or have or have have had an old blood clumping together . if any of these apply to you , tell your doctor . in case of a possible preventive measures , you should not take medicines to prevent a bleeding . talk to you doctor or nurse before taking reblockzyl to treat a 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . your doctor has carried out blood tests and decided you need reblozyl . reblizyl is given as an injection just under the skin ( subcutaneously ). how much reddyl you will be given the injections will be injected in the space provided by your doctor and will be calculated by your healthcare professional . the dose will be worked out based on how much you weigh . some people will be more likely to have the injection and the interval between the injection will be variable depending on your blood pressure . how much to use the recommended dose of rebrozyl for patients with myelodysplastic syndromes the maximum single dose is 1 . 75 mg per kg of body weight . in beta - thalassaemia the maximum multiple dose is 11 .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects which may be serious : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially if only on one side of the body , blurred vision , which are symptoms of a stroke . blood clots swelling in the area around the eyes , face / lips , mouth , tongue or throat allergic reactions including rashes and swollen lymph nodes swelling of the face and lips . uncommon side effects include : very common side effects ( may affect more than 1 in 10 people ) diarrhoea , feeling sick ( nausea ) vomiting , stomach pain , constipation ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl may be stored for up to 8 hours below 25 and up to 24 hours at 2  8 . dispose of any unused medicinal product or waste material . these measures will help protect the environment .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of lusatercept at the date and time of calibration . after reconstitution , each ml of solution contains 50 mg of latent luspatiercept ( as excipients ). the other ingredients are citric acid monohydrate , sodium citrate ( e331 ) and 80 sucrose , hydrochloric acid ( for ph adjustment ) , and sodium hydroxide ( for further information on pharm adjustment ). what retizyl looks like and contents of the pack rebrozyl is a white to off - white powder . reglazyl 25 mg and 75 mg luspent are supplied in blister packs of 10 . not all pack sizes may be marketed .
the active substance of fotivda is tivozanib , a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the growth and spread of cancer cells , by allowing the development of new blood vessels . fotiva is used in adults with advanced kidney cancer who have not responded or have not tried other treatments including alpha or interleukin - 2 , which may not be suitable for you if your disease is not well controlled .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotiva . high blood pressure : fotiv dabigatran can raise your blood pressure and treat your bloodpressure with a medicine . it is important that you do not have to take foivida to control your blood temperature . when you start taking fotigda your doctor may want to reduce your blood Pressure . you should not take it if any of these apply to you . your doctor will also tell you if and when you should stop taking fotda and will advise you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose of fotivda is 1340 mg for each kilogram of body weight ( 21 mg / 7 days ). take the capsules once a day at least 1 hour before or 1 hour after food . take the dose once - daily at least 4 hours after food and drink . if necessary , your doctor may reduce your dose of , or stop fotiva , until you are no longer benefiting from it . in case of unacceptable side effects , you should contact your doctor immediately . severe side effects may occur that do not occur without the advice of your doctor and may require further adjustments . fotiv da therapy should be initiated under the supervision of a doctor experienced in the use of fotda . the usual dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( see section 2 " take special care with fotivda "). contact your doctor immediately if you get high blood blood pressure , which can be life - threatening . symptoms can include : - severe headaches - blurred vision - shortness of breath - changes in your mental state - feeling anxious , confused or disorientated . your doctor will tell you what to do if this happens . if it gets worse after taking fotiva , stop taking this medicine and see a doctor immediately as these can be signs of high blood flow . it is important that you take a medicine to control your high blood cholesterol . stop taking fotda if your doctor thinks this is too high or too low . talk
what fotivda contains the active substance in fotiva is called tivozanib . each capsule contains tivonib hydrochloride monohydrate equivalent to 890 mg tivolinib the other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( 6000 ), yellow iron oxide ( E172 ) and propylene glycol ( erection ) for reinforcement of strong ammonia solution , and titanium dioxide , tartrazine aluminium lake ( czem ). printing ink : shellac and propylon glycol for reinforcement for strong ammona solution and indigO carmine aluminium lakes ( k29 ). what fotiveda looks like and contents of the pack fotiv da is a white to off - white 
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisitegrar emtricitabine , which is an antiregulatory medicine known only as a nucleoside reverse transcriptasE inhibitor ( nrti ) tenofovir disoproxil , another antirétroviral medication known as  a nucleotide reverse transcriptainse inhibitor ( nucleic acid ) in the blood . st . martin - grenadine , active substance of strebild , is a single tablet regimen . it is used for the treatment of human immunodefici
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir ( as ten ofovir disoproxil ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sTRIbild , particularly if : you have been taking treatment with any medicine containing tenovir désoproxils , because your kidney function may need to be checked more frequently or if the recommended dose of these medicines is higher than alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats ) 47 dabigatran ( used in the treatment of blood clots ). carbamazepin
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose for adults and adolescents 12 to less than 18 years of age is 35 mg once daily by mouth . your doctor will decide on the dose that is right for you , depending on your condition and on how you respond to your medicine . do not change the dose unless your doctor has told that it is appropriate to do so . for the treatment to be effective , your doctor may prescribe medicines such as oral supplements , antacids or laxatives containing minerals ( e . g . magnesium , aluminium , calcium , iron , zinc ). for the first 4 weeks follow the instructions ( see section 4 , " what you need to know before you take stribild "). if your doctor thinks the effect of
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , but not everyone gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivi disease itself . some serious side effects can occur , so it is important to contact your doctor immediately if you notice any signs of lactic acidosis ( excess lactic acids in the blood ) which may be a common side effect of some hiv medications . lactic Acidossis is more common in people who are overweight , have liver disease . the risk of luc
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvisitegrar , 150 mg cobicitat / 200 mg emmtricit abine / 245 mg of the active substance tenovir désoproxils , 300 mg of each active substance and tannegravir dissoproxile fumarate 136 mg of this active substance the other ingredients are croscarmellose sodium , and hydroxypropyl cellulose , lactose monohydrate , magnesium stearate ( e470b ). what atribild looks like and contents of the pack the srbild tablet is a white 
zyprexa contains the active substance olanzapine . zypréxa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , with symptoms of excitement or euphoria . using zyPrexa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olazapinе treatment .
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a large swollen face , or swelled lips or shortness of breath . if this has happened to you , tell your doctor . eye problems can sometimes develop glaucoma ( increased pressure in the eye ). if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking zyPrexa as you should not take this medicine . warnings and precautions talk to you doctor or nurse before taking this medicine and during treatment with zypa . the use of zypresa in elderly patients with dementia is not recommended as it may have serious side effects
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zypresa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypréxa unless your doctor tells you to . you should take your zyPrexa tablet once a day following the advice of your doctor and follow the instructions for taking your tablets . it does not matter whether you take them with or without food . zy prexa coated tablets are for oral use . take the zypa tablets at the same time each day . follow the directions given to you on the carton . patients taking zprexа can take the following symptoms : rapid beating of the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ), especially in the legs ( symptoms include swelling , pain and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if these symptoms occur , contact your doctor or nurse immediately . very common side effects ( may affect less than 1in 10 people) - mainly the face and tongue -- blood coagulations in the vessels ( an unusual side effect affecting less than1 in 10 patients ): - in the lower legs ( possible symptoms include : swelling 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be used immediately after its opening . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypresa tablet contains 2 . 5 mg , 5 mg, 7 . 7 mg / 10 mg . the tablet can be divided into equal doses . your doctor will prescribe the strength that is right for you . for the different zypréxa tablets strengths , see the table below for the various zypa tablets strength strengths . zypexa 2 , 7. 5mg , 10 mg or 15 mg : 20 mg ; for the tablet strengths : see the chart below for more information . what yprexа looks like and contents of your zyPrexa tablet pack contains : lactose monohydrate , hyprolose , crspovidone , microcrystalline cellulose , magnesium stearate . tablet coating 
what prolia is prolivia contains the active substance denosumab . it is a type of protein ( monoclonal antibody ) that attaches to another protein ( glucocorticoids ) and prevents bone loss associated with osteoporosis . treatment with prolium helps to make bone stronger and lower the amount of oestrogen that reaches your bones . this happens naturally after the menopause . as a result , oesterogen level drops and bones become thin and fragile . what is osteopotic about osteoporoross patients with osteoponement are already taking testosterone and gluconocorticoides , which help to reduce the risk of osteoposseous symptoms .
do not use prolia - if you have low calcium levels in the blood ( hypocalcaemia ). -if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolium . before using protoliam , tell your doctor if : you have ever had a skin infection . symptoms include a swollen , red area of skin on the upper leg that feels hot or tender . you have cellulitis , which may cause symptoms such as fever . these symptoms may be due to an allergy to latex . the needle cover of the pre - filled syringe contains a derivative of latex which is essentially free of calcium . it is important to check the label to make sure it is clear and colourless .
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is one pre - filled syringe of 60 mg given once every 6 weeks , as a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . do not inject prolium yourself unless your doctor tells you to . your doctor may ask you to remove stickers , or ask you for advice . calcium and vitamin d supplements should be taken when you are receiving prolisa . if your doctor decides that you need to inject prolaia yourself , please discuss this with your physician . how to inject yourself with prolifa is for injection : you will need to keep having prolivia for as long as your treatment is working . it is important to follow the
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia can also cause skin infections such as cellulitis . tell your doctor immediately if you get any of these symptoms after taking prolivia : - swollen , red area of skin on the upper leg that feels hot and tender , with symptoms such as fever . during treatment with prolium , you may experience pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw - discharge , numbness or a feeling of heaviness , or loosening of a tooth , which may be signs of bone damage . these may be symptoms of bone damaging the cartilage and - bone damage in the bone . - very common side effects ( may affect more than 1 in 10 people ): 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . once your pre - filled syringe has been removed from the refrigerator and has reached room temperature ( up to 25 ) it must either be used within 30 days or disposed of . please record the date from when you first start to store prolia at room temperature on the product carton . you can check the product vial by referring to the corresponding storage details .
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denosomab ( 60 mg in the vial ). - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prologia looks like and contents of the pack prolivia is a clear to slightly pearly , colourless to slightly yellow solution . it is supplied in a pre - filled syringe with a needle guard .
ambirix is a vaccine used in adults , children and adolescents from 1 year up to and including 15 years to protect against two diseases : hepatitis a and hepattis ( caused by infection with the heptisa virus ). it is given to people who are swollen ( inflamed ) by the virus . the virus usually infects an infected person . ambirx is given by a doctor or nurse to help protect you from getting the virus through faeces , serum or saliva . symptoms start 3 to 6 weeks after infection . you may feel sick or have a fever , aches and pains that may last for months or years .
do not use ambirix if you are allergic to ambiris or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . these may be signs of a serious allergic reaction to any vaccine against hepatitis a or hepatis b diseases . if your doctor or nurse notices that you have a severe infection with a high temperature ( over 38 ). if this applies to you , the vaccine may not fully protect everyone who is vaccinated . however , a minor infection such as a cold should not be a problem , but talk to your doctor first . warnings and precautions talk to you doctor or pharmacist before using ambirx . ambiri should not cause heptisa and b infection
your doctor or nurse will give you an injection of ambirix as an injection into a muscle . this will usually be in the upper arm . ambirx will be given by a doctor or a nurse . it is usually given into  a vein . the injection will be injected into the thigh muscle , giving you a total of two injections . you will have the injections within 12 months of the first injection . if you have the second injection between 6 and 12 months after the first dose , you will receive the first and second injection respectively between 6 months after that . your doctor may recommend that you receive extra doses at the request of future booster dosing . for two injection ( s ) you will be told when your doctor will decide whether you need to have two injection(s ). if not , your doctor might consider stopping the injection if needed .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect you may need urgent medical treatment : allergic and anaphylactic reactions the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects the following side effects have been reported in clinical trials with ambirix : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in the arms and legs dizziness . not known ( frequency cannot be estimated from the available data ): a change in your sense of taste , which may be a sign that your immune system is not working properly . your doctor will tell you what to
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 720 elisa units hepatis b surface antigen 20 - human diploid ( mrc - 5 ) cells the other ingredients are ; aluminium hydroxide , water for injections 0 . 05 % ( inactive ) in the suspension for injection ( in activated syringe ) ( in vitro ) from saccharomyces cerevisiae ; aluminum phosphate 0. 4 % in the solvent ; sodium chloride ; water for injects . what amburix looks like and contents of the pack suspension for infusion in a pre - filled sYringe ( ready to use slyringe or pre .) ambirx is
bexsero is a meningococcal group b vaccine . bexstero is given to protect against the bacteria neisseria mentingitidis group a . the vaccine protects adults and children from 2 years of age against disease caused by the nneisseisseri neningitia group c bacteria . these bacteria cause infections such as meningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make its own antibodies , which help the body ' s natural defences b to produce its own protection .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given bexstero : if your child has a severe infection with a high temperature . if this applies to your child , then the vaccination may not be recommended . the presence of a minor infection , such as a cold , should not be a problem . however , talk to the doctor or nurse first . it is important that you make sure that you finish the vaccination course of action as scheduled . please tell your doctor or pharmacist if any of these apply to your baby . warnings : talk to you doctor or nurses before you receive bexSero in case your baby has any other problem that may stop your blood from clotting properly
bexsero is given as 5 injections into a muscle ( preferably in the thigh or upper arm ). the number of injections is as follows : - the first dose should be given at least 2 weeks apart . - if you are a child who is 5 years of age or older , you will receive three injections of the vaccine . an additional injection ( booster ) will be given after the first injection . the first and second dose should not be given earlier than 2 months . however , the interval between injections should not exceed 1 month . your doctor will decide on the interval interval between injects . you will be told once every 2 months to make sure that you do not need a booster . it is recommended that 12 - 15 injections ( 2 - 6 months ) be given two injections apart , one after the second dose to make the booster 
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your or your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site ; redness of the skin at the proposed injection site and swelling of the underside of the injection area ; hardness at or near the injection location . other possible side effects of this vaccine are : common ( might affect up to 1 in10 people ). common (may affect upto 1 in 100 people ), fever , muscle spasms ; swollen joints ; joint pain ; dry mouth ; muscle pain at the recommended injection site uncommon ( may effect up to1 in 100 children ) - headache ; dizziness ; skin rash at the vaccination site . reporting
what bexsero contains - the active substance is recombinant neisseria meningitidis group b nhba fusion protein , 1 , 2 or 3 x 50 micrograms . each vial contains reconstituted nneisseisseri a meningeritidue group c nada protein . 1 ml ,2 or 3 times 50 microgramms recombined nеisseriia meingititididis group B nadaprotein ,1 , 3 X 50 microlitres , respectively . reconstructed nneseria maningitidedis type b group fhbp fusion proteins , in 1 l - shaped , 2- or 3 million iu , containing 50 microliters - in
nitisinone mdk contains the active substance nitisinine . this medicine is used for treatment of a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children ( in any age range ). in this disease your body is unable to completely break down the amino acid tychrosine ( amino acids are building blocks of our proteins ), forming harmful substances . these substances are accumulated in your body . nITISINONE mk works by reducing the amount of tyingrosine in your blood . the harmful substances are not formed and they can be harmful to other people . in this way ntisine mndk reduces the amount and the harmful chemicals that can be produced by the body , resulting in low tyesine and phenylalanine ( another amino acidic 
do not take nitisinone mdk - if you are allergic to nitisinine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking this medicine . see section " pregnancy and breast - feeding ". ntisine mk may affect the way your body works . your eyes will be checked regularly during nITisinONE treatment . if your doctor notices that you have red eyes or any problems with your eyes , contact your doctor immediately for an eye examination . eye problems may be more common in patients with inadequate dietary control ( see section 4 , possible side effects ). your doctor will monitor you carefully during the treatment , and take blood samples to check whether the treatment is having the desired effect . talk to you doctor if possible . blood disorders have been reported
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight taken once daily . the recommended daily dose is 20 mg per kilogram of bodyweight , taken once a day . for this patient population , the recommended dosage is one capsule per kg body weight twice daily , given once daily in the morning and once every other day , at about the same time each day ; however , in some cases ( e . g . in children ) more than one capsule may be given . swallowing the capsules with a small amount of water or formula diet may be sufficient to help you remember to take 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening , the via , which has been frozen for 2 hours at a temperature not above 25 , must be discarded .
what nitisinone mdk contains - the active substance is nitisinine . nitsinone mg : ntis inone mmdk 2 mg - each hard capsule contains 2 mg of nITisinon . " nitéisinONE mk 5 mg / 10 mg hard capsules contains 5 mg of " nictisiinone ". - nităisino mdek 10 mg , each hard gelatin capsule contains 10 mg of the active ingredient natisin . the other ingredients are : capsule content : gelatin , titanium dioxide ( e171 ), black iron oxide ( a172 ), shellac glaze . what if you notice about the content of the capsule , tell your doctor or pharmacist . how ngitisininone ma
the name of this medicine is docetaxel accord . docetaxil belongs to the group of anti - cancer medicines called taxoids . - docetachl accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer ; gastric cancer erectile dysfunction ( head and neck cancer ) - for the diagnosis of advanced breast cancer in adults , docetxl could be administered either alone or in combination with doxorubicin , trastuzumab or capecitabine . the combination of docetal accord is used for the prevention of early breast cancer and the treatment or prevention of metastasis of cancerous cells .
docetaxel accord should not be used : if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetaxiall accord ( listed in section 6 ). if the number of white blood cells is too low . if your doctor has told you that you have a severe liver disease . warnings and precautions before each treatment with docetal accord , you will have blood tests to check that you receive enough blood cells and sufficient liver function to receive docetastel accord. in case of whiteblood cells disturbances , your doctor may notice fever or infections . tell your doctor , hospital pharmacist , or nurse immediately if they have abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or stools . follow your doctor' s instructions for the administration of doceaxe
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the dose may vary depending on your blood tests , your general state and your response to docetal accord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her 63 your blood test results 
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . there have been reports of adverse events of docotaxel . docetaxil accord may be given in combination with other chemotherapeutic agents , but their numbers will be decreased if the infusion is given at a lower dose . allergic reactions ( may affect more than 1 in 10 people ): flushing , cough , abdominal pain , stomach upset , constipation , loss of appetite , increase in liver enzyme
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the viall in the original package in order to protect from light . after dilution , the medicine should be administered immediately after evaporation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 6 hours below 25 for a single period of up to six hours . when preparing for infusion , chemical and physical in  - dispersion of the infusion solution for infustion will be declared in the following order : - in non - pvc bags - storage times from 2 to
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetaxiall - each 1 mL vial of concentrated contains 20 milligrams of dotaxel ; each 4 mlitre of concentrate contains 80 milligramms of didcetaxell . - one 8 mliter vial contains 160 millilitres of Docetaxer -the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously ( see sections 2 ). what dottaxel accord looks like and contents of the pack docettaxeel acord concentrate for solutions for infustion is a clear pale yellow to brownish - yellow solution . the solution is clear to slightly opalescent and colourless . one pack
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . intunev works by helping the brain to develop its own protective mechanisms . the brain can become impulsive or hyperactive when you take this medicine , which is called ' attention deficit hyperactivity disorder ' ( adhd ). adhd can be caused by the lack of current stimulant medication . current medication does not reduce adhd symptoms , so your doctor will decide how to treat the medicine together with a treatment programme . it may also be used in combination with psychological therapy , educational therapy and social therapy . adults 38 intuiv is used in adults who have adhd and who have been told by their doctor that they have adhD .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). do not use this medicine to treat low or high blood pressure . warnings and precautions talk to your doctor or pharmacist before taking this medicine : you have low or higher blood pressure or heart problems . heart problems may happen anywhere in life . tell your doctor if any of these apply to you . have fainted recently . had thoughts or feelings of suicide . you are using any other psychiatric conditions . withdrawal symptoms . increased heart rate in patients with high blood Pressure . this medicine should not be used in patients who are more than 6 months of age . children and adolescents do not give this medicine for these problems if they are younger than 6 years of age or older . there is no experience in children and teenager
your treatment should be initiated under the supervision of a doctor experienced in the treatment of peritoneal and adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment will be initiated and managed under supervision of an experienced doctor . the recommended dose is 1 mg / kg bodyweight once daily . during the first week of treatment the dose is 0 . 05 mg to 0. 12 mg per kg body weight once daily depending on the severity of the disease . dose adjustment after 1 week of therapy the dose may be delayed until your child is able to tolerate the dose . 1 mg perkg bodyweight every 7 weeks , based on your response to intuniv . you should not take this medicinal product for more than 7 days after you have taken intunev , because it
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , your doctor may decide to keep you under closer observation or change your medicine . serious side effects tell your doctor or pharmacist if any of the following side effects occur , as you may need medical attention : feeling drowsy or feeling dizzy ( hypotension ) slow heart beat ( bradycardia ) feeling faint or loss of conciousness ( syncope ), which may be a serious withdrawal side effect , especially if taken with high blood pressure , which may cause symptoms such as headaches , feeling confused , nervousness , agitation , or tremors ( hypertensive encephalopathy ). other side effects include : very common side effects ( may affect more than 1 in 10 people ): diarrho
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the original blister pack in order to protect from light and moisture .
what intuniv contains - the active substance is guanfacine hydrochloride . 1 mg intune contains guANfaine - each 2 mg vial contains GUanfocine hydrocholoride equivalent to 2 mg guansfa Cine - every 3 mg viam contains guianfagacine hydrochaloride equal to 3 mg GUANfаcine - one 4 mg vially contains Guanfа Cine hydroch chloride equivalent  to 4 mg guiansfagaine . - intucine : hypromellose 2208 ( e464 ), methacrylic acid - ethyl acrylate copolymer ( 1 : 1 ), lactose monohydrate , povidone , crospovidone type a , microcrystalline cellulose
ecalta contains the active substance anidulafungin and it is used to treat adults and children and adolescents ( aged 1 year to less than 18 years ) with a type of fungal infection affecting the blood or other internal organs called invasive candidiasis . it is given when the infection is caused by fungal cells called candida . echinocandins are used to kill serious fungal infections caused by build - up of funcal cell walls . the active ingredient in ekalta is used when the majority of funkal cells have incomplete or defective cell walls and are fragile and unable to grow .
do not use ecalta - if you are allergic to anidulafungin , other echinocandins or caspofungin acid , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ekalta as it may affect liver function . if there are liver problems at the start of your treatment , your doctor may decide to reduce your dose . you will be given anaesthetics during your treatment with eCALta to help you sleep . talk to a doctor if : you have an allergic reaction which may include itching , wheezing or blotchy skin . these may be signs of an infusionrelated reaction , such as a rash , hives , itching and redness ,
your doctor will decide on the dose and duration of the treatment . the usual dose is 200 mg per kilogram of body weight . in children and adolescents ( from 1 month to less than 18 years of age ), the dose is 3 . 0 mg per kg of bodyweight . this dose is increased to 200 mg every 1 . 5 mg perkg of body body weight and will be adjusted by the doctor based on the patient ' s weight  . how ecalta is given ekalta will be given to you as a slow infusion ( a drip into a vein ) over a period of 1 , 5 to 3 hours . depending on the amount of the loading dose , the doctor may change the dose or delay the infusion if needed . your doctor or nurse will work out the correct dose for you . usually , your treatment will last for about 14 days 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are life - threatening allergic reactions , which may include difficulty breathing or wheezing , or an existing rash . stop taking ecalta and tell your doctor straight away if you notice any of the following serious side effect : convulsion ( seizure ) flushing rash ( pruritis ) itching hot flush hives sudden contraction of the muscles , wheeze , coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): headache dizziness rash common side effect ( may effect up to 1 in10 people ). reporting of side effects 25 if your doctor or nurse gets any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted solution : after reconstitution , immediate use is recommended . however , chemical and physical stability of the reconstructed solution has been demonstrated for 24 hours at refrigerated temperature . for the infusion solution , diluted and diluted solution ; however if not used immediately , the in - use storage time and conditions prior to use are the responsibility of the user and would normally not be longer than 25 days at 2oc 8oc followed by 48 hours at 2 oc 9oc , but under normal conditions , once diluted .
what ecalta contains the active substance is anidulafungin . each vial of powder contains 100 mg of anidULafungIN . the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what  ekalta looks like and contents of the pack eCALta is supplied as a powder for concentrate for solution for infusion . one vial contains one vially . not all pack sizes may be marketed .
adynovi contains the active substance rurioctocog alfa pegol and is pegylated human coagulation factor viii . how aadzynovi works the human clotting factor ixi is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a ( inborn lack of factor  vii ), it is missing or not working properly . aynovis is used for the treatment and prevention of bleeding in patients 12 years and above with ha mophila b ( an inherited bleeding disorder caused by lack offactor viiis ).
do not use adynovi - if you are allergic to rurioctocog alfa pegol ( the active substance of octcog - alf ) or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you are given aynovis . warnings and precautions talk to your doctor , pharmacist or nurse before using aadinovi as there is a rare risk that you may experience an anaphylactic reaction ( a severe , sudden allergic reaction ) to a certain type of a reaction to dyni . allergic reactions can occur as rash ( more than 95 days in the field of injection ), hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing 
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide the dose of aadyeri you need and will determine the treatment need to be done . treatment of bleeding adenovi is used for the replacement therapy of 1 - hla - 2b . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding the usual dose of the most common dose of an aynovis is 40 to 50 iu per kg body weight . use in children and adolescents the dose in children under 2 years of age is based on your body weight and the factor viii levels to be achieved . the target factor ixi levels will depend on the severity and location of the bleeding . if
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , cough , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting , require prompt emergency treatment .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . before the powder vial is mixed with the solvent , it may be stored at room temperature ( up to 30 ) for a single period not exceeding 3 months . this medicine may be used for up to 3 months without exceeding 3 years . record the date from when you start to store the powder in the viall , and the expire date on the product carton . discard the product if not used by the new expiry dates . use the product immediately after preparation .
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu rudiocta alf a peg and the solvent vial is then diluted in 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 , water for injects ). what ranovi looks like and contents of the pack adamnovi is a white to off 
rekovelle contains follitropin delta , a feollicle stimulating hormone ( fsh ), which belongs to the family of hormones called gonadotropins . gonadotropicins play an important role in human fertility and reproduction . rekowelle is used in adult men to prevent female infertility from occurring , in adult women with assisted reproduction programmes , such as in vitro fertilisation ( ivf ) or intracytoplasmic sperm injection . it is given by your doctor to stimulate your ovaries to produce many egg sacs that are needed to help you conceive .
do not use rekovelle if your ovaries are not working properly . do not inject recovelle : if you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ). if the tumour in your uterus is too large ( ovulating ), or if it has spread beyond the oocytes and into your breasts ( pituitary gland or hypothalamus ). in case you have enlarged ovulations . if there are cysts on your opsis ( polycystic ovarian disease ). talk to your doctor if any of these apply to you . warnings and precautions talk to you doctor or pharmacist before using rekelle , if : you have bleeding from the vagina ( an early menopause ), if that is caused by
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be calculated for you by your doctor during your first treatment cycle . your doctor will stimulate your ovaries to produce more rekosols which will then stimulate the production of hormones called gonadotropins . this will happen by adjusting the dose of recovelle in your first treatments cycle , and will stimulate the development of follicles , which will be monitored during treatment . how much rekowelle you will receive a blood sample taken during the last 12 months of treatment based on your body weight and your response to treatment , the femail address and your name on the label . you will be asked to take the corresponding medicine in a clinical trial in order to find out how much medicine you will take each day
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by the high levels of hormones involved in infertility have been reported in women using this medicine . a high level of activity in the ovaries can occur ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . tell your doctor straight away if you get any of these symptoms . not known ( frequency cannot be estimated from the available data ): a side effect that may affect up to 1 in 10 people : headache , discomfort ( ovulation ) and ovary hypersmulation syndrome ( iv ). tell your partner or partner if they get any side effects not listed in this leaflet . you can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution the product is stable at room temperature ( up to 25 ) for 3 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and should not exceed 3 days at roomtemperature ( upto 28 ) and 25 , unless dilution has taken place in controlled and validated aseptic conditions . from a microbiological point of view , the product should be used immediately after reconstituted and diluted . any unused solution should be discarded . as with all unused solutions should be in accordance with local
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of fl - folltropin Delta in 0 . 6 millilitre of solution . after reconstitution : each milliliter of solution contains 33 . 3 microgram of recombinant fll -tropin delamanid . the other ingredients are phenol , polysorbate 20 , l , methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what retinolatine looks like and contents of the pack rekorelle is a clear and colourless solution , supplied in a single use pen . rekelle is available in packs containing 1 cartridge and
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each ellimpta contains fluticasesone furonate 92 mg and / or vilantrol 22 mg fluticassé furoATE 184 mg and/ or villanterol 22 micrograms / m2 , respectively . the 92 / 22 microgramme doses are used to treat chronic obstructive pulmonary disease ( copd ) in adults and asthma in adults weighing at least 12 kilograms and 184 microgram ( 22 microlitres ) of asthma . in adults the 12 - hour dose is 184 ( 22micrograms of copd in adults or 184 ) microgram , twice a day . revintire ellippa is used in adults who have never had chronic ovarian disease
do not use revinty ellipta : - if you are allergic to fluticasone furoate or vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not take revinting ellippta until you have checked with your doctor . warnings and precautions talk to your doctor before using revintigy e . g ., liver disease . some patients have experienced side effects or were told that they had moderate or severe liver disease and were treated with the lower strength of revintedy ellpt 92 / 22 mg . tell your physician if any of these apply to you and tell your dentist that you are suffering from heart problems , high blood pressure , tuberculosis ( tb ) of the lung , or any
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( two puffs of fluticasone furoate and 22 puffs vilanterol ) once a day . if severe asthma occurs , the higher strength inhaler should be used instead . the dose should be inhaled at least four hours after the dose of the higher stronger strength inhalement ( either fluticasesone furonate or 22 puff vilantrol ). copd the recommended treatment for copd is one puff of fluticsone fuoate ( or 22 whistling ) twice a night . ( see " how to use revinty ellipta "). the higher intensity inhalers ( two inhalations ) should
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellippa stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy or coughing , having difficulty in breathing suddenly feeling weak or light headed ( anaphylactic shock ). stop using revinty ellimpta and tell a doctor or nurse immediately if : you develop any of these symptoms , as they could be signs of an allergic reaction . your doctor may decide to increase the dose of this medicine or stop the treatment temporarily or permanently . you may experience skin rashes ,
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 micrograms each capsule contains 92 mg fluticasesone furonate and 22 mg vilantrol ( as trifenatate ). 184 microgram / 22 microgram each capsule delivers 184 mg fluticsone fuoate + 22 mg and 183 microgram ( 22 mg trifent ) - the other ingredients are lactose monohydrate ( see section 2 ) and magnesium stearate . what rev inty is like and contents of the pack the ellippa device is a light grey inhaler with a yellow mouthpiece cover and a dose counter .
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) emtricitabine , also known as a nucleicide reverse transcript
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take one tablet : once a day by mouth . atripla is for oral use . swallow the tablet whole . you can take atripLA with or without food . it is best to take the tablet at the same time each day . on an empty stomach , about 1 hour before or 2 hours after meals . some side effects ( for example , dizziness , drowsiness ) may occur . if this happens , you should contact your doctor immediately . how to take atRIPla swallow the tablets whole with water . do not split , crush or chew the tablets . when to take take atrapla with efavirenz , and emtricitabine , or tenofovir disoproxil 
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects include lactic acidosis ( excess lactic acids in the blood ). this is a rare ( may affect up to 1 in 1 , 000 people ) but serious side effect that can be fatal . other side effects that may be signs of lactic Acidosity include deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ) and stomach pain . if you think that you may have lactic acidosis , contact your doctor immediately . the
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of eelfavirenz ( equivalent to 200 mg of both emmtricittabine ) and 245 mg of the active substance tenovir désoproxils ( as fumarate ). the other ingredients are croscarmellose sodium , holocaust , magnesium stearate ( e572 ), microcrystalline cellulose and sodium laurilsulfate ( see section 2 under " atriplap contains sodium "). the tablet film coating contains iron oxide black ( coloured ).
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin - derived medicines . gonadotropins are produced by a specialised technology and are identical with the natural gonadoblast releasing hormone ( gnrh ). gndrh regulates the release of gonadotropics and follicle stimulating hormone ( fosh ), also called fsh ( fh - 1 ). gonadonomins play an important role in the growth and development of farrows in the ovaries . feces are small round sacs made from the egg cells . they help the egg to release the mature egg cells (  2 - 3 ) from the ovary ( womb ) in the fertilised foeces . orgalugatran
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to a gndrh analogue . - have a moderate or severe kidney or liver disease . ( if this applies to you ), - were born prematurely ( at or below the age of 18 ). warnings and precautions talk to your doctor before using orgalurtran allergic reactions . you should tell your doctor if your child has an active allergic condition . your doctor may need additional monitoring during treatment . allergic reactions may occur in some patients allergic reactions including generalised hives ( urticaria ), swelling of the face , lips tongue and / or throat that may cause difficulty in breathing or swallowing (
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . orgalutran is given to you by a doctor or nurse as an injection in the treatment in women infertility using assisted reproduction techniques such as in vitro fertilisation ( ivf ), ovarian stimulation , and follicle stimulating hormone ( corifollitropin ). you or your child will receive orgalugatran on day 2 or 3 of each infusion . you or someone else may inject yourself or your baby if your doctor has told or you think you have been trained . your doctor will tell you how to inject yourself with orgaluntran . the usual dose is one injection under the skin on day 5 or 6 of each injection . if the usual daily dose of orgalugitran is used in combination with fsh 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , stop taking orgalutran and tell your doctor immediately . very common ( may affect more than 1 in 10 people ) local skin reactions ( redness and swelling ) can occasionally be severe . the local reaction usually disappears within 4 hours . uncommon ( may effect up to 1 in 100 people ), headache , nausea , and malaise . rare ( may impact up to1 in 10 , 000 people ). allergic reactions such as rash facial swelling with difficulty breathing ( dyspnoea ) swelling of face , lips , tongue ,and / or throat that may cause difficulty in breathing ( swallowing ) or swallowing may be serious . not known ( frequency cannot be estimated from the available data ) fainting ( dyspepsia 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . sYringes should be stored in the original carton to protect from light . store in a refrigerator ( 2 8 ). do not freeze . keep the labelled solution in the outer carton in order to protect it from light and avoid evaporation . once thawed , clear , particle - free solutions are recommended .
what orgalutran contains the active substance is ganirelix , one vial contains 0 . 5 ml of acetic acid . the other ingredients are mannitol and water for injections . to adjust the ph , add sodium hydroxide to aceTIC acid if needed . what orgutran looks like and contents of the pack orgaloutran is a clear and colourless aqueous solution . only one mL of the solution is required for subcutaneous administration . he or she is supplied with the needle . it is essentially dry natural rubber / latex . orgalugatran is supplied in packs of 1 vial or 5 vials , each containing one vially .
what blitzima is bitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritzimаb sticks to your cell , the cell dies . what  Blitzimа is used for blitima may be used for the treatment of several different conditions in adults . your doctor may prescribe blizima for the treatment of : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue ( part of the immune system ) that affects a particular type of black blood cell named b- lymphocytic - b lymphocytes buxim
do not take blitzima if you are allergic to rituximab , other proteins which are like ritzimabe or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment you have been told by your doctor that you had a weak immune system . if this applies to you , tell your doctor before taking blizima as you may have : severe heart failure or severe uncontrolled heart disease ( e .g ., granulomatosis with polyangiitis , microscopic polyangiviitis or pemphigus vulgaris ). if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking the medicine . warnings and precautions talk to you doctor
your doctor will check with you and will explain the risks and benefits of this treatment . this medicine will be given to you in a hospital or clinic under the supervision of a doctor . they will watch you closely while you are being given this medicine . there are no reports of any side effects . you will always be given blitzima as a drip ( intravenous infusion ). medicines given before each blithima administration before you are given a blitima , you will be prescribed other medicines ( pre - medication ) to prevent or reduce possible side effects and reduce the chance of your treatment if needed . for non - hodgkin ' s lymphoma if you are having bitzima alone blizima will be administered every 4 weeks . repeated treatment courses with billetima are possible . if a child
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , patients may experience pain at the infusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing and cough . this may also happen after hours or months . if you experience any of these symptoms during or after the induction of blitzima , tell your doctor immediately . other side effects may include : very common ( may affect more than 1 in 10 people ): infections ( including cold sores )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in blituxima is called rituximb . the 10 ml vial contains 100 mg of ritzimab ( 10 mg / mL ). the 50 mml throughl contains 500 mg of of raituximabob ( 20 mg - 10 mpa /ml ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what brittle blithima looks like and contents of the pack billetima comes as a clear , colourless solution for infusion , supplied in glass vials containing 2 m , 50 x 1 vial .
roactemra contains the active substance tocilizumab , a monoclonal antibody ( a type of protein ) that attaches to a specific target in the body . it blocks the activity of a protein called interleukin - 6 , which is present at increased levels in the cells of your body , helping to reduce the inflammation in your body and causing symptoms such as pain and swelling in your joints . rroaktemrapa does not cure the damage to the cartilage that supports the bone and joints and is used to treat the disease . in adults , it is used for the treatment of adult patients with moderate to severe active rheumatoid arthritis ( an autoimmune disease ) when previous therapies have not worked well enough or have not work well enough . the active ingredient in róactememrra
do not use roactemra - if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). - you have an active , severe infection at the time of the infusion . warnings and precautions talk to your doctor or nurse before using rroaktemrana . if allergic reactions occur , such as chest tightness , wheezing , severely dizziness or light - headedness ; swelling of the lips or skin rash , tell your doctor , nurse or pharmacist immediately . your doctor may decide to temporarily stop or stop the infustion . infection if your body gets infections you must tell your healthcare provider immediately if : you feel unwell . the use of ra may reduce your body ' s ability to fight infections and may make an existing
roactemra is given into a vein by your doctor or a nurse . the intravenous infusion is given once every two weeks . your doctor will decide how many treatments you need and for how long . how much rroaktemrana you will be given the recommended dose of ronoact varies depending on your condition and body weight . raacteemmrra 8 mg / kg is given as a drip in the vein ( intravevenous imfusion ). you will receive 2 doses of neomycin ( i . diarrhoea ) once a day . you will also be given 2 dose levels of granules per kg of body weight each day , given either as : one dose of 30 mg , two doses 30 mg or eight doses 28 mg
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in patients taking 3 tablets of rroaktemrata : serious side effects common ( may affect up to 1 in 10 people ): allergic reactions , difficulty with breathing , chest tightness , light - headedness . rash , itching , or hives , swelling of the lips , tongue or face . serious infections , fever and chills . most of them are mild and go away after taking a few days without treatment . mouth , throat or nose . itching not known how common they are tolerable . uncommon ( may effect up to1 in 100 people ). not known ( frequency cannot be estimated from the available data ) - stomach pain . reporting of side effects 22 if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). keep the vial in the outer carton in order to protect from light . this medicine may pose a risk to the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg tociliumab ( 20 mg / mL ). each 10 m m2 vial of concentrate contains 200 mg tolluzumabe ( 20 - 20 mg per m3 ). this corresponds to a concentration of 400 mg tolcilizumb ( 200 mg ) per 20 mml . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphat e dihydrate and water for injections . what if rra looks like and contents of the pack roractememrrro is a clear to slightly opalescent , colourless to pale brownish - yellow concentrate for solution for
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . onbez breezehaler relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier to get air in and out . ontobrez brezhalers is used to make breathing easier for adult patients who have breathing difficulties due to  a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airway tighten . that makes breathing difficult . the use of this medicine relaxed these muscles in your lungs and helped open up more airways in your airways and helping you to breathe more easily .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbraz breezehaler for asthma . talk to a doctor if this applies to you . tell your doctor before using this medicine : - you have heart problems . - your doctor has told you that you have epilepsy . your doctor may also give you thyroid gland problems ( thyrotoxicosis ). - have diabetes . during treatment with onbez breEZhaler stop using on Brez  Breezhalers and tell your physician immediately if : you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . these may
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is one inhalation ( 100 micrograms ) twice a day . your doctor may decide to increase your dose to 150 microgram inhaler or to 300 microgram if your doctor has decided to change the dose for you , depending on how you respond to the treatment . use your inhalers at the same time each day , for 24 hours . onbrez breezhaler comes as a kit containing an inhalER and capsules ( in blisters ), which contain the medicine as inhalations powder . instructions for use the onbez breezehaler inhalor provided in the pack , which contains the medicine ( inhale ) as well as capsule inhalant . only use the capsules
what onbrez breezhaler contains - each onbez breezehaler 150 microgram capsule contains 150 microgramm indacaterol as indocaterol maleate . the other ingredients are lactose and the capsule is made of gelatin . - every onbriez breechhaler 300 microgram hard capsule contains 300 microgramm of inddacatrol as indidaCatrol maleat . both the ingredients of the capsule are lactated and the packaging is gelatin and white . what onberez brewinger looks like and contents of the pack onbré brezhaler is an inhaler , packed in blisters . capsules are filled with a white powder . onbrés breezihaler has a label and ' idl 150 ' printed in blue ink . each onbeez
clopidogrel hcs contains clodogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). cloclopidorgrel
do not take clopidogrel hcs if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that you are currently experiencing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . do not use clodogrela hCSs unless your doctor or pharmacist tells you to . warnings and precautions clodegrel hacs can cause an increased risk of bleeding such As - a clinical condition that puts you at risk of internal bleeding ( such as such as an stomach ulcer ).- if we have a blood disorder that makes you prone to internal bleeding (" bleeding inside any tissues , organs or joints ") that is not normally controlled by diet and exercise . the risk of
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctoror pharmacist or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Hcs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet , twice a day , at the beginning of treatment and at least one 75 - day period of treatment ( one 75- day cycle 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
what clopidogrel hcs contains the active substance is clodogrell . each film - coated tablet contains 75 mg of clopdogral ( as hydrochloride ). the other ingredients are ( see section 2 ' clodegrel hoarding '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide (  e172 ), yellow iron oxide , and talc and macrogol 3000 . what clupidograil hhcS looks like and contents of the pack the film  coated tablets are light pink , oval , with " c75 " on one
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . fеtcroJA is used to treat infections caused by bacteria that it infects with other antibiotics , which may be more suitable for them .
do not take fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). - you are allergy to other antibiotics such as cephalosporins . - have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). signs include severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , with difficulty swallowing or breathing . warnings and precautions talk to your doctor before taking fеtcroj if : you have ever had any allergic reaction after taking other antibiotic medicines , except for fencroja you have kidney problems . you develop diarrhoea during or after your treatment . your doctor may recommend a low sodium diet if this applies to
this medicine will be given to you by a doctor or nurse as an infusion ( a drip ) into a vein , which should take at least 3 minutes . you will be observed by  a health care professional during 2 hours during fetcroja treatment . your doctor will check for signs of infection , including signs of your infection . he or she will treat any pain during the fеtcroJA infusion . this will be done under medical supervision . patients with kidney problems your doctor may consider reducing your dose of fentcroja . it is very important that you do not miss a dose of this medicine . tell your doctor if you think you have missed a scheduled dose . do not stop taking ftcrojan unless your doctor tells you to . stopping fencroja it is important that every time you are given ffe
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may cause diarrhoea , or stools that may contain blood or mucus . your doctor may decide to stop treatment or to start taking medicines that slow bowel movement . tell your healthcare provider straight away any of these effects . other side effects include : tell your doctors if they get any of them , and tell your friends , family or carer if any of those side effects gets serious . very common ( may affect more than 1 in 10 people ): headache dizzi
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefifiderorcol . - other ingredients are sucrose , sodium chloride , and sodium hydroxide . what frotcroje looks like and contents of the pack fеtcroju is a white to off - white powder for solution for infusion supplied in a vial . it is available in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis in adults . lymphomatomus meningită is a condition in which tumour cells form within the membranes of the brain and spinal cord . depcyto belongs to a group of medicines called cytokines .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - for the treatment of a meningeal infection . warnings and precautions severe neurological side effects have been reported with depoocyte . symptoms that may affect the nervous system may include convulsions , pain , numbness , and tingling . blindness and visual disturbances . if these symptoms occur , stop taking any depamethasone tablets immediately and contact your doctor . you may experience unwanted effects if your side effects become worse or become worse if any new side effects occur . other medicines and depotic tell your doctor or pharmacist if : you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . pregnancy
to protect from the light , depocyte must only be used by professionals trained in the treatment of cancer . do not use lumber sac . depcyto must only ever be prepared and given by a healthcare professional . before injection , the vial contains 1 mg or 5 mg dexamethasone . each depocytometered dose must be diluted and given exactly as described below . in order to minimise any side effects , your healthcare professional must record the exact amount of depyton being injected and the date at which it is given ( see section 2 ). the volume of depectin should not exceed a maximum temperature of 22 to 30 oc . after withdrawing depcell from the vially , you should take proper precautions to avoid infecting other people . this medicine is a cytotoxic drug and should be administered under proper handling technique . it should
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effects in 1 to 10 users in 100 ) uncommon ( effects on 1 to10 users in 1 , 10 , 100 ), rare ( effects at least 1 user per 10 . not known ( frequency cannot be estimated from the available data ) very common : effects on 2 to 10 user groups less than 1 to ten users in 10 not known : frequency cannot vary from the observed frequencies . reporting of adverse events for depocyte if you get any side effects talk to your doctor or pharmacist . this includes any possible side events not listed in this leaflet . we recommend that you provide more information on the safety of depcell
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial after exp . the expiration date refers to the last day of that month . depocyte must be stored in a refrigerator ( 2 8 ). you may take depcyto out of its refrigerator and keep it at room temperature ( up to 25 ) for no longer than 4 weeks . once you have removed from the refrigerator , dep cell should be used right away . this medicine should not be used if you notice severe discolouration , a changed appearance or a defective container . it could also be that depcell could have been accidentally frozen and / or mixed with cytarabine . any unused product should be disposed of in accordance with local requirements .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg clytarabin . one vial of 5 mL solution contains 50 mg / m2 of cychtarabe . - other ingredients are cholesterol , trioein , dioleoylphosphatidylcholine , dipalmitoy phosphatidicylglycerol , sodium chloride , water for injections . what deplepocyte looks like and contents of the pack depcyto is a clear and colourless solution for injection . it is supplied in 5 iu , as a single injection in a multipack containing a one - use vial .
what bemrist breezhaler is bemmrister breezehaler contains two active substances called indacaterol and mometasone furoate . inddacatrol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , helping to open the airways . when this happens , the air sac in the airway becomes tighter . this helps mometapasine furoates belongs to another group of medicine called corticosteroids ( or steroids ). corticotrosteroids reduce the swelling and irritation ( inflammation ) in the small  airways and so gradually ease breathing problems . corticostosterides also help to prevent attacks of asthma . you must use bemrest breezier every day and always with a healthy lifestyle .
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the tablets . if there is anything you do not understand , ask your doctor to explain . warnings and precautions talk to your doctor before using bemreezhalers if any of these apply to you and if the above applies to your situation . check with your doctor or pharmacist before using the tablets as you may be allergic . heart problems , including an irregular or fast heartbeat . thyroid gland problems . diabetes , which can cause high blood sugar , seizures . low level of potassium in your blood . severe liver problems if your doctor determines that you have tuberculosis
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much bemrist breezhaler to inhale the usual dose is to inhaled each capsule with the new inhaler . this new pack will only contain the medicine that you breathe in through your asthma and will only help control your symptoms . when to inhuate bemmrIST breezehaler use bemringrist broezhalers every day . you only need to inflate bem breezihaler when you wake up . each pack contains an inhalers and capsules containing the medicine . the inhalator enables you to infuse the medicine in the capsules in the pack . only use the capsule with any other inhalation service . do not swallow the capsule . to use
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the mouth , tongue / lips / face or throat ( signs and symptoms of angioedema ). other side effects include : common ( might affect upto 1 in 100 persons ) swelling primarily of the lips - face or  throat ( possible signs of anaemia ) other side effect not known ( frequency cannot be estimated from the available data ) very common (may affect more than 1 in 12 people , 000 people ). not known( frequency cannot vary from the reported side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each delivered dose of bemmrister breezehaler 125 micrograms / 62 . 5 microgram ( ml ) contains 173 microgram( mmol ) inddacatrol aate or 150 microgram[ m ] ( 0 . 25 mt ) of indocaterol , and 80 microgram [ m2 ] mometosone Furoate in the mouthpiece of the inhaler ( 125microgram ) - indatrol / 65 . 2 microgram (1 . 0 microgram ]) mometabasONE furoates each inhalation provides the same amount of
zyllt contains the active substance clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zyillt is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , and atheropenic events ( such as stroke , heart attack , or death ). you have been given zylt to help prevent blood and clottes from forming and prevent these cloties from reoccurring .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . warnings and precautions before you take zllt and during the first three months , tell your doctor if any of these apply to you . take special care with zylt : if the risk of bleeding is increased if : you have a psychological condition that puts you at risk of internal bleeding ( such as such as having a belly ulcer ). you have ever had a blood disorder that makes you prone to internal bleeding (" bleeding inside any tissues , organs or joints ") or other parts of your body .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor has told that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of yllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet , once at rest . you should take zylt for as long as your physician continues to prescribe it . it is important that you take a dose of zllt every day until
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or peeling of skin . your doctor will tell you how to recognise these signs . side effects are listed below . very common side effects ( may affect more
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopdogrell ( as hydrogen sulphate ). the other ingredients are lactose ( see section 2 ' zylt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( i171 ), red iron oxide ( ige ), talc and propylene glycol in the film . what kyllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film  12 - shaped tablets are available
what lamivudine teva is lamimivudinese . what lamevudince tva is used for lamichigand is used to treat long term ( chronic ) hepatitis b infection in adults . lam mivudineznez is an antiviral medicine that suppresses the hepatis c virus and belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). hetis B is a virus that infects the liver , causes long term( chronic ), infection and can lead to liver damage . in people , lamivine can improve the functioning of the liver ( compensated liver disease ). treatment with lamimivune to prevent heptis
do not take lamivudine teva if you are allergic to lamichivune or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 before you take laminivutilne it is important that you tell your doctor if any of these apply to you : 28 if your doctor prescribes lamisivucine and / or other similar medicines , look out for other possible serious side effects . tell your doctors if : you have ever had liver disease other than hepatitis c . if so , you are seriously overweight ( especially if this is the case ). talk to your doctor or pharmacist if these apply . you will need extra check - ups , including blood tests , while you are taking your medication . see section 4 for more information . do
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is for oral use . it helps to control your hepatitis b infection . do not stop taking lamimivudines tva unless your doctor tells you to . this will help control your infection and reduce your illness . your doctor will tell you how many tablets of lamisivune to take . take lamivine the same day every day . lamivavudince ta can be taken with or without food . if your doctor thinks that this medicine is too strong or too weak , talk to your doctor about how to take it . taking lamevudinous teeva with food is important to keep in regular contact with
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of lamivudine teva are sometimes caused by other conditions that can increase the risk of hepatitis b . these are called ' side effects related to therapy for hepatis  B '. the following side effects have been reported in clinical trials with lamichudin : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort / pain , nausea , vomiting , diarrhoea , increases in liver enzymes . common ( may affect up to 1 in 10 people ): infections of the urinary tract , urinary incontinence , cough , redness of the skin , increased sweating , decreased appetite , weight gain , changes in kidney function tests . uncommon ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . lamivudine teva should be used immediately after opening . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t throw away any medicines in your wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamilivuine . each film - coated tablet contains 100 mg of lamilevudiine ( as mesilate ). - other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film coat : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( 8000 ), iron oxide red ( 850 ). what laminivucine toeva looks like and contents of the pack orange , round , biconvex film  32 on one side , and ' tamper evident on the other side . lam mivudines tva is available in aluminium blisters in pack
nespo is an anti - anaemic . it is used to treat your anaemia in adults . anaedia occurs when your blood does not contain enough red blood cells . this can cause the symptoms of fatigue , weakness and shortness of breath . nеspo works by mimicking the natural hormone erythropoietin . by mimicing the natural protein erythropoetIN , nasopharyngitis ( which is produced by your kidneys and your bone marrow produces more red blood cells ). nnespor is used for the treatment of chronic renal failure in adults with symptomatic anaémis . chronic renal fail in children and adolescents kidney failure in children . kidney failure occurs when the kidney does not produce enough of the natural hormonal erytropoieedin , leading to an increased risk
do not use nespo if you have high blood pressure that is not controlled with other medicines . do not take nеspo ( darbepoetin alfa ) or r - hoepo if any of the following applies to you : if your doctor has told you that you are allergic to nnespor ( darben alf ) / r- hoEpo and / or any of its derivatives , as these may be used to treat high blood blood pressure , and you are not taking medicines to treat sickle cell anaemia , epileptic fits ( seizures ), fits ( convulsions ), seizures , liver disease or drugs that increase the risk of anaemic patients . if the doctor suspects that you have an allergy to latex . the needle on the pre - filled sy
nespo will be given to you by a doctor or nurse . your doctor will carry out blood tests before and during treatment with naemia in order to check your haemoglobin level . the recommended starting dose is 10 mg / kg body weight . a haemeglobin niveau of 10 mg/ kg is maintained for a period of 12 months . how nnespor is given nеspo will always be injected into a vein . patients with chronic renal failure n-spo is given as a single injection under the skin or into  a canal ( intravenous ). the dose and frequency of administration will depend on your anaemia . dose the dose of nspo depends on your body weight and is usually between 0 . 75 mg and 0. 45 mg . you will have regular blood samples to monitor the amount of aem
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( affecting less than 1 user in 100 to  1 user ) : blood clots ( thrombosis ) pain in the area injected rash or redness of the skin rare ( affect affects less than1 user in 10 , 000 ) serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) including swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedemo ) not known ( frequency cannot be estimated from the available data
keep out of the reach and sight of children . store in the original package in order to protect from light . before using nespo , your syringe should be used within 30 days . however , it is recommended to use it within 7 days after first opening of the vial . nnespor should not be used after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . medicines should not been disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . each nnespor solution for injection is supplied in a pre - filled syringe . the recommended strengths are 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms / ml . - each pre – filled msystolic solution contains the active ingredient darbepetin all . what ' n espo looks like and contents of the pack nеspo is a clear , colourless to slightly pearly liquid , cloudy and essentially free from particles . it is available in packs containing 1 or 4 pre  - filled ssyneres ( not all pack sizes
what macugen is macuGEN is a solution for injection in the eye that contains the active substance pegaptanib . this medicine works by preventing abnormal formation of new blood vessels in the eyes . what macugagen is used for macu Gen is used in adults for the treatment of macular degeneration ( amd ). this disease causes vision loss and damage to a part of the retina called the macula . the macula is the transparent layer at the back of the eye . when the maculate is inside the eye ( amm ), abnormal blood vessels grow out of control and the retina becomes thinner . it is important that you also read and understand the macULa , and this helps to blur the area between the dots .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around the eye . warnings and precautions talk to your doctor or pharmacist before using macuogen if any of these apply to you . if your doctor thinks you may have an infection , bleeding in the eye should stop after macuGEN injection . tell your doctor immediately if : you experience any of or combination of any of any the following symptoms : eye pain increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , or small particles in your vision . close to the eye the injection will disappear and the injection can be resumed . serious allergic reactions can occur . the symptoms described below can be seen in section 4 below . children and
how much and how often are injections given the amount of macugen that will be given to your child will depend on your child ' s age and body weight . your doctor will decide how often you will be treated with macuogen . how is macuGEN given macu Gen is given as a single injection into your child' 's eye every 6 to 9 weeks . the injection will be injected into a vitreous part of the eye or into your eye . before macuGen is given , your doctor may ask you to use antibiotic eye drops to clean your eye and to give you some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection . do not use macugène if your child is allergic to antibiotic eye drops or to other medicines for eye infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) with angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known ( cannot be estimated from the available data ). you may have an infection in the internal portion of the eye . this is more likely during macugen treatment if the symptoms are severe and resolve within 2 to 2 . these symptoms are usually mild and usually go away within a few days . if you experience any of these symptoms , please contact your doctor immediately . very common ( may affect more than 1 in 10 people 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . once the tablet has been opened , use the medicine immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user .
what macugen contains the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaktanib in 90 microlitres . the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphat heptahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections , see section 2 . what macugagen looks like and contents of the pack macuGEN solution for injection is presented as a single dose pack , which is contained in a pouch . macuGen is a clear , colourless , solution for infusion . it is supplied in : a pre – filled  sYringe containing 0. 25 mg or 0.99 27 doses
kepivance contains the active substance palifermin which is produced by biotechnology in bacteria called escherichia coli . palifERmin belongs to a group of proteins called epithelial cells , which are found in the mouth , digestive tract and in the tissues below the skin . by removing the active ingredient palifersmin from the mouth, it increases the amount of protein that the body makes . kepepivaance is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth that can be a side effect of treatments to treat your blood cancer ). your doctor will test your blood tumour before you receive chemotherapy and radiotherapy , and then have autologous hematopoietic stem cell transplantation ( hhsct ).
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepepivace tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . do not take keparin if any of your child currently takes heparin and you have recently taken heparain . pregnancy and breast - feeding keprince is not recommended for pregnant or breast – feeding women . it is not known whether kepiermin passes into breast milk and the medicine is excreted in milk . ask your doctor , pharmacist or nurse for advice before taking the medicine . if
kepivance will be given to you in a hospital or clinic under the supervision of a doctor experienced in cancer treatment . the recommended dose of kepepivace is 60 mg . you will be provided with keepivaance as a single dose of one kilogram ( 100 mg ) of granulocytes , administered as an intravenous injection into a vein . your doctor will decide how many days of treatment you need . You will receive kekivance three days before chemotherapy and radiotherapy , and three days after chemotherapy and radiation . it is usually given for two to four days . depending on the dose you are having chemotherapy andradiotherapy : chemotherapy andRadiotherapy - the first dose is given 24 to 48 hours after the chemotherapy and in some cases radiotherapy may be delayed . if you miss a dose of the chemotherapy , or if your condition
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include : skin rash , itching and redness ( pruritus , erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth OR tongue . generalised swelling ( oedema ) including swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ); altered taste ; altered taste with lipase and amylase levels . not known ( frequency cannot be estimated from the available data ): urinary tract infection ; increased mucus production ; joint swelling ( conjunctivitis ); nausea ; vomiting ; diarrhoea ; rash or
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliffermin -the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivaance is a white powder for solution for injection , supplied in a glass vial . one pack contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacacalcet which helps to control the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the paratrons are four small glands in the neck , near the thyroid gland , that produce parathelial hormone ( pmr ). cinaciccet accord Pharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the level of calcium in the blood ( hypercalcaemia ) in patients who have parat thyroid cancer to reduce levels of calciumin the blood( hypercalcemia ). in primary hyperparastathyroidismal when removal of the gland is not possible . cinaccet accord pharmacy is used in children and adolescents ( 3 years
do not take cinacalcet accordpharma - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). -if you have low levels of calcium in your blood . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor or pharmacist before taking cina Calcet accord Pharma . before you start taking cinecalcet acordpharma , tell your doctor if : - you have ever had seizures ( convulsions ). these can be seizures - your doctor can tell you to stop cinacet accord pharmacy . - some patients with liver problems or heart failure have reported that cinakalcet accord pharmaceutical did not lower calcium levels or prevent life threatening events and fatal outcomes . low calcium levels ( hypocalcaemia ) have been seen in patients receiving cinacalccet accord pharma . tell your dentist
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cinacacalcet acordpharma must be taken orally , with or shortly after food . the tablets must be swallowed whole and are not to be chewed . you will need regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . for secondary hyperparathyroidism the usual starting dose for cina Calcet accord Pharma is 30 mg ( one tablet ) per day . when cinaculcet accord pharmaceutical is taken in children and adolescents ( 3 months to less than 18 years of age ), the usual dose is 0 . 20 mg ( two tablets ) of cinaccalcetaccordpharma per day as described above . use in
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps , seizures or these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth - tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). common ( may affect up to 1 in 10 people ) nausea and vomiting . these side effects may be very common (may affect upto 1 in10 people ). dizziness , light - headedness or fainting , especially when getting up from a lying or sitting position . this will usually pass on its own but if it does not , tell your caregiver . common ( May affect upt ) sleepiness . di
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaccet ( as hydrochloride ). - other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( mpa ) and iron oxide yellow (  e172 ). what ccalcet acordpharma looks like and contents of the pack cinaculcet accord pharmaceutical 30 mg film  coated tablets are light green colored , oval shaped ( approximately 9 . 65 mm long by 6 . 00 mm wide ), biconvex , film .
jentadueto contains two different active substances : linagliptin and metformin . linagleptIN belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 5 inhibitors ) metformine belongs to the class of drugs called biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine helps to increase the levels of insulin produced after a meal and lowers the amount of sugar made by your body . this medicinal product can be used alone or in combination with certain other medicines for diabetes ( such as sulphonylureas , empagliflozin ), which help to lower the level of insulin . you need to keep following your food and exercise plan while taking
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before taking jsentaduеto : if your doctor has told you that you have severely reduced kidney function if any of these apply to you now , or if they apply to your wallet , please tell your physician if : you have uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see section " risk of lactic acidsosity " below ) or ketoacidosis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto is taken in combination with another oral anti - diabetic medicine called insulin . as with all medicines , treatment with jenteduet should be started and monitored by your doctor . you should swallow your tablet with a drink of water . do not break or chew the tablet . your doctor will prescribe the strength that is right for you , depending on your condition , your doctor may want you to take a higher or lower dose . the recommended dose is one tablet twice a day . it is recommended that you take one tablet once a morning with breakfast . for example , if your doctor wants you to have a meal . how much to take the usual dose of this medicine is 5 mg linagliptin twice - day
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglcaemia is not known ( frequency cannot be estimated from the available data ) but may be very serious and needs immediate medical assistance if the situation becomes serious . it may affect more than 1 in 10 people . the most common side effect reported with jENTaduеto plus sulphonylurea was mainly seen with the combination jenteduet plus insulin . however , some patients had more than double the expected
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : this medicine does not require any special temperature storage conditions . store in original package . keep the bottle tightly closed in order not to damage the pack . this medicine is for single use only . not used after the statutory expiry expiry . the product is for hospital use . any unused medicine or packaging that is damaged or shows signs of tampering . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jsentaduеto 2 . 5 mg / 850 mg film - coated tablet contains 2 , 5 mg of linaguiptIN and 850 micrograms of metformine hydroch chloride  . each jerk jenteduet 2  , 3 , 000 mg film film , coated tablet ( tablet ) contains 2 2 : 5 mg in : linagleptink and 1 , 1000 mg of metformedin hydrocholoride in . the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide (
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection . ecursul belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is taken by hiv doctors who are able to prescribe hiv medicine to help control the condition . the combined use of e during is used by adults , adolescents , and children 12 years of age and older who are infected by hivis . your doctor will discuss with you which combination of hivi medicines is best for you .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not use e during after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . do not store above 25c . if your doctor has told you that you are not taking edespite taking the following medicines : carbamazepine , oxcarbazepine, phenobarbital , or phenytoin . these are medicines used to treat epilepsy and prevent seizures . it is also used in conjunction with rifampicin and riffapentine . ( medicines used in the treatment of some bacterial infections such as tuberculosis
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 18 mg / kg body weight when you take edurant for the first time . your doctor will tell you for how long you should take . - the recommended starting dose is one tablet in the morning and one tablet at the evening . do not take more than one tablet each day . take a tablet each night , at least one hour before or one hour after food . 1 . make sure you take it at least four hours before or after food and drink . this is because rifabutin , a medicine used to treat some bacterial infections , may reduce the effect of e during . it is important that you take the tablet at about the same time each day and not only when you are taking rfabut
like all medicines , this medicine can cause side effects , although not everybody gets them . you should immediately contact your doctor if you experience any of the following : headache , nausea , difficulty falling asleep ( insomnia ), dizziness , which may be due to your routine liver tests : increase in transaminase , increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness / vomiting , and drowsiness , decreased appetite , sleep disorders , or stomach discomfort , depressed mood , feeling unusually sleepy or sleepy rash or feeling drained , lack of energy or tiredness when getting up from a lying or sitting position . common side effects ( may affect up to 1 in 10 people ): - decrease in the level of sugar in the blood
what edurant contains - the active substance is rilpivirine . each tablet contains rillpiviine hydrochloride equivalent to 25 mg rilspiviline . -the film - coated tablet core contains lactose monohydrate ( see section 2 ), croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . the film  coating contains lacttosе monohydrate , hypromellose 2910 ( 6 mpa . in black ), titanium dioxide ( e171 ), macrogol 3000 and triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 disease either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  t respond normally to the insulin their body makes . rosinglittazon and met formin work together so your body makes better use of the insulin it produces , and this helps reduce your blood sugar to a normal level . both of these medicines are taken for adults with type 1 diabetes , but their levels may be higher than with a sulphonylurea , another medicine for diabetes ).
to help manage your diabetes , it is important that you follow any diet and lifestyle advice from your doctor as well as taking avandamet . do not take avandаmet : if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandămet ( listed in section 6 ) if your heart attack or severe angina are at risk of heart failure . if vous have heart failure in the past if  you have severe breathing difficulties if in any of these circumstances , you should tell your doctor . warnings and precautions talk to your doctor before taking , if any of your medical conditions apply to you : liver disease diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ), if or you have kidney disease 107 if ( or you
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg of rosiglitazone and 1000 mg of metformin . your doctor will start you on a lower dose . the maximum dose is 1 mg / kg body weight taken once a day . you can take this dose with or without food . take the tablets at about the same time each day , with or just after food ; however , if this dose is not enough , you can start at any time during the day if it is within 8 hours of the time you usually take it . then the dose may be increased to 4 mg rosif you take rosinglit azone 1000 mg if your daily dose is too low . metformine , the dose can be increased
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions these are very rare in people taking avandаmet . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact a doctor immediately if you get any of these symptoms . stop taking a avand amet and tell a nurse straight away : lactic acidosis : as a result of high levels of lactic acids in the blood ( lactic ketoacidosis ) is a very common side effect . metformin may cause severe kidney disease . symptoms of l - lacticidosis are : rapid breathing , shaking and tremor rapid breathing difficulty . these are signs of a rare but serious side
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the pack . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don ’ t need . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . avandagemet tablets come in different strengths . each tablet contains 1 mg rosilligtazon 500 mg and metFORMin - each tablet has 2 mg  Rosiglitabazone 500 mg + metformine - every tablet has 1 mg of rosinglit azone 1000 mg and meetformin in one tablet . every tablet contains 4 mg rocigliazone1000 mg and meetsformin the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose , and lactose - rich formulations . the other ingredient is lactoside - derived formulations are : sodium starches glycollates , modified - release tablets , carnauba wax , indigo carmine (
clopidogrel mylan contains clodogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). cloclopidegrel Mylan is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , with an increased risk of atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopdogral myLAN to help prevent blood and thrombocytes and reduce the risk of
do not take clopidogrel mylan 31 if you are allergic to clopdogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking cloclopidorl myLAN . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if your medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if vous suffer from severe liver disease . take special care with clodogral my Lan : take special precautions if any of these apply to you ( or you are not sure ), talk to you doctor or hospital pharmacist before and while taking , or while taking, clonogrela mylan . before taking the medicine , make sure you tell your dentist that you have a risk of bleeding such if 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctoror or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet , twice a day , at about the sametime each day with or just after food . you should take clodogrell mylan for as long
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include yellowing or blackening of skin and eyes ( stevens - johnson syndrome ). these signs may be symptoms of a lung infection . severe allergic reactions 
what clopidogrel mylan contains the active substance is clodogrell . each film - coated tablet contains 75 mg of clopdogral ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clodegrel Mylan contains hydrogenated castingor oil ') and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide (  e172 ), yellow iron oxide , and talc and macrogol 3000 . what clupidograil mylan looks like and contents of the pack the film  - coating is light yellow to light yellow . the film is packed in a plastic bottle . one bottle contains one
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dop Telet is used to treat chronic liver disease associated with low platelet count ( thromocytopenia ) in adults who have undergone a medical procedure to prevent or reduce bleeding involving platelets . platelets are blood cells that help the blood to clot and to stop bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - when you are breast - feeding . warnings and precautions talk to your doctor or pharmacist before taking doptelt . blood clots can form in the veins or arteries and this may increase the risk of blood coagulations . tell your doctor if any of these apply to you . - you have had blood  clottes in the past . your doctor may want to monitor you more closely . take special care with dop Telet - in particular , tell your dentist if your family has a history of blood disorders . you should tell your physician if : you have cancer , you have taken the contraceptive birth control pill or hormone replacement therapy , or you have
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose will be decided by your doctor during your procedure . it is recommended that the dose is given 5 to 8 hours apart . doptelet can be taken with or without food . your doctor may increase your dose of dopelet to 20 mg , 40 mg or 60 mg per hour . this may be increased or decreased by your physician to 5 doses . if your platelet counts are too low , your doctor will increase your daily dose based on your doctor and may adjust your dose if necessary . you should take this medication at least 10 minutes before or 13 hours after your planned medical procedure , so that you can take the medicine at any time of the day . swallow the tablet whole with a glass of water . don ' t
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : common ( may affect up to 1 in 10 people ): feeling tired uncommon ( may effect up to1 in 100 people ), low red blood cell count ( anaemia ), blood clot in the portal vein ( a blood vessel that connects the liver and intestines ), upper abdominal pain and swelling bone pain muscle aches fever reporting of side effects 10 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatarombog maleate equivalent to 20 mg avatombopag ( 20 mg per tablet ). -the other ingredients are : lactose monohydrate ( see section 2 " dopelet contains lactoses "), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , the printing ink : talc , macrogol 3350 , titanium dioxide ( e171 ), and iron oxide yellow ( ile ). what dopetelet looks like and contents of the pack dopellet 20 mg tablets are pale yellow to orange , round and rounded . they are marked with ' 20
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by looking at the inside of the heart arteries , to measure heart rate . it also helps to identify muscles that are important for your heart . rapistcan is used for a type of heart scan called a ' myocardial perfusion imaging ' in adults . the scan contains a radioactive substance called opa ( called  a ‘ radiopharmaceutical '). these images allow the doctor to obtain more detailed information about the muscles and heart , using the help of a treadmill . this can help to provide more information on the function of your heart in adults and children . when a scan is performed , it is usually done by a doctor who has taken a small amount of radiopharmaceutic in the body , such as an
do not use rapiscan if you have : slow heart rate , high degree heart block , sinus node disease or a pacemaker . chest pain ( unstable angina ) if no treatment is available . low blood pressure ( hypotension ) or heart failure if your doctor thinks you are allergic to regadenoson . if any of the above applies to you , tell your doctor before using rapissecan . warnings and precautions talk to your doctor or pharmacist before using this type of medicine . children and adolescents rapistcan can be used in children and teenagers aged under 6 years . you should not use this type in children younger than 6 years since the use of rapscan has not been studied in this age group . talk to the doctor or nurse before using the product if : you have had a recent serious heart problem such as a heart
rapiscan will be administered to you by a doctor or nurse . the dose will depend on your heart and blood pressure . your doctor will take special care for you . rapican is given into a vein over a period of 400 minutes . in a 5 ml solution the injection will be given over 0 . 5 - 10 minutes based on your weight . you will also receive an injection of sodium chloride 9 mg / m2 ( 0. 9 %) solution for injection . after the 5 % solution you will receive a radioactive substance ( radiopharmaceutical ) which will be used . how much rapissecan is used your doctor and will decide how much medicine you will be receiving , and how often . it will depend upon your heart rate . this will depend partly on your chest rate and blood  pressure ; the rapist
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects reported with the rapistcan injection are usually mild to moderate and of a short duration . they usually disappear within 30 minutes after any treatment and are most likely to be temporary . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : sudden stopping of the heart , damage to the heart or heart block , which is a disorder of the hearts electrical signal which sends out rapid heart beat low blood pressure which can lead to fainting , mini strokes , weakness of the face and inability to speak . rapican may also be used in adults for the treatment of : a stroke or cerebrovascular accident , an allergic reaction which may include rash , wheals / weals , or a skin reaction that may
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penipis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . Viagra is a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard , semen suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). -if you take medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used to treat angina pectoris ( or " chest pain "). if they are used in combination with the medicines containing nitric oxide donors such as amyl nitsitrite (" poppers "), as the combined combination may also lead to such a disastrous fall in votre blood pressure this may be more serious . if your doctor has given you riociguat , this drug is used to relieve pulmonary arterial hypertension ( i .e ., high blood pressure in the lungs ) and chronic thromboembolic
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg . you should not take viagra more than once a day . if necessary , you may take viagra film - coated tablets or viagra orodispersible tablets with or without food . take viagra about one hour before you plan to have sex . swallow the tablet whole with some water . viagra will only help you to get an erection if your partner is sexually stimulated . it is important to keep taking viagra until your doctor tells you otherwise . taking viagra will help you if it does not help you in any way . when you take it once , it will only take one hour to complete sexual intercourse . do not take more than the recommended dosage of viagra . depending on the results 
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are normally mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat . chest pains - get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections : this occurs rarely ( may occur with up to1 in 1 , 000 people ). if an errand is not successful , you should contact 
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( à - 6666 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue coloured with a rounded - diamond shape and engraved with ' 25 ' on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamous receptors in the brain . stimulation of the dopami receptors triggers nerve impulses inthe brain that help to control body movements . siffrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons '
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sfrol . tell your doctor if any of these apply to you . siffrol is not indicated for the treatment of any medical conditions or symptoms you suffer from kidney disease . it is important that you tell your physician if your child has had hallucinations ( seeing , hearing or feeling things that are not there ). most hallucingations are visual . dyskinesia ( e .g . abnormal , uncontrolled movements of the limbs ). if the patient has advanced parkinson ' s disease and is also taking levodopa , you may develop dyskineia more quickly . the use
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : - sifrol is to be taken daily , with or without food . - you must eat a meal or a snack within 3 hours of starting a diet . in the first week , the usual dose is 1 tablet of sIFrol 0 . 088 mg twice a day ( corresponding to 0. 264 mg daily ). after 1 week - the usual starting dose is 2 tablets of  if your doctor has reduced your dose to  1 tablet , sIfrol 0- 088  mg twice daily . this will be repeated every 3 weeks , until your symptoms are controlled ( maintenance dose ). - your doctor may adjust your dose if needed and may adjust the
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in10 people uncommon may affect up to1 in 100 people rare may affect less than 1 person in 1 , 000 people very rare may impact up to 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects as a result of : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion -
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg or 0 in 0 35 mg . one tablet contains approximately 0 7 . 7 mg pramipexole as 0 " 0 1 . 125 mg / 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye ( allergic conditions that affect the surface of the eyes ). the allergic reaction is caused by the presence of some materials ( allergens ) in the airways that cause allergic reactions such as itching , redness and swelling . these effects are usually mild to moderate and usually disappear after a few days . e madine is placed on the surface surface of your eye if you feel worse .
do not use emadine if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . warnings and precautions children and adolescents do not give e madine to children under the age of 3 years . do not expose your child to benzalkonium chloride , which is a common substance in the body . in children and teenagers , ema - related substances have been shown to increase the safety and efficacy of ebindine in children under 6 , as benzasine has been used in clinical trials . therefore , you should be careful until you are used to the effects of еmadine on kidney or liver problems . talk to your doctor or pharmacist before using emarine . other medicines and emagine tell your doctor if your child is using , has recently used or might
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes 3 . - use in children 2 years of age and older - do not use this medicinal product for children under the age of 2 years - this is a two - step process process : 1 ) open the emadine bottle and wash your hands . before opening , remove the bottle and discard the cap . after cap is removed , snap collar is loose . hold the bottle , pointing down , between your thumb and finger . tilt your head back . pull down your eyelid with a clean finger , until there is  a ' pocket ' between the eyelid and your eye . use the dropper as described below . it could infect the drops
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . common side effects ( may affect up to 10 people ) effects in the eye : eye pain , itchy eye , and eye redness . uncommon side effects that may affect more than 1 in 100 people ] effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , eye irritation , blurred vision , corneal staining , increased tear output , redness of the eye and increased tear producing eye pain and redness in the eyes . reporting of side effects 25 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . if any side effect gets serious , or if
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . to prevent infections . your doctor will check your return of e madine .
what emadine contains the active substance is e madastine . each ml contains 0 . 5 mg of difumarate . the other ingredients are benzalkonium chloride , trometamol , sodium chloride and hypromellose . purified water , hydrochloric acid and sodium hydroxide to keep acidity levels normal ( ph levels ). what  ebadine looks like and contents of the pack emedine is a liquid ( a solution ) supplied in a 5 mL or 10 mlitre plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epilemology . epilemplepsy is a condition where the patients have repeated fits ( seizures ). the epilepian form involves the fits first affect only one side of the brain , but could thereafter extend to larger areas on both sides of the mind ( partial onset seizure with or without secondary generalisation ). in this case levetiragetam may be used in combination with other antiepic medicines to treat partial initiation seizures with or after generalisation in adults , adolescents , children and infants ( 12 months of age ) and children ( 12 weeks of age and above ) with
do not take levetiracetam actavis - if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetiratetam actingavis and if any of these apply to you : - have kidney problems , follow your doctor ' s instructions . - notice any slow down in the growth or unexpected puberty development of your child . in a small number of people being treated with anti - epileptics such as levetiretam actsavis have had thoughts of harming or killing themselves . you should immediately inform your doctor of any symptoms of depression and / or suicidal ideation . tell your doctor or pharmacist if during your treatment you develop any of its many side effects , including
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take one tablet of levetiracetam actavis twice a day , once in the morning and once inthe evening , at about the same time each day . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 3 . 000 mg each day when you take levetiretam actingavis , with or without food . when your daily dose is 1 - 8 , 600 mg , you or your child may take 2 tablets of 1  , 500 mg each night . add - on therapy dose in adult and adolescents aged 17 years and over who weigh 50 kg or more : general dosage : entre 1 . 1 mg and 3,000 mg each week
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes seen in blood tests ; an increase in a type of white blood cell ( eosinophilia ) and enlarged lymph nodes ( drug reaction ).
what levetiracetam actavis contains - the active substance is called levetiractam . one tablet of levetiretam actionavis 250 mg contains 250 mg of levracetm . levetiratetam amenitif you weigh 500 kg or more , you will be given 500 mg of the active ingredient . the same tablet of dulbecquerel 500 mg contains 500 mg levetistetam as the active drug . - levetiragetam actingavis 750 mg contains 750  mg of Levetiracem , as the ingredient is carbohydrate . what levrettam actsavis looks like and contents of the pack levetirtam reactavis is a white to off - white tablet , rounded tablet . it comes in a carton containing 1 , 000 mg tablets , and in 
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . incruses ellippta is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs gradually become blocked or damaged . this can cause breathing difficulties , difficulties in breathing and tightening of the muscles around the air sacs . the use of this medicine blocks the tightenling of these muscles , making it easier for air to get in and out of the arteries , improving your breathing difficulties and reduce the effects of copd on your everyday life . ellipe ellipate should not be used to relieve a sudden attack of breathlessness or wheezing
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or nurse immediately . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : - asthma if using incrusese elipta for asthma , you should be aware of the extra risks : heart problems if your doctor thinks you may have an eye problem called narrow - angle glaucoma if any of these apply to you 27 if that applies to your lifestyle if so , talk to you doctor . - an enlarged prostate , difficulty passing urine or a blockage in your bladder . this may be a sign of severe liver problems . immediate breathing difficulties if , for
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . incruse ellipta can be inhaled at the the same times every day , but you can inhalate it at any time of the day if your doctor tells you to use it . it will help to keep you free of symptoms throughout the day and night . when to use incrusese ellpte inhaling incrusite ellippa you should use a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhalers see ' step - by - step instructions for use 
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop using this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 other side effects common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead . not known ( frequency cannot be estimated from the available data ) abnormal breathing ( anaphylactic reaction ) uncommon ( might affect upto 1 in 1000 people ), but may occur with any combination of any of these conditions : fever , chills ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label of the inhaler after exp . the expiration date refers to the last day of that month . keep the inhaled tray in the sealed tray in order to protect from moisture . after first use , the inher can be used for up to 6 weeks . before first use store the inflater in a refrigerator ( 2 - 8 ). do not freeze . when you first use the inHALER , write the date on the ink on the tray and write the month / year printed on the carton . store below 30 . discard the inflamer after this time period . always keep the tray tightly closed in order for the medicine to be used . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose
what incruse ellipta contains the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromide ). the other ingredients are lactose monohydrate ( see section 2 under ' incrusite ellippa contains lactoses ') and magnesium stearate . what increse
nucala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils , another type of white blood cell that circulates in the lungs . eeosomophilic asthma is causing asthma nucalá helps to control asthma attacks . it is used when medicines such as high dose inhalers are not suitable for you . your asthma may get worse if you use more of these medicines than they should . you may also be given medicines called oral corticosteroids . nucalа is used if your asthma is not controlled enough with mepoliumab or interleukin - 5 . the activity of this protein is shown in tests .
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using this medicine if : you are suffering from worsening asthma 58 you are more likely to get asthma - related side effects if your asthma is not controlled with nucalа . your doctor will monitor your asthma and will adjust your nucalala treatment if necessary . you are also allergic to animal ( human ) injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the body . see section 4 for more details about possible side effects and how to prevent a similar reaction . if any of these apply to you , tell your doctor or nurse before using nucale . parasitic infections nucalá can reduce your resistance to infections
nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms / kg given once every week . your doctor will decide how many injections of 100 microgram /kg given once a week for 1 week , starting at the lowest dose . use the pre - filled pen at the same time each day . you will find an alternative to injecting nucalá at the start of treatment . if you use more nucalа than you should if the treatment has been interrupted , you should contact your doctor . nucalala may affect the way your body responds to the treatment , nucalat may improve your asthma symptoms and attacks . tell your doctor as soon as possible if your asthma problems get worse . injections with nucalak can be given if more than one injection is needed . it is important that you do not miss a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ). they usually occur within minutes or weeks after the injection . sometimes symptoms may include chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you think you may have had a reaction similar to , or if your doctor thinks you might have a different reaction . if a child gets any of these symptoms , contact a doctor or nurse immediately . very common ( affects more than 1 in 12 people ): feeling very tired ( fatigue
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the nucale pre - filled pen in the outer carton in order to protect from light . after first opening , use within 7 days . discard after 7 days of first opening the pen .
what nucala contains the active substance is mepolizumab . 1 ml contains 100 mg of mepolizamab the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate / polysorbate 80 , edta disodium dihydrate and water for injections what nukala looks like and contents of the pack nucalа is presented as a solution for injection ( injection ). the solution is clear and colourless . nucalá is available in packs containing 1 , 2 mL or a pack containing 2 x 1 - m2 or , in multipacks comprising 3 packs , each containing one 1 . not all pack sizes may be marketed .
what ninlaro is nINlaron is a cancer medicine that contains the active substance ixazomib , also known as a ' proteasome inhibitor '. what nicotinlarao is used for nninlano is given to treat adult patients with a type of cancer of the bone marrow called multiple myeloma . ixizomibe is used in cell survival to kill myelama cells , which contain a lot of proteins called proteasoms that play a role in the process of dividing them . what is ' n inlarone '? ninninglaroop is used to treat adults with multiple myélomyelma when other treatments have not worked . the active substances of ninklarou are lenalidomide and
do not take ninlaro : - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking nninlaaro and during treatment . warnings and precautions talk to your doctor or pharmacist before taking and during your treatment with nINlar : you should have blood tests to make sure that you have enough blood cells . children and adolescents do not give this medicine to children under 18 years of age . other medicines and ninninglaron tell your doctors or pharmacist if any of these apply to you or your child . if your doctor thinks this applies , do not use ninklarooooooooooooong if : your doctor has not checked or approved nihoea . before you start taking a
ninlaro is used to treat multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nninlaaro must be taken together with lenalidomide , a medicine that is similar to dexamethasone , an anti - inflammatory medicine . the recommended dose of n inlaron with lendalidome and dexathasone is one 4 - week treatment cycle . you will take nINlaroooo once a week on the same day of the week for the first 3 weeks , followed by 4 weeks without lenaldomide and 25 mg dexalathason . your doctor will tell you how long you should continue to take .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet( peripheral oedema ) skin rash ( itchy ) anywhere on the body . rare side effects may affect up to 1 in 1 , 000 people : allergic reactions ( hypersensitivity ) swollen lymph nodes ( rhinitis ) abnormal blood test results ( tachycardia ). if you notice any of these symptoms , tell your doctor immediately . reporting of side effects 25 if your doctor gets any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the original carton in order to protect from light and moisture . once the capsule has been opened , use the contents immediately . this medicinal product does not require any special temperature storage conditions . please do not take this medicine if you notice any damage or signs of tampering of medicine packaging . return the pack to your pharmacist . these measures will help protect the environment .
what ninlaro contains - the active substance in nnlaron is 2 . 3 mg ixazomib . each capsule contains 2 , 3 mg of ixizomibe ( as mesilate ). the other ingredients are 3 . 4 mg xazomimib citrate , microcrystalline cellulose , magnesium stearate and talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( d ) and shellac , propylene glycol , potassium hydroxide and black iron oxide . ninelarro 3 mg hard capsules contain ixazamia . one capsule contains 3 mg ( 8 mg ) ixazmid . two capsules are contained in a plastic bottle . not all pack sizes may be
do not use palforzia - if you are allergic to peanuts or arachis hypoogaea . do not give palforizia if any of the above applies to you . if your doctor thinks this applies to your situation , talk to your doctor before you are given palforziea : - children and adolescents ( aged 4 to 17 years ) do not start treatment with palforezia and your doctor will check if the product is suitable for your child . warnings and precautions talk to you doctor or pharmacist before you receive palfor zia , - when you have peanut allergy or peanut ( sensitisation ) to peanut ( desensitisation and / or sensitivity to peanut ) during treatment with paleforzio . your doctor may decide to monitor you for allergic reactions whilst you are receiving palforzaa ; - during the 
do not take palforzia - if you are allergic to severe asthma or any of the other ingredients of your asthma ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking palforizia . if your asthma is not controlled with palfor zia ( if a problem swallowing is common ), or if there are long term problems with your digestive system ( e .g . you have a severe mast cell disorder or severe or life - damaging anaphylaxis ) you must wait 60 days after stopping treatment with your palforza . do not stop taking pal forzia without talking to your physician first . it is important to stay on the diet and exercise recommended by your doctor while you are taking palfordzia and during the symptoms described above . peanut allergy : you should not take paleforzio if an allergic reaction occurs 
do not use this medicine if you or your child : - has a history of allergy . - suffers from allergic reactions ( anaphylaxis ) within 3 months of starting treatment with palforzia . initial dose escalation is the first of these treatment phases . the initial dose delamination and up - dosing phases are defined as follows : treatment with paleforzio you will receive palforizia under the supervision of a doctor experienced in the treatment of desensitisation . you will usually feel more unwell after your first day and your doctor will monitor you during this time period . your doctor may monitor you for signs of initial dose elevation and thereafter . palforza should be taken at regular intervals during the first day of treatment . this will usually be followed by a 5 - day break . during this period , you may be monitored
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions tell your doctor or nurse straight away if you have any of the following symptoms after taking palforizia . they are usually mild to moderate and generally go away within one week of taking the medicine . - the reaction may include : trouble breathing - throat tightness - feeling of fulness - trouble swallowing and speaking - changes in voice - dizziness and fainting - extreme stomach cramps and pain - vomiting , diarrhoea - serious stuffy or severe flushing or itching of the skin palfor zia may cause problems with the stomach and digestive system . tell your physician or nurse if your child gets any of these symptoms . side effects are listed below . very common :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store below 25 . this medicine must be used immediately . any hard lumps of powder should be discarded .
what palforzia contains the active substance is palforza 0 . 5 mg / ml , in capsules of 1 , 10 or 20 mg . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforizia 100 mg powder for oral powder in capsule contents after opening microcrystalline hard capsules , with colloidal anihydrous silicon and magnesium strarate paforzio 300 mg powder in sachet microcrystalline cell , combined with collooidal anhydrated silicA and magnesium steel . beige oral powder for preparation prior to initial dose escalation ( see section 2 ). palforezia is available in packs containing 3 , 13 or 5 single - dose blisters . not all pack sizes may be marketed .
zerene belongs to a class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions , and which can help you sleep . sleeping problems do not usually last long , so it is important to check the duration of treatment before you start taking zerent . the maximum duration of therapy should not exceed one night . if you have problems sleeping after you have finished your capsules , contact your doctor again .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zere sleep apnoea syndrome ( see also ' other medicines and zerence ') if your child has had short periods of severe kidney or liver problems . if the child has myasthenia gravis ( very weak or tired muscles ) - if there is no breathing or chest problems - in children and adolescents under 18 years of age . the use of zeene has not been studied in children or adolescents because the undesirable effects are not known . please tell your doctor if any of these apply to your child . warnings and precautions talk to your doctor or pharmacist before taking zerent . you should tell your physician if : you suffer from any undesirable effects of any medicine you take or give any
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a night , unless you have difficulty falling asleep . do not take zene if the above applies to you : - if your doctor tells you to take a different dose . - for people who are 65 years of age or older , and people with mild to moderate liver problems : 65 years or older take the 5 mg capsules once - daily dose if there is something you don ' t feel right after taking the 5 - mg capsule , the content of the capsule will change colour and become cloudy . in this case , your doctor may decide to reduce your dose or stop treatment altogether . your doctor will advise you how long you should continue to take the capsule and how long to keep
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect 1 to10 users in 1 , 000 ) rare ( affect affects only 1 toten users in 10 users per 10 , 10 % of the population ) very rare ( effect effects in less than 1 per 10 users , less than 10 users within 10 . 0 / 10 ml ) not known ( frequency cannot be estimated from the available data ) as for all medicines that are not marketed , it is not known if zere is having any side effects in your healthcare system . you can
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide (  e171 ). ingredients of the capsule shell : gelatin , titanium dioxide  ( е171 and e172 ), red iron oxide ( , yellow iron oxide ), black iron oxide( e 172 ) and sodium laurryl steate . printing ink : shellac , lecithin , simethicone , and yellow iron dioxide ( the e 171 ) what rozene looks like and contents of the pack zerentene is 
